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ABSTRACT 
 
The American Academy of Operative Dentistry cites glass polyalkenoates (Glass 
Ionomer) as the material of choice to restore root surface caries lesions. 
Although apparently successful in the majority of cases it is not always possible 
to achieve a reliable seal from the oral environment when such lesion extends 
subgingivally. This is due to haemorrhage impeding placement and attachment 
of displaced gingival tissues.   
This in vitro project comprises two inter related strands; 
a) A postal survey of UK and Libyan dentists to ascertain their management 
strategies on root surface caries. 
b) An investigation into the biocompatibility of two currently available 
glass polyalkenoates (GC Fuji VIII, ChemFil Superior) in manufactured 
form and in biologically modified forms to promote cellular attachment. 
Where results indicated this was appropriate to do so.  
In addition the properties of surface hardness, strength [compressive, 
diametral, flexural (3 point and biaxial)], diametral fatigue strength and 
adhesive bond strength were determined prior to and following addition.  
The results indicated that in Libya root caries was more often on interproximal 
surfaces than in the UK. Gingival bleeding was a common clinical problem at 
restoration placement. Additions of Type I Collagen and RGD to ChemFil 
Superior improved all physical properties measured except shear bond strength 
where no detriment was observed.  GC Fuji VIII was shown by cell observation 
and viability tests not to be as biocompatible as ChemFil Superior. 
Cell attachment to ChemFil Superior with the above addition was demonstrated 
by MTT. It is concluded that this approach has clinical potential to improve the 
restoration of root caries. 
1 
 
1 INTRODUCTION 
Root surface caries is both prevalent and difficult to treat. Behavioural, cultural 
and age related changes play on an individual’s susceptibility to this condition.  
Where prevention has failed operative intervention is required. In this process the 
gingival tissues become displaced and traumatised and the clinician is faced with a 
cavity extending downwards towards the root apex amidst blood from the gingival 
tissues. Under such circumstances a restoration of resin composite, due to 
appalling moisture control, is not going to work. Both dental amalgam and glass 
ionomer whatever offer some prospect of success. The latter also promises slow, 
fluoride release with the potential to seal the cavity by nature of its adhesive 
properties. Thus any residual caries may be deprived of its nutrient supply. This 
effective seal is however fragile for the cavity preparation often results in loss of 
tooth attachment to the gingival tissues. The incorporation of biopolymer 
additions to the material could offer cellular adhesion potential to reform this loss 
of attachment. To date little work has been carried out to address this possibility 
and this thesis therefore seeks to explore this possibility in some detail. 
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2 LITERATURE REVIEW 
This literature review examines the origin and development of glass ionomer 
(glass polyalkenoate) cements and the treatment of root surface caries. It also 
explores manipulation of the behaviour of fibroblasts with emphasis upon 
achieving this to promote cellular attachment to dental restorative materials used 
to treat subgingival root caries. 
2.1 GLASS IONOMER (GLASS POLYALKENOATE) CEMENTS 
The glass-Ionomer cements were first developed at the laboratory of the 
government chemist by Wilson and Kent in the early 1970s (Wilson and Kent, 
1972). They were derivatives of the earlier dental silicate and zinc polycarboxylate 
cements. The dental silicate cement is the result of a hardening reaction between 
an alumino-silicate glass (powder) and an aqueous solution of phosphoric acid 
(liquid) (Wilson and McLean, 1988). The resultant material has an appearance 
similar to tooth enamel, a high compressive strength, a coefficient of thermal 
expansion value that is equivalent to the tooth tissues and cariostatic properties as 
a consequence of the slow release of fluoride ions (Wilson and McLean, 1988).  
The zinc polycarbcarboxylate cements consist of a zinc oxide powder and a poly-
acrylic acid liquid (Smith, 1968). When the polyacrylic acid (liquid) is mixed with 
the zinc oxide (powder) the zinc ions react with the polyacid molecules linking 
them together in a gel like structure. The adhesion of the cement to the tooth is due 
to interaction of the polyacid with the calcium ions of the tooth structure (Smith, 
1968).  
The glass ionomer cements consist of an ion-leachable glass (powder) and a poly 
(alkenoic) acid (liquid).These components react together to form a tough cement 
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(Walls, 1986). The material combines the strength, rigidity and fluoride release of 
the dental silicates with the biocompatibility and adhesive characteristics of the 
poly acrylic acids and is an aesthetically acceptable adhesive restorative material 
(McLean and Wilson, 1977a). Since such developments a number of modifications 
and changes have been carried out to both the glass ionomer powder and liquid 
with a view to improving the properties of these materials (Moshaverinia et al., 
2012).  
 
2.1.1 TYPES OF GLASS IONOMER CEMENTS 
The term glass ionomer refers to a material that involves a considerable acid–base 
reaction as part of its setting process, where the acid is a water-soluble polymer 
and the base is a special glass (McLean et al., 1994). Two types of glass ionomer 
cement presentation exist; the conventional, prepared from a glass powder and a 
concentrated solution of a polyalkonic acid (Wilson and Kent 1973), and the resin 
modified glass ionomer. In recent years such materials have been renamed glass 
polyalkenoate cements by the International Standards Organisation (ISO), a term 
that better reflects their setting chemistry. Both terms glass ionomer and glass 
polyalkenoate are used in this thesis. 
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2.1.1.1 CONVENTIONAL GLASS IONOMERS CEMENT 
The conventional glass ionomer cement is considered to be the simplest form of 
glass ionomer cement; it is formed by an acid-base reaction between an ion 
leachable glass and a poly acid (Culbertson, 2001). Its setting reaction includes the 
neutralization of acid groups of a water-soluble acid polymer by a chemically basic 
powder. The powder is a special calcium alumina-silicate glass that also contains 
fluoride. Incorporation of this last element is an important feature of this material 
because it enables it to release clinically useful quantities of fluoride to 
theoretically prevent the occurrence of recurrent caries around restorations 
(Swartz et al., 1984).   
 
2.1.1.2 RESIN MODIFIED GLASS IONOMER CEMENT (RMGI) 
This type of glass ionomer cement is also known as a visible light cured (VLC) glass 
ionomer cement. It is a hybrid type of material, which cures by both a free-radical 
resin polymerisation and an acid base neutralisation reaction. The resin  modified 
glass ionomer cements (RMGI) therefore set partially via an acid-base reaction and 
partially via a photochemical (visible light) or redox polymerisation process 
(Culbertson, 2001).  
 
2.1.1.3 MISNAMED GLASS IONOMERS CEMENT 
Other materials marketed by some companies as ”light-cured glass ionomer”, are 
basically resin composites, even though these materials contain the 
fluoroalumioslicate glass of conventional glass ionomer cement. However, these 
materials do not have the good adhesive properties of glass ionomers and release 
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lesser quantities of fluoride. They also tend to contract during setting (Nicholson, 
1997).   
 
2.1.2 COMPOSITION OF GLASS IONOMER 
The compositions of commercial glass ionomer cements differ and are complex. No 
two commercial products of glass ionomer are chemically identical. All glass 
ionomer products however share certain common elements (Wilson and McLean, 
1988). The original glass ionomer cements were formed by a reaction between 
polymers of polyacrylic acid with a powder that contained a calcium fluoro-
alumino-silicate glass (Kent et al., 1973). Since then, in an endeavour to improve 
their properties, lots of changes and modifications to both the powder and liquid 
components of the original glass ionomer cement have been made. These have also 
been carried out to circumvent patented technology and bring to the market 
products of rival manufacturers. A consequence of this is that there are 
considerable differences in the composition and properties of commercial types of 
glass ionomer materials to cater for different applications and uses (Moshaverinia 
et al., 2012).   
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2.1.2.1 GLASS COMPOSITION 
The original ion leachable glasses were based on a calcium alumino-silicate glass 
with high fluoride contents known as G200 (Table2-1) (Wilson and McLean, 1988). 
This was the culmination of much research effort that resulted in a glass optimised 
for chemical reaction that yielded the most desirable physical properties.  
Table ‎2-1 The composition of the original   glass ionomer (G-200) (modified from Wilson and Mclean 
(1988)). 
 
 
 
 
Fluoride is an important component of ionomer glass; at manufacture it decreases 
the temperature of glass fusion, improves working properties of the cement paste 
and increases the strength of the set cement. Moreover, it has some therapeutic 
effects on the restored tooth (Wilson and McLean, 1988) though this last property 
is disputed by some (Mickenautsch et al., 2011). 
The inclusion of Silica (SiO2), Alumina (Al2O3), and Calcium Fluoride or Fluorite 
(CaF2) enables the formation of a glass that is a fusion of these compounds. They 
produce a glass suitable for reaction with a polyacid with subsequent formation of 
a dental cement (Wilson and McLean, 1988). 
The glasses are formed by fusing the raw components at high temperatures 
between 1100 °C and 1500 °C (the fusing temperature is depended upon the 
materials used to make the fusion mixture) in a sillamite crucible, then pouring the 
resultant molten glass frit onto a metal plate, that is quenched in cold water. One 
solidified the glass is then ground to give an ultimate particle size of no more than 
Component Percent (%) 
SiO2 30.1 
Al2O3 19.9 
AlF3  2.6 
CaF2 34.5 
NaF2 3.7 
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50 µm in diameter for restorative cements and 20 µm for luting cements (Wilson 
and McLean, 1988). 
The physical properties of the set glass ionomer may be improved by adding some 
non-matrix-forming inclusions into the glass (Walls, 1986). Metallic inclusions 
fused to glass offered potential to improve the physical properties of the set 
cement, for example the inclusion of crystallites of Corundum, Rutile, Aluminium 
Titanate and Baddeleyite into the glass were found to improve the flexural 
strength of the set cement (Walls, 1986). These found application in commercial 
products such as the cermets when gold and silver were used. It would however be 
true to say that these materials have found limited clinical application by clinicians 
in the UK (McLean, 1992). 
 
2.1.2.2 LIQUID COMPOSITION 
In the early glass ionomer cement, a 50 % aqueous solution of polyacrylic acid was 
used to react with the glass powder (Walls, 1986). This solution was unstable and 
prone to gelation during storage, due to a slow increase in the number of hydrogen 
bonds within the solution (Crisp et al., 1975, Walls, 1986). Some different types of 
polyacids used to form glass ionomer cement are shown in Figure 2-1. The 
functionality and strength of these poly acids differs depending on the acid 
structure and the molecular weight and concentration of the acid (Lohbauer, 
2009). The poly maleic acid has double the number of carboxyl groups than the 
polyacrylic acid and is a stronger acid (Wilson and McLean, 1988). It is more active 
and therefore needs less reactive glasses than those used in combination with 
polyacrylic acid in order to form a set material  (Wilson and McLean, 1988).  
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Figure ‎2-1 Polycarboxylic acids used to form Glass ionomer cements (Lohbauer, 2009) 
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The polyacid can be presented either in the form of a 40% to 50% aqueous 
solution of the poly acid or as a freeze-dried poly acid mixed with glass powder. In 
the latter case  the setting  reaction is started by mixing with either water or an 
aqueous solution of tartaric acid (McLean et al., 1984).  
The addition of small amounts of optically active isomers of tartaric acid increases 
the rate of the setting reaction and also the ultimate compressive and tensile 
strength of the glass ionomer cements. Such an addition however, has no 
significant  effect on  the working time of the material (Wilson et al., 1976 ).  
 
2.1.3 THE SETTING REACTION 
The setting reaction of the glass ionomer cements is complex and differs according 
to the composition of the material (Culbertson, 2001). The setting reaction of glass 
ionomers is principally an acid-base reaction between the poly (alkenoic) acid and 
the glass particles (Wilson and McLean, 1988).  
Three overlapping phases are distinguishable in the setting reaction of glass 
ionomers (Figure 2-2) (Crisp and Wilson, 1974b);   
1- Initial poly-acid attack upon the outer layer of the glass particles in which 
ion leaching occurs. 
2- Precipitation process and salt hydrogel formation. 
3- Reaction and diffusion processes that continue for several months. 
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Figure ‎2-2 Glass ionomer setting reaction stages 
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The setting reaction starts by the attack of the poly acid upon the surface layer of 
the glass particles in the presence of water, this releases cations, (mainly calcium, 
aluminium, and fluoride ions from the glass) to form a silaceous hydrogel 
(Culbertson, 2001). 
The liberation of metallic ions is facilitated by the presence of chelating agents 
such as D-Tartaric acid (Wilson et al., 1976 , Prosser et al., 1982).  
An increase in pH and concentration of soluble ions derived from the glass 
demonstrate that the initial reaction is an acid base one where the powder acts as 
a proton acceptor and the liquid a proton donor. The essential change is that 
hydrogen ions in the liquid are replaced by metallic ions (Crisp et al., 1974). 
In the early stages of the reaction the calcium salt (calcium poly-acid) alone is 
formed (Crisp et al., 1974). This corresponds to gelation and the initial set of the 
material. Final hardening occurs as the aluminium salt (aluminium poly-acid) is 
formed (Crisp et al., 1974) 
The hydrogel may be considered as the materials binding matrix. Inter and 
intramolecular salt-bridges are formed within the poly acid by their release the 
calcium and aluminium ions, form a hard cross linked, ceramic like cement, with 
some molecular structures retained in the matrix ( Figure 2-3) (Culbertson, 2001).   
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Figure ‎2-3 Inter-and intramolecular calcium or aluminium carboxylates (salt-bridges) in set glass 
ionomer cements. Where X represents OH⁻ or F⁻ (modified from Culbertson (2001)). 
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The cement undergoes further hardening in the first 24 hours following mixing 
and beyond. During this time translucency develops as the chemical reactions 
continue, the ratio of bound and unbound water increases, and the mechanical 
properties (compressive strength) increase gradually until their maximum values 
are eventually reached (Wilson and McLean, 1988).  
There are a number of factors affecting the setting reaction and the final strength 
of the glass ionomer cement (Wilson and McLean, 1988). These factors include; the 
type and composition of polymers or copolymers, the presence or absence of 
tartaric acid or chelating agents, the composition of the glass powder and the 
powder liquid  ratio used to mix the material (Smith, 1990) .  
The final set structure of the glass ionomer cement consists of the original glass 
particles surrounded by a siliceous hydrogel that is bounded by a matrix phase 
consisting of hydrated fluoridated calcium and aluminium poly acrylates (Smith, 
1990) (Figure 2-4). 
 
Figure ‎2-4 The fully hardened glass ionomer cement the matrix phase and the structure of the filler 
(glass core attached by a silceous hydrogel) smaller particles are completely degraded to siliceous 
hydrogel. (Modified from Wilson and McLean (1988)). 
14 
 
In the laboratory raising the temperature of conventional glass ionomer to 333-
343 degrees Kelvin almost sets such materials on demand and improves early 
compressive strength (Algera et al., 2006).  
 
2.1.4 PROPERTIES OF GLASS IONOMER 
Conventional glass ionomer cements are clinically attractive materials and have 
unique properties that make them useful dental restorative materials. They set 
quickly in the oral environment in three to eight minutes; their translucency 
matches those of the tooth enamel especially in the case of recent commercial 
materials. The glass ionomer cements however are slightly brittle materials though 
they deform a little under load. They display high compressive strengths but 
slightly weak flexural strengths; compared to other dental cements they have a 
higher resistance to acid erosion and have the ability to form permanent adhesive 
bonds to dental enamel and dentine irrespective of the type of glass ionomer. They 
also release fluoride over prolonged periods of time (Wilson and McLean, 1988). 
 
2.1.4.1 THE MECHANICAL PROPERTIES 
Glass ionomer cements are moderately hard brittle materials, that display an 
ability to adhere to mineralized tooth structures (Walls, 1986). In vitro flexural or 
compressive strength testing of glass ionomer cements has been revealed to 
closely model the clinical loading situation (Lohbauer, 2009). Under compressive 
stress the glass ionomer cements (ASPA) (167 N mm-2) were considerably stronger 
than polycarboxylate cements (60-85 N mm-2) but usually weaker than dental 
silicate cements (250 N mm-2) (Crisp et al., 1975). The tensile strength of early 
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glass ionomer cements (ASPA) (10-17 N mm-2) is higher than the tensile strength 
of polycarboxylate cements (6-12 Nmm-2 ) but is almost in the same range as the 
tensile strength of silicate cements (15 Nmm-2 ) (Crisp et al., 1975).  
 
The alteration in composition of the glass powder, by the incorporation of some 
metallic particles has been found to have some effect on the mechanical properties 
of glass ionomer cement (Walls, 1986). Williams et al (1992) compared the in vitro 
mechanical properties (compressive and diametral strengths in addition to tensile 
strength using the four point test) of metal reinforced and non–metal reinforced 
glass ionomer cements. It was found that the reinforced materials displayed 
significantly higher strengths than all the other materials though there was less 
difference in compressive strength. Table 2-2 summarises the mechanical 
properties of ten commercial glass ionomer cements (Xie et al., 2000).  
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Table ‎2-2 The mechanical properties of ten commercial glass ionomer cements (Xie et al., 2000). 
 
Mechanical properties (flexural strength (FS), compressive strength (CS), and diametral tensile 
strength (DTS))  
 
Variations in powder liquid ratio,  the concentration and molecular weight of the 
poly acid, and the proportion of tartaric acid, together with the amount of 
hydration and proportions of loose and tight water of the cement have been shown 
to have some effect on the mechanical properties of the glass ionomer cements 
(Walls, 1986). The effect of these variations on the properties of glass ionomer 
cements properties are summarised in Table 2-3. 
  
Materials FS (MPa) CS (MPa) DTS (MPa) 
Ketac-bond 11.1 (1.1) 222.7 (7.3) 20.0 (0.8) 
α-Silver 31.4 (3.4) 176.0 (6.5) 18.7 (0.9) 
α-Fil 26.8 (3.1) 196.5 (8.3) 18.2 (1.0) 
Ketac-Silver  22.9 (1.9) 211.8 (3.2) 22.1 (1.3) 
Ketac-Fil 22.6 (2.5) 251.2 (10.0) 25.2 (0.6) 
Ketac-Molar 21.2 (3.1) 301.3 (10.1) 23.8 (1.1) 
Fuji II 26.1 (3.9) 202.0 (10.0) 20.1 (0.6) 
Vitremer (Tricure) 82.1 (3.3) 265.3 (7.5) 47.5 (0.9) 
Fuji II LC (Improved) 71.1 (3.6) 306.2 (6.8) 44.4 (1.1) 
Photac-Fil 74.4 (5.1) 243 (7.6) 37.9 (1.7) 
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Table ‎2-3 The effect of component variation on the glass ionomer cements properties (modified from 
Walls (1986)). 
Variable Working 
time 
Setting time Early 
hardness 
Compressive 
strength  
Tensile 
strength 
24-hour 
water  
Leachabl
e 
material 
Increased P : L 
ratio 
Decreased  Decreased  Increased  Increased  _________ Decreas
ed  
       
<38%  Poly-
acid 
concentration 
Unaffected Decreased with 
increasing 
concentration  
 
_____________ Increased with 
increasing 
concentration 
Increased with 
increasing 
concentration 
Decreas
ed with 
increasi
ng 
concentr
ation 
       
Increased 
molecular 
Weight of  the 
poly acid  
Decreased  Decreased   
 
_____________ Increased  Increased  __________ 
P=powder, L=liquid.  
 
More recently the effects upon compressive strength of adding both boric and 
phosphoric acids to conventional glass polyalkenoate have been investigated 
(Prentice et al., 2006). The addition of 1% boric acid decreased the compressive 
strength whereas the incorporation, of up to 2% of phosphoric acid resulted in an 
increase in this property. This was attributed to increased cross linking of the acid 
chains with aluminium. 
Moshaverinia et al. (2008b) demonstrated that copolymers of acrylic acid and N-
Vinylpyrrolidone, with side chains of itaconic acid, improved the physical 
properties (compressive and diametral strength) by increasing the space available 
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for ionic bond formation, with ions from the glass particles, and permitting more 
flexibility in the side chains. Concentration of these polymers was critical with 
detriment to properties if too high. The same workers also explored the synthesis 
and incorporation of nano-hydroxyapatite and fluorapatite particles into 
commercially available glass-ionomer powders. These enhanced mechanical 
strength. (Xie et al., 2005). 
When applied to glass ionomer tethered amino acid residues have the results of  
1- Providing greater degrees of freedom for the pendant carboxylate ions to 
form salt bridges with the Ca2+ and Al3+ ions released from the glass particles. 
2- Enhance the degree of adhesion to tooth structure as a consequence of 
more availability of –CO2H residues (Culbertson, 2001). 
It is well documented that the powder : liquid ratio at which the cement is mixed 
impacts on the physical properties (Crisp et al., 1976). Encapsulation reduces the 
potential for such variation and results in better physical properties (Dowling and 
Fleming, 2009). In the case of hand-mixed glass ionomers improvements in mixing 
characteristics result from granulation of glass particles at manufacture (Syrek, 
2006). This increases the wetability of particles upon exposure to polyacrylic acid 
and, from a health and safety perspective, reduces the potential for dust. In 
addition, such cements are easier to proportion as they adhere less to the 
manufacturers supplied proportioning spoon (Syrek, 2006). 
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2.1.4.2 SOLUBILITY AND EROSION OF GLASS IONOMER CEMENT 
The glass ionomers, zinc polycarboxylate/ phosphate and silicate cements show 
many similarities in structure as they are formed by acid- base reactions with a 
highly cross linked ionic matrix. These materials are thought to have equal 
susceptibility to aqueous or acid erosion. Aqueous erosion values reported using 
disc specimens made to BSI specification BS3365, are; 0.4 percent for Glass 
ionomer cement (ASPA IV), 0.5 percent for silicate cement, and 0.2 percent for 
polycarboxylate cement (Wilson, 1976 ). Crisp, (1980), found that the glass 
ionomer cements displayed more resistance to acid erosion in vitro than silicate or 
zinc polycarboxylate cements. Olio  (1984) found that the glass ionomer cements 
were more susceptible to the erosion within the first 5 to 10 minutes of 
preparation. The rate of erosion of glass ionomer cement declined dramatically 
thereafter as the time after mixing increased.  The amount of erosion of glass 
ionomer cement is dependent upon the pH of the eroding acidic solution and the 
stability constants of the complexes formed between aluminium or calcium and the 
acid anions (Walls, 1986). 
 
2.1.4.3 FLUORIDE RELEASE 
The fluoride release from some restorative materials has been known to have a 
localised caries inhibitory effect (Lind et al., 1964). The mechanism of fluoride in 
preventing caries is complex and not fully understood (Wilson and McLean, 1988). 
Its anti-caries effect has been attributed to the uptake of fluoride by enamel apatite 
at hydroxyl sites, and to the high levels of fluoride on the tooth surfaces that 
increase the resistance to plaque acids. Fluoride may also change  the composition 
of the bacterial plaque and its biochemistry (Wilson and McLean, 1988). The glass 
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ionomer cements release fluoride by a similar mechanism to that of silicate 
cements (Mount, 1995). The glass ionomer cements too, including the resin 
modified types, are capable of releasing considerable amounts of fluoride. Perrin 
and his co workers (1994) reported that fluoride release from four different types 
of glass ionomer cements over a year followed a similar trend but differed in 
amount. In the first few days  glass ionomer cements released a large amount of 
fluoride and thereafter the quantity of released fluoride decreases to a constant 
amount over a prolonged period of time (Creanor et al., 1994). The rate of fluoride 
release from glass ionomer cements depends on many factors that are not fully 
understood (Perrin et al., 1994). Of these the acidity of the surrounding 
environment and the powder liquid ratio have an effect on the rate of fluoride 
release (Cranfield et al., 1982). It should also be noted that Creanor and his co 
workers (1994) reported that the glass ionomer cements also posses an ability to 
take up fluoride again when its concentration is higher in the environment 
surrounding the restoration than within it (Creanor et al., 1994).  
A mathematical equation has been proposed by Xu and Buryess (2002) to model 
fluoride releases from both conventional and resin modified glass ionomers. 
                
         
Where [F] = Fluoride concentration  
 C= Cumulative  
 I= Initial  
 t= Time.          Both b and β are mathematically derived constants.  
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2.1.4.4  ADHESION 
In common with the glass polycarboxylate cements the glass ionomer cements 
have an ability to adhere permanently to untreated enamel and dentine under 
moist conditions (Wilson and McLean, 1988). This may be helpful in the 
restoration of root caries lesions where moisture control is often suboptimal. The 
exact mechanism of adhesion of glass ionomer cements is unclear (Walls, 1986). 
Wilson and Kent (1972) thought that the metallic ions in the set cement could 
make salt bridges between the poly acid and the negatively charged groups on the 
enamel surface. It seems that the adhesion of the cement with tooth structure 
occurs following displacement of phosphate ions from the surface of the tooth, 
with the place of  each displaced phosphate ion being replaced with a calcium ion 
to retain electrolytic balance (Mount, 1998). An elegant mechanism of adhesion to 
tooth has been described by Van Meerbeek et al. (2006). They describe an initial 
micromechanical interlocking with the hydroxyl apatite coated collagen fibril 
network of dentine fostered by the self etch effect of the polyacid component of the 
glass ionomer. Thereafter substantive ionic bonds are formed between the poly 
carboxyl groups of the glass ionomers poly acid and the calcium ions of the tooth. 
In the oral cavity following tooth preparation, the tooth surface is usually covered 
with a smear layer. An improvement in adhesion between the glass ionomer 
cements and the cavity enamel and dentine surfaces can be achieved by treating 
and cleaning the tooth surfaces with agents such as an aqueous solution of tartaric 
acid, poly (acrylic acid), or dodicin to remove the smear layer and other 
contaminants that leave the dentinal tubules quite closed but the rest of the 
surface clean. This also changes the surface energy of the tooth structure to allow 
better adaptation of the cement and facilitate optimum placement of the 
restoration (Wilson and McLean, 1988, Mount, 1998). According to Chadwick and 
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Woolford (1993) the use of tooth cleanser has no statistical effect upon restoration 
longevity, but is non detrimental to it, thus optimising the chances of restoration 
survival. Other recent laboratory work supports the use of a poly-alkenoic acid 
conditioner to enhance bonding of resin modified glass ionomer cements to bur cut 
dentine as its application removes smear layer interference (Cardosoa et al., 2010).  
 
2.1.4.5 BIOCOMPATIBILITY  
In modern medicine and dentistry any material or substance has to be investigated 
carefully for its biocompatibility prior to clinical application. Many systems are 
used to evaluate  the biocompatibility of materials; In vivo systems, where the 
biological effects of the materials on animals are tested ; in vitro systems use cell 
culture and microorganisms to test biocompatibilities (Leyhausen et al., 1998). For 
patient and operator safety it is essential to evaluate the biocompatibility of any 
restorative material, which has a direct contact with living tissues (pulp, dentine, 
gingival tissue or other oral mucosa) for prolonged periods of time (Sidhu and 
Schmalz, 2001) . 
 
The conventional glass-ionomer cements posses a number of properties which are 
claimed to make them biocompatible with oral tissues; (i) low setting exotherm  
(ii) rapid neutralisation (iii) release of generally benign ions from the set cement 
(Nicholson et al., 1991). Glass ionomer cements are generally biocompatible with 
the surrounding tissues with minimal release of organic components (Kuhn et al., 
1983, Schmalz et al., 1994). Due, however, to the presence of the monomers 
hydroxyethyl methacrylate (HEMA ) within resin modified glass ionomer they are 
considered to have less biocompatibility than the conventional cements (Nicholson 
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and Czarnecka, 2008). In contrast cytotoxicity of freshly mixed glass ionomer 
cements has been reported by both Dahl and Tronsatad  (1976) and Meryon et al 
(1983), while Kawahara (1979), found that freshly mixed glass ionomer cements 
inhibited cellular proliferation, but were not cytotoxic. Glass ionomer cements 
have been shown to bring  about mild irritation of the pulp at a level similar to that 
caused by zinc poly carboxylate and zinc phosphate cements (Plant et al., 1988). 
Tests upon the pulpal response to glass ionomers in caries-free human premolars 
demonstrate that the glass ionomer cements cause a greater inflammatory 
response than zinc-oxide and eugenol cement, but the inflammation resolves 
spontaneously within 30 days, with no increase in reparative dentine formation 
(Cooper, 1980, Plant et al., 1984, Tobias et al., 1978).  
Cox et al. (1987) tested the effect of a number of restorative materials including 
glass ionomer cement on a traumatic exposure (non bacterially infected) pulp, and 
noted a mild inflammatory response of the pulp tissue after a short period, 
followed by complete healing with dentine bridge formation. The reactions of the 
exposed pulp to direct contact with freshly mixed glass ionomer cements are 
severe at the start, but with time pulp inflammation resolves and bacterial layers at 
the cavity floor are prevented (Sidhu and Schmalz, 2001). With respect to the 
gingival tissues the response to glass ionomer cements in class V cavities is 
reported as minimal (Garcia et al., 1981).  
 
Three components of glass ionomer cements can cause adverse effects, the 
material itself, metals which have been added to the original composition, and non-
polymerised resin components (Sidhu and Schmalz, 2001).  
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The toxicity of components released from the glass ionomer cements has been 
studied and there is some evidence that the dentine of the tooth prevents diffusion 
of the strong acids. The sodium, aluminium, silica, phosphate and fluoride are 
usually released from the conventional glass ionomer under normal conditions but 
calcium is only released under acidic conditions (Czarnecka et al., 2002). Apart 
from aluminium these components are considered to be acceptable in the body at 
the level released from such material. Most attention has been paid to aluminium 
since it has the ability to be toxic and affect the central nervous system (Yokel and 
McNamara, 2001). However, the total amount of aluminium released from glass 
ionomer cements is small and has no adverse biological effect on the body 
(Czarnecka et al., 2002) . This statement however sits a little at odds with that 
reported by Reushe et al. (2001). They report upon the use of glass ionomer bone 
cement used safely many times, in reconstructive otoneurosurgery In one case 
however death resulted due to aluminium accumulation in the brain arising from 
failure to close the dura.   The resin modified glass ionomer cements are in 
addition, able to release HEMA (2- hydroxethyl methacrylate). This can penetrate 
the dentine to the pulp and cause some adverse biological effects ranging from 
constant inflammation to sensitisation and potential allergic reactions in the 
patient (Nicholson and Czarnecka, 2008). It is also a known dermatological irritant 
that is capable of penetrating clinical procedure gloves (Tinsley and Chadwick, 
1997) and therefore care must be exercised in the manipulation of the material. 
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2.1.4.6 POTENTIAL TO INCORPORATE MEDICAMENTS OTHER THAN 
FLUORIDE 
Apart from incorporation of fluoride for its therapeutic effect (discussed 
previously) other agents have been examined. 
The conventional glass ionomer cements lend themselves to this as their hydrogel 
permits release and uptake of such agents and their setting reaction has no 
appreciable temperature rise to damage incorporated agents (Hatton et al., 2006). 
Prentice and Tyas (2006) explored the incorporation of oxalic acid into glass 
ionomers with the aim of reducing dentine hypersensitivity by its release. It 
accelerated the set of the material without affecting strength but, due to its low 
water solubility could only be introduced in low concentration. 
Palmer et al. (2004) examined the potential for chlorhexidine release from an 
experimental glass ionomer cement. This was with the intention of assessing the 
possibility of its incorporation and release due to its bactericidal effect.  Their 
additions ranged from 0.5 to 13.0% by weight and in proportion to quantity added 
the working and setting times increased as the compressive strength decreased. 
The incorporation of casein phosphopeptide-amorphous calcium phosphate (CPP-
AcP) into a self cure glass ionomer was investigated by Al Zraikat et al (2011). This 
agent inhibits demineralisation and favours remineralisation of tooth substance. 
They found that the incorporation of 3% casein phosphopeptide-amorphous 
calcium phosphate (CPP-ACP) had the potential to improve the cements 
anticariogenic properties without affecting adversely its mechanical properties.   
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With regard to promoting cellular adhesion and enhancing biocompatibility, 
factors relevant to the work presented in this thesis, Choi et al (2008) 
demonstrated that the addition of a bioactive Sol-Gel glass (70SiO2 . 25CaO . 5P2O5) 
to a commercial glass polyalkenoate (GC,Fuji I cement) produced higher cell 
viability with no detrimental effect upon the only physical property measured in 
this work , that of diametral tensile strength. More recent work indicated that the 
inclusion of bioactive glass improves the biocompatablilty of glass ionomer to 
fibroblasts (Subbarao et al., 2012). 
In this vein Chang et al (2009) explored the effects of adding Type I collagen to 
promote the cellular adhesion, to glass polyalkenoate, of gingival fibroblasts. 
Although etching the surface of the material enhanced adhesion the addition of 
Type I collagen to the cement significantly improved adhesion to these cells. This 
was not detrimental to the materials compressive strength; indeed it improved it, 
providing the addition did not exceed 0.01% collagen. 
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2.1.5 CLINICAL APPLICATION IN DENTISTRY  
It is over 30 years since the glass ionomer cements were first introduced into 
clinical dentistry. The original glass ionomer cements did not receive widespread 
acceptance until the mid 1980s, especially in the United States (Nicholson, 1997). 
The clinical development and use of the glass ionomer cement cements was first 
explained by Mclean and Wilson (1977a, 1977b, 1977c) who were instrumental in 
the material development. However these materials had some advantages such as 
ion exchange adhesion to the enamel and dentine, ability to release and up take 
fluoride ions, and good thermal expansion and contraction (Nicholson, 1997). 
Original glass ionomer cements had low wear resistance, fractured easily, and 
required some protection to avoid over-hydration, it is likely that such problems 
accounted for the slow widespread acceptance of those materials.  
Glass ionomer cements now include a wide family of materials that includes direct 
restoratives, luting agents, liner and bases, as well as pit and fissure sealants. All 
such products are available in both conventional and resin modified form (Hewlett 
and Mount, 2003). The differences consist of powder particles size, reactivity of the 
surface of powder particles, speed of setting and resistance to water loss and 
uptake. The glass ionomer cements may be classified according to their use in 
restorative dentistry as; 1-Type I for luting cement. 2-Type II for restoration, 3-
Type III lining cement (Mount, 1998). 
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2.1.5.1 LUTING CEMENT  
Luting cements have fine powder particles size and are mixed at a low powder-
liquid ratio of around 1.5:1 (Mount, 1998). The luting  glass ionomer cements are 
used for cementing stainless steel crowns for deciduous teeth, precision cast 
crowns fixed prostheses for permanent teeth, space maintainers and single 
orthodontic bands (Nicholson, 1997). The luting cement used to treat caries-prone 
patients is glass ionomer because of its ability to release fluoride ions as it is 
claimed to prevent the development of caries at the restorations margins (Wilson 
and McLean, 1988). 
 
2.1.5.2 RESTORATIVE CEMENTS  
There are three different formulations of glass ionomer restorative materials 
available commercially; auto-cured glass ionomer cements, resin modified glass 
ionomer cements and reinforced glass ionomer cements (Mount, 1998). The auto 
cured glass ionomer cements are ideal to restore areas which are not subjected to 
excessive occlusal load such as the Class V and Class III lesion. The resin modified 
glass ionomer cements are stronger than the auto-cured glass ionomer and can 
therefore be used in places where there is a moderate occlusal load. The reinforced 
glass ionomer cements display higher physical properties but lack translucency. As 
a consequence their clinical applications are limited to use in places where 
strength is required more than aesthetics. They may also be used as long-term 
temporary restorations  where their fluoride release is used to stabilise and 
remineralise cariously affected dentine (Mount, 1998). 
In general the restorative glass ionomers are used to restore non carious tooth 
lesions (erosion/abrasion) without cavity preparation, to restore primary teeth 
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and Class V and Class III cavities. In addition they may be used as fissure sealants, 
repair defective margins of restorations, core buildups, and sealing of root surfaces 
for overdentures (Wilson and McLean, 1988).   
Recent guidelines for treatment of dental caries in children (Scottish Dental Clincal 
Effectiveness Programme SDcepScottish Dental Clincal Effectiveness Programme 
SDcep, 2010) does not recommend the use of Glass ionomer restorative materials 
citing the work of Chadwick and Evans (2007)to support this.  
In relation to the treatment of root surface caries, the subject of this thesis, the 
American Academy of Operative Dentistry (The Academy of Operative Dentistry, 
2004) recommends glass ionomer as the material of choice when prevention has 
failed.  
 
2.1.5.3 LINING AND BASE CEMENTS  
The only difference between the lining and base cement is the powder liquid ratio 
at which they are mixed. The lining cement is a thin layer of quite low strength 
cement placed underneath the metallic restoration to work as a thermal insulator 
and to protect the underling dentine and pulp from traumatisation due to  
temperature (Mount, 1998). They are also used to seal and obturate occlusal 
fissures that show early signs of decay (Wilson and McLean, 1988). 
 
2.1.5.4 CONCLUSION  
The foregoing has reviewed the development, composition and properties of glass 
ionomer cement. they have widespread clinical application and would appear 
suitable for modification for root caries treatment. 
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2.2 ROOT SURFACE CARIES 
Root surface caries is defined as “ a soft irregular shaped lesion either (1) totally 
confined to the root surface or (2) involving the undermining of enamel at the 
cemento-enamel junction but clinically indicating that the lesion initiated on the 
root surface”  (Katz, 1995). Root surface caries usually occurs supragingivally at or 
close to (within 2mm) of the cemento-enamel junction (CEJ) (Banting, 2001). 
Experts generally agree that root caries can occur anywhere on the root surface 
occlusal to the gingival margins but there are contradictory views about root 
lesions involving the cemento-enamel junction (CEJ). These relate to the 
classification of such lesions and some think they should be classed as root surface 
caries extending onto the crown or indeed as coronal caries extending onto the 
root or even both. This however  is  more a measurement issue than a  diagnostic 
issue (Banting, 1993).  
The occurrence and location of root surface caries is usually associated with age 
and gingival recession. This is consistent with the idea that root caries occurs in a 
location close to the crest of the gingiva, where dental plaque accumulates. Root 
surface caries most commonly occurs on the proximal surfaces followed by the 
facial surfaces of the tooth (Banting, 2001). In a similar way to coronal caries root 
surface caries can be classified as an active or inactive (arrested) lesion according 
to the following criteria: 
 Active root surface caries appears as well-defined, softened area on the 
root surface yellow brown in colour. The lesion is usually covered by observable 
dental plaque, as the root surface caries progresses the surface of this lesion 
becomes brown or black  and is of a “leathery” consistency (Nyvad and Fejerskov, 
1986).  
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 Inactive (arrested) root surface caries appears as a dark brown or black 
coloured lesion with relatively smooth, shiny surfaces which are hard to probing 
upon application of moderate pressure (Nyvad and Fejerskov, 1986). 
 
2.2.1 PREVALENCE AND INCIDENCE  
The prevalence of root surface caries in the general population increases with 
peoples age (Beck, 1993). This increase in the prevalence of root surface caries is 
related to the retention of teeth in older people for longer than in previous 
generations. Also, root surfaces at this age become exposed due to gingival 
recession putting the root surface at greater risk (Griffin et al., 2004). The 
occurrences of root surface caries can be prevented using a variety of preventive 
methods e.g. water fluoridation, and use of fluoridated dentifrices. Maximum 
efficiency of prevention could be achieved if high-risk individuals were identified 
earlier and appropriate preventive methods instituted (Ritter et al., 2010).  
The evaluation of the prevalence of root surface caries in epidemiological studies 
of the older population is affected by the presence of fillings on the roots of teeth. 
Such restorations may have been placed either because of the presence of a carious 
lesion or due to a cervical non carious wear lesion. However, when conducting the 
epidemiological studies it is very difficult to discover the reason why a specific 
surface has been restored (Walls et al., 2000). 
Various epidemiological studies have been carried out on different populations, 
but due to the lack of standardised diagnostic criteria, reporting methods and 
diversity of the population, inter study comparison is problematical. Some 
incidence studies have found that around 30-40% of people surveyed have root 
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surface caries. Many risk factors have been linked to the occurrence of root surface 
caries and these comprise oral, medical, mental, behavioural and  psychological 
conditions (Galan and Lynch, 1993).  Table 2- summaries some of risk factors 
associated with root surface caries (McCombes, 1999).  
Table ‎2-4 some of risk factors associated with root surface caries. 
 Risk factors  
Oral hygiene state 
Frequency of sugar intake 
Reduce salivary flow 
Total amount of sugars consumed 
Mental disability/senility 
Physical disability 
Poor general health 
Cigarette smoking 
Presence of a partial denture 
Consumption of fizzy drink 
Active periodontal disease 
Gingival recession 
Poor crown margins 
Overhanging restoration 
Degree of crowding 
Presence of erosion 
Consumption of alcohol 
Number  of teeth present 
Presence of abrasion cavity 
 
In a National survey of adult health in the Republic of Ireland between 1989 and 
1990 a total of 1,527 adult people over 25 were examined for root surface caries It 
was found that the old people, males, residents of non-fluoridated communities 
and people of low incomes had the highest prevalence of root surface caries 
(Whelton et al., 1993)  
 
2.2.2 THE PROCESS OF ROOT SURFACE CARIES  
Gingival recession, resulting from bad oral hygiene and loss of periodontal 
ligament attachments with age, leads to exposure of the cement-enamel junction. If 
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this area retains dental plaque, caries formation is likely (Zhang et al., 2009). The 
caries process associated with root surface caries is similar to that of coronal 
caries. Bacteria, able to metabolize carbohydrates into acids, upon exposure to this 
substrate produce a drop in pH that initiates the decalcification of the tooth 
structure that they are in contact with (Nyvad and Fejerskov, 1982). 
At first there is loss of calcium ions from the crystal apatite of the calcified dental 
tissues (enamel, dentine and cementum) due to this microbial activity. Under 
normal conditions, this loss of calcium ions (demineralization) is compensated by 
the uptake of the calcium ions (remineralisation) by dental calcified tissues from 
the surrounding oral environment. In an unfavourable environment however, the 
rate of remineralisation becomes less than the rate of demineralization and the 
caries process progresses (Banting, 2001). 
In root surface caries the demineralization and remineralisation processes involve 
cementum first, although in some cases the process can start in dentine. There is 
simultaneous loss of both mineral and protein (proteolysis) from the root tissues 
so affected  (Banting, 2001). Figure 2-5 summaries this process.  
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‎2-5 The process of root surface caries ( modified from Dung and Liu, (1999)). 
 
 
  
Root surface caries is a dynamic process with lesions of different clinical severity 
and treatment requirements displayed in the same person. The dynamic nature of 
root surface caries makes the diagnosis of active root caries surface difficult (Lynch 
and Beighton, 1994). 
 
2.2.3 CLINICAL SIGNS AND SYMPTOMS 
The presentation of root surface caries involves different clinical signs that range 
from slightly softened and discoloured areas to large, yellow-brown soft or hard 
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areas, which may eventually involve the whole surface. Cavitation may also be 
present but the pulp may not be involved in an extending cavitated lesion 
(Fejerskov and Kidd, 2008). The most frequently used clinical signs to describe 
root surface caries use visual (contour, surface cavitation, colour) and tactile 
(surface texture) descriptive criteria (Banting, 1993).  
Many extrinsic factors affect the clinical appearance of root surface caries. These 
include the uptake of stain from some dietary foodstuffs, smoking and the micro-
flora of the lesion itself (Lynch and Beighton, 1994). 
Root surface caries is usually asymptomatic although pain may present where the 
lesions are advanced (Banting, 1993). 
 
2.2.4 HISTOPAHTOLOGICAL FEATURES OF ROOT SURFACE CARIES 
Histological studies of primary root caries reviewed by Lynch and Beighton (1994) 
clearly show that soft, leathery and hard lesions exhibit different manifestations 
which reflect the level of bacterial infection of root dentine. The soft lesions are 
characterised by the presence of bacteria within the dentinal tubules and these 
spread laterally between the tubules as result of loss of both mineral and organic 
matrix. Hard lesions are characterised as being fully mineralized with the presence 
of bacterial ghosts within the amorphous mineral of the remineralised lesion. 
Leathery lesions show a different appearance than those observed in soft and hard 
lesions and often there is a fully mineralised surface layer. 
Micro radiographically, loss of minerals occurs deep to a fairly well mineralised 
surface zone, which usually shows mineral content that is higher than that of the 
unaffected dentine. This high mineral content of the surface zone may reflect a 
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selective redeposition of minerals in this area, as it has been shown that the size of 
the apatite crystal in the surface zone is considerably larger than normal 
cementum (Fejerskov and Kidd, 2008).  
 
At the early stage the root surface caries lesion may appear softened. This is due to 
the penetration of microorganisms into the surface zone of the lesion between 
partially demineralised collagen fibres.  
At more advanced stages demineralisation usually extends several hundred 
micrometers into the underlying dentine below the surface. In the case of shallow 
cavities which may be associated with the root surface caries lesion, the exposed 
dentine surface may show a relatively well mineralised surface layer below which 
demineralisation takes place.  
 
2.2.5 DIAGNOSIS OF ROOT SURFACE CARIES  
Clinical diagnosis is the process of recognising diseases by their characteristic 
signs and symptoms (Banting, 2001). The visual (colour, contour, surface 
cavitation) and tactile (surface texture) signs are the most commonly used signs to 
recognise root surface caries (Banting, 1993). 
Although no connection between the colour and the activity of the root surface 
caries has been found, it is generally agreed that the discoloration of the root 
surface indicates the presence of caries (Lynch and Beighton, 1994) 
Fejerskov et al. (1991) introduced a classification to assist in the diagnosis of the 
root surface caries lesion. This combines activity assessment as well as an 
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evaluation of surface integrity. On the basis root surface caries may be classified as 
follows: 
 Inactive lesion without surface destruction 
 Inactive lesion with cavity formation  
 Active lesion without definitive surface destruction  
 Active lesion with surface destruction (cavitation), but cavity is estimated 
not to exceed 1 mm in depth (visually) 
 Active lesion with a cavity depth exceeding 1 mm , but not involving the 
pulp 
 Lesion expected to penetrate into the pulp  
 Filling confined to the root surface or extending from a coronal surface onto 
the root surface  
 Filling with an active (secondary ) lesion along the margin  
 Filling with an inactive lesion  (secondary) confined to the margin  
Although the root caries lesion is usually detected by changes in colour (yellow, 
brown, black), texture (soft, hard), or surface contour (regular, irregular) of the 
root surfaces, the examination should also focus on the patient’s risk of developing 
root caries. Therefore the diagnosis of the root caries should start  by the 
identification of contributory factors and oral hygiene practices (Berry et al., 
2004).   
The diagnosis of root surface caries can be carried out visually by gentle gingival 
tissue displacement with an air syringe and retraction with hand instruments that 
can give a better view to check subgingival and interproximal areas. The visual 
diagnostic capability of the root surface caries can be improved by using 
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transillumination and/or lighted mirrors and intra-oral cameras (Berry et al., 
2004). Early interproximal root surface caries can also be detected by radiographs. 
Vertical bitewing radiographs give better evaluation of inter proximal root surface 
caries in individual with significant periodontal problems (Jones, 1995). 
 
2.2.6 MANAGEMENT OF ROOT SURFACE CARIES  
The management of root surface caries should start by preventive and 
remineralisation therapies that will help inhibit or eliminate the lesion before 
further damage to dental tissues occurs. Restorative treatment is indicated in case 
of excessive distraction of the tooth tissues by active root surface caries (Berry et 
al., 2004). 
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2.2.6.1 NON –OPERATIVE TREATMENT OF ROOT SURFACE CARIES 
LESION  
It is generally accepted that root surface caries can be prevented or arrested by 
plaque removal, diet modification and topical fluoride application (Emilson et al., 
1993). 
Active root surface caries can be converted to inactive lesions only by advising 
patients to improve their oral hygiene by the use of a toothbrush with fluoride 
toothpaste (Nyvad and Fejerskov, 1986). Many studies have shown the advantage 
of substituting dietary polyols for sucrose in chewable dietary items. Xylitol, a five-
carbon sugar alcohol, is not metabolized by Streptococcus mutans and has been 
shown to have an anticariogenic effect (Nuuja et al., 1993). Removal of dental 
plaque from root surface caries has been shown to be a promising factor in 
arresting the active root lesion (Emilson et al., 1993). A 0.12% chlorhexidine rinse 
(peridex, Periogurd) can also be helpful in the treatment root surface caries. 
Chlorhexidine is an antimicrobial solution used to treat gingivitis and periodontal 
diseases and is also very effective in eliminating cariogenic bacteria (Berry et al., 
2004). Despite this there has been relatively limited research into the non-invasive 
(pharmaceutical) management of root caries. Early studies have demonstrated that 
an application of ozone for a period of either 10 or 20 seconds is able clinically to 
change leathery root caries lesions to an inactive lesion (Baysan and Lynch, 2006) 
although to date there is no independent report to confirm this. It is generally 
agreed however that fluoride ions promote remineralisation of tooth substance 
and reduce the rate of demineralisation. The use of a dentifrice with high fluoride 
content may be considered  to reverse primary root caries lesions, since more 
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fluoride is required for the remineralisation of roots than for enamel (Lynch and 
Baysan, 2001). 
2.2.6.2 RESTORATIVE TREATMENT OF ROOT SURFACE CARIES 
Some cases of root surface caries do not need restorative treatment for if shallow 
they can be saucerised using hand instruments, finishing burs or polishing discs 
(Billings et al., 1985, Wallace et al., 1993). 
When the active caries root lesion progresses, it causes destruction of the root 
tissues and so restorative treatment is indicated to remove the caries and replace 
the destroyed tissues. Many difficulties face the clinicians during this process. 
These  include impaired visibility, limited access, moisture control, pulpal 
proximity and the nature of the dentinal tissues themselves (Berry et al., 2004).  
Many different restorative materials are used to restore the root surface caries. 
Glass Ionomer (Conventional, Resin modified) glass ionomer cements are the 
materials of choice for restorative treatment of most root surface caries lesions 
(Berry et al., 2004). These materials provide good adhesion to the hard tissues of 
the tooth and have anticariogenic effects by releasing fluoride over time. Resin 
composite materials including compomers (polyacid modified resins) and flowable 
composites are indicated to restore root surface lesions when good aesthetics are 
required. These materials undergo polymerization shrinkage and some release 
fluoride (Berry et al., 2004) but as these are resin based they are not moisture 
tolerant. Amalgam is indicated to restore root surface caries in posterior teeth 
where aesthetics is unimportant and there is a problem with moisture control 
(Berry et al., 2004) the use of this material is to be phased down (World Health 
Organisation, 2010). 
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Placement of a restoration for a root caries lesion involves the disruption of many 
tissues (Figure 2.6) namely attached gingiva, periodontal ligament, enamel, 
dentine and cementum. Scope therefore exists for surface interaction of the 
restorative material with the cell population of both the attached gingiva and 
periodontal ligament. This offers the potential for cellular attachment to these 
tissues to augment the adhesive bonding of glass polyalkenoate to hard tissues of 
the tooth 
 
 
Figure ‎2-6 The restoration of a root caries lesion showing potential tissue interaction. 
 
The next section of this literature review examines the nature of the attached 
gingiva for this is the region disrupted by operative root caries treatment and one 
that could offer cellular interaction with the restorative material.  
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2.3 GINGIVA  
Gingiva is that part of the oral mucosa that surrounds and is attached to the teeth 
of the maxilla and mandibular covering the alveolar process (Bath-Balogh and 
Fehrenbach, 2011). 
 
2.3.1 ANATOMY OF THE GINGIVA 
The gingival tissue is divided to three anatomical zones; (1) the attached gingiva, 
(2) inter-dental papillae and (3) free or marginal gingiva (Figure 2-6). 
 
2.3.1.1 ATTACHED GINGIVA 
Attached gingiva is the portion of the gingival tissues that is tightly attached to the 
underlying bone and around the neck of the tooth by means of junctional 
epithelium. The attached gingiva is a masticatory mucosa; pink in colour though it 
may have some areas of melanin pigmentation. The width of the attached gingiva 
varies depending on its location. The attached gingiva is separated from alveolar 
mucosa by the mucogingival junction, which in healthy normal gingiva is located at 
3 to 5 mm below the level of the crests (Bath-Balogh and Fehrenbach, 2011). 
 
2.3.1.2 INTER-DENTAL PAPILLAE 
Inter-dental papillae are an extension of the attached gingiva located between 
adjacent teeth and fill in the space between the teeth apical to their contact. The 
inter dental-papillae are a conical shape around anterior teeth but have a blunt 
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shape buccolingually  in the case of posterior teeth (Bath-Balogh and Fehrenbach, 
2011).  
 
2.3.1.3 FREE OR MARGINAL GINGIVA 
Free or marginal gingiva is the narrow rim of the mucosa that is not attached to the 
underlying bone and is located just coronal to the attached gingiva. The free or 
marginal gingiva is bound on its margin by the gingival sulcus, which separates it 
from the tooth, on its outer margin by the oral cavity and apically at its free surface 
by the free gingiva. The free gingiva is separated from the attached gingiva by the 
free gingival groove; the depth of this groove varies according to anatomical site. 
The groove is very clearly pronounced on mandibular anterior and premolars 
(Bath-Balogh and Fehrenbach, 2011, Avery and James, 2000). 
 
2.3.2 HISTOLOGY OF GINGIVAL TISSUE 
Although the attached and marginal gingiva has some similar histology each one 
has specific histological features. 
 The attached gingiva is formed from a thick layer of mainly parakeratinised 
stratified squamous epithelium, which obscures its extensive blood supply in the 
lamina propria, making the attached gingiva tissue look pinkish in colour. The 
lamina propria also consists of tall, narrow connective tissues, papilla and rete 
ridges that manifest as different amounts of stippling in the overlying gingiva. 
Therefore, the interface between the epithelium and lamina propria is highly 
interdigitated. The lamina propria is directly connected to the underlying bone, 
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making the attached gingiva firm and fixed, and thus serves as a mucoperiosteum 
(Bath-Balogh and Fehrenbach, 2011). 
 The marginal gingiva is a masticatory mucosa consisting of a surface layer of 
orthokeratinised stratified squamous epithelium. The connected lamina propria 
also has tall, narrow papillae. However this lamina propria is continuous with the 
lamina propria of the gingival tissue that opposes the tooth surface. The marginal 
gingiva is not connected to the underlying bone, making this part of the gingival 
tissue firm but mobile. The gingival fibre group is located in the lamina propria of 
the marginal gingiva. The gingival fibre group is considered as a part of the 
periodontal ligament by some histologists, but the gingival fibre group supports 
only the gingival tissue and not the tooth in relationship to the alveolar bone. The 
lamina propria of the marginal gingiva is also continuous with the adjacent 
connective tissue, which consists of the lamina propria of the attached gingiva and 
the periodontal ligaments (Bath-Balogh and Fehrenbach, 2011). 
 
2.3.2.1 DENTOGINGIVAL JUNCTION TISSUE 
The connection between the tooth surface and the gingival tissues is called the 
dentogingival junction. During the clinical examination of the healthy gingival 
tissue it is difficult to distinguish between the sulcular epithelium and junctional 
epithelium. 
The cervicular epithelium or sulcular epithelium is located away from the tooth 
surface, forming a gingival sulcus, which is filled with gingival cervicular fluid 
(GCF). The depth of the healthy gingival sulcus range between 0.5 to 3mm, with 
average of 1.8mm (Bath-Balogh and Fehrenbach, 2011).  
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The junctional epithelium (JE) is the deeper extension of the sulcular epithelium, 
which lines the floor of the gingival sulcus and is attached to the tooth surface by 
means of an epithelial attachment. The junctional epithelium can be attached to the 
enamel, cementum, or dentine. The location of the epithelial attachment (EA) on 
the tooth surface is initially on the cervical portion of the anatomical crown when 
the tooth becomes functional after eruption (Bath-Balogh and Fehrenbach, 2011).   
 
2.3.2.2 HISTOLOGY OF DENTOGINGIVAL JUNCTIONAL TISSUE  
Similar to the epithelium of the attached gingiva and adjacent outer marginal 
gingiva, the sulcular epithelium consists of stratified squamous epithelium. 
However, the sulcular epithelium is either nonkeratinised stratified squamous or 
para-keratinised stratified squamous epithelium with its cells tightly packed, 
unlike the keratinized marginal gingiva and attached gingiva (Bath-Balogh and 
Fehrenbach, 2011).  
The interface between the sulcular epithelium and the lamina propria that it 
shares with the outer gingival are fairly smooth, compared with others the deeper 
interface between the junctional epithelium and the underlying lamina propria is 
also relatively smooth, without are ridges or connective tissue papillae. The 
junctional epithelial cells are loosely packed, with less desmosomal junction 
between cells comparing with other gingival tissues, therefore the number of 
intercellular spaces between the epithelial cells of the junctional epithelium is 
increased. The intercellular spaces allow mobile white blood cells (WBCs) to move 
from the blood vessels in the lamina propria into junctional epithelium.        
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The junctional epithelium is thinner than the sulcular epithelium, ranging 
coronally from 15 to 30 cells at the floor of the gingival sulcus, tapering apically to 
3 to 4 cells at the apical portion. The superficial or suprabasal epithelial cells of the 
junctional epithelium serve as part of the epithelial attachment of the gingiva to 
the tooth surface. The suprabasal epithelial cells of the junctional epithelium 
provide the hemidesmosomes and an internal basal lamina that gives the epithelial 
attachment since this is a cell-to-noncellular type of cellular junction. The structure 
of the epithelial attachment is similar to that of the junction between the 
epithelium and subadjacent connective tissue. The internal basal lamina consists of 
a lamina lucida and lamina densa (Bath-Balogh and Fehrenbach, 2011).  
This internal basal lamina of the epithelial attachment is continuous with the 
external basal lamina between the junctional epithelium and the lamina propria at 
the apical extent of junctional epithelium. The epithelial attachment is very strong 
in a healthy state, acting as a type of seal between the soft gingival tissues and the 
hard tooth surface(Bath-Balogh and Fehrenbach, 2011).  
The deepest layer of the junctional epithelium or basal layer undergoes constant 
and rapid cell division, or mitosis. This allows a constant coronal migration as the 
cells die and are shed into the sulcus. The few layers present in the junctional 
epithelium, from its basal layer to the suprabasal or superficial layer, do not show 
changes in cellular appearance related to maturation, unlike other gingival tissues. 
They do not mature into a granular layer or intermediate layer. Thus, junctional 
epithelium does not mature like keratinized tissue, which fills it is maturate 
superfacial cells with keratin. Nor does junctional epithelium mature like 
nonkeratinised tissue, which enlarges its cells as they mature and migrate 
superficially (Bath-Balogh and Fehrenbach, 2011). 
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2.4 PERIODONTAL LIGAMENT (PDL) 
The periodontal ligament (PDL) is that part of periodontium that provides for 
attachment of teeth to surrounding alveolar bone using the cementum (Bath-
Balogh and Fehrenbach, 2011). It is a specialized soft connective tissue situated 
between the tooth root and alveolar bone. Its thickness ranges between 0.15 to 
0.38 mm. The thinnest part of PDL is located around the middle part of the root. 
With age the thickness of PDL progressively becomes thinner with age. The 
principle function of the PDL is to connect the tooth to the alveolar bone socket 
and simultaneously provide a cushion enabling them to cope with the masticatory 
forces applied on them. However, the PDL also acts as a reservoir of cells necessary 
for tissue healing and regeneration (Nanci and Bosshardt, 2006). 
 
2.4.1 DEVELOPMENT OF THE PERIODONTAL LIGAMENT 
PDL development starts when root formation begins as it is shown in Figure (2-7). 
This is prior to tooth eruption. Hertwig’s epithelial root sheath (HERS) grows in an 
apical direction separating cells of the dental papilla from those of the dental 
follicle located between the alveolar bone and the outer side of HERS. This sheath 
forms as a result of the continuous growth of the inner and external enamel 
epithelia initially forming the cervical loop of the tooth bud that, later on, matures 
into HERS (Cho and Garant, 2000).  
Two subpopulations of mesenchymal cells make up the cellular component of the 
dental follicle. These are the mesenchymal cells of dental follicle proper and the 
perifollicular mesenchyme. Each subpopulation is morphologically and spatially 
distinct from the other. The perifollicular mesenchyme is located between the 
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dental follicle proper and the alveolar bone. Its cells are small, unorganized, 
scattered and star-shaped (Cho and Garant, 2000). Their small cytoplasm contains 
inactive Golgi complex, a small number of mitochondria, rough endoplasmic 
reticulum and free ribosomes. These cells connect with each other through long 
and fine cytoplasmic processes and are surrounded by a small number of short 
collagen fibrils. In parallel with root formation, cells of the perifollicular 
mesenchyme begin the process of synthesizing and depositing the extracellular 
matrix collagen fibrils and glycoproteins of the nascent periodontal ligament as a 
result of an increase in size, polarity and synthetic activity of these cells. These 
cells gain an elongated morphology, higher numbers of rough endoplasmic 
reticulum and mitochondria and an active Golgi complex (Cho and Garant, 1989 , 
Freeman and ten Cate, 1971). The PDL space between the alveolar bone and 
cementum that was initially occupied by an unorganized connective tissue 
becomes remodelled, and the provisional extra cellular matrix (ECM) matures into 
a system of organized fibre bundles that extend between the alveolar bone and 
cementum surfaces. This remodelled PDL can now provide a firm attachment of 
the tooth to bone. Later on, eruptive and occlusal forces will further reorganize the 
PDL (Nanci and Bosshardt, 2006).  
Undifferentiated stem cells are present in both developing and mature PDL tissues. 
They have to the potential to differentiate into fibroblasts, cementoblasts, or 
osteoblasts (Wallace et al., 1993, McCulloch, 1985). However, whether or not these 
cells differentiate from a common progenitor or from a specific line of 
undifferentiated stem cells is still unknown. 
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Figure ‎2-7 PDL development and root formation modified from (2014)  
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2.4.2 CELLULAR COMPONENTS OF THE PERIODONTAL 
LIGAMENT 
 
2.4.2.1 FIBROBLASTS 
The fibroblast cells are the most common cells in all cells of the PDL. Despite the 
microscopic morphological similarity amongst them, fibroblasts of different 
connective tissues as well as those of the same connective tissue are composed of a 
heterogeneous mix of cell populations. PDL fibroblasts have a rapid turnover of the 
ECM, especially collagen. PDL fibroblasts are active cells that synthesize and 
deposit proteins of the ECM. They have a large size with a cytoplasm rich in rough 
endoplasmic reticulum, Golgi complex, and many secretary vesicles (Nanci, 2013). 
The PDL is subjected to mechanical forces and strains. These strains determine the 
morphology and synthetic activity of PDL fibroblasts. They also determine the 
interaction of PDL fibroblasts with its surrounding ECM including adhesion. PDL 
fibroblasts show a prolonged, polarized cytoplasm extensively contacting with 
collagen fibrils of the surrounding ECM (Garant and Cho, 1979, Beertsen et al., 
1979). The presence of a highly organized cytoskeleton, which has a well-
developed network of actin, provides these cells with the capability to migrate and 
change their shape in coping with the functional demands placed on them. PDL 
fibroblasts frequently contact with each other through gap and adherens junctions. 
Their alignment follows the orientation of the fibre bundles, and they attach 
themselves to these fibres by wrapping their cytoplasmic processes around them. 
PDL fibroblasts have the ability to produce and degrade collagen. This ability 
allows them to remodel bundles of collagen fibrils in a continuous manner. Since 
the collagen turnover is unusually rapid, any disease process that causes an 
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impaired PDL fibroblast function results in an accelerated loss of the tooth-
supporting tissues. Periodontal lesions of an inflammatory nature such as 
periodontitis are associated with an increased expression of matrix 
metalloproteinases (MMPs) that causes a massive destruction of collagen. 
Therefore, therapeutic strategies that involve MMP inhibition may be 
advantageous in controlling periodontal disease (Nanci, 2013). 
 
2.4.2.2 EPITHELIAL CELLS 
The PDL epithelial cells are known as the epithelial rests of Malassez. They are 
remnants of the Hertwig’s epithelial root sheath. They are seen as clusters of 
epithelial cells with deeply stained nuclei in hematoxylin-and-eosin-stained 
sections near the cementum especially in furcation areas of multi-rooted teeth 
(Nanci, 2013, Nanci and Bosshardt, 2006). The function of these cells is unknown 
but they have been speculated to play a role in periodontal regeneration and repair 
(Bosshardt, 2005). 
 
2.4.2.3 UNDIFFERENTIATED MESENCHYMAL CELLS 
Human PDL has been shown to contain cell subpopulation with stem-cell 
characteristics (Delima et al., 2002). They are referred to as undifferentiated 
mesenchymal stem cells (UMSCs), or progenitor cells. The production of new PDL 
cells is thought to be balanced by selective apoptosis of older PDL cells, as PDL cell 
number is known to be in a state of steadiness. PDL provides cells for its own 
healing as well as cells that help in the regeneration of adjacent alveolar bone and 
root cementum (Freeman and ten Cate, 1971, Gillard et al., 1977). 
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2.4.2.4 OTHER CELLS OF THE PERIODONTAL LIGAMENT 
In addition to the main cells of PDL (PDL fibroblasts, epithelial rests of Malassez, 
and UMSCs), PDL also contains other cell types such as osteoblasts and osteoclasts 
(physically present in the ligament but functionally associated with alveolar bone) 
monocytes, macrophages, odontoclasts, and cementoblasts (although present in 
the ligament, they are functionally associated with cementum) (Nanci, 2013). 
 
2.4.3 EXTRACELLULAR MATRIX  
The extracellular matrix is a complex of different proteins and glycosaminoglycan 
families defining structural integrity and a variety of physiological function. The 
main function of extracellular matrix is to provide tissues with their specific 
biochemical and biomechanical properties. The local cells are responsible for 
synthesis secretion and maintenance of extracellular matrix (Gelse et al., 2003). 
Fibroblasts synthesise and secrets different extracellular molecules. These consist 
of the components of the fibres, the component of the ground substance 
(extrafibrillar matrix) and a variety of biologically active molecules, such as 
cytokines and growth factors (Nanci, 2013).  
 
2.4.3.1 COLLAGEN FIBRES  
 Collagen is one of the most abundant proteins in the body (Nanci, 2013). Made 
from very long fibrils with a characteristic axial periodic structure. The fibrils offer 
the major biomechanical scaffold for cell attachment and anchorage of 
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macromolecules, allowing  the shape and form of tissues to be defined and 
maintained (Kadler et al., 1996). The name collagen is a general term that refers to 
proteins forming a characteristic triple helix of three polypeptide chains and all 
members of the collagen family form these supramolecular structures in the 
extracellular matrix (Gelse et al., 2003). The name collagen derives from the greek 
meaning literally animal glue.  
Collagen is different from other proteins in that the molecule contains three 
polypeptide chains (α-chains) which form a unique triple-helical structure. For the 
three chains to wind into a triple helix they must have the smallest amino acid, 
glycine, at every third residue along each chain. Each of the three chains therefore 
has the repeating structure Gly-X-Y, in which X and Y mean any of the 20 amino 
acids in proteins but are usualy the imino acids proline and hydroxyproline 
(Kadler et al., 1996).  At least 29 types of collagen have been identified (Bath-
Balogh and Fehrenbach, 2011).  
The collagens can be subdivided according to their structure and supramolecular 
organization into :- (Nanci, 2013)   
  Fibrillar collagens the include types I, II, III, V, XI, XXXIV and XXVII. These 
types of collagens aggregate in a highly organised way to produce fibrils 
with a typical 62-nm banding pattern.  
  Basal lamina collagen includes type IV collagen. The size of collagen IV is 
similar collagen type I, but does not assemble in fibrils.  
 Fibril-associated collagen includes types IX, XII, XIV, XIX, XX, XXI and XXII 
collagens. These types are found in different location in different tissues for 
example type XIX collagen found in basal laminae and it is important for 
skeletal muscle cell differentiation.     
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 Network–forming collagen includes type VIII and X collagens. Type VIII is 
believed to provide compressive strength while providing an open, porous 
meshwork. Type is X usually found in the hypertrophic zone of the 
epiphyseal cartilage growth plate.     
 Anchoring-fibril collagen includes type VII collagen which form an 
anchoring fibrils extend from the basal lamina into the underlying 
connective tissues. 
 Microfibirl-forming collagen includes type VI collagen which is found in 
most connective tissues  
 Transmembrane collagens includes type XIII, XVII, XXIII, and XXV. Type XVII 
collagen is present in hemidesmosomes of basal epidermal cells and 
attaches the cells to the basal lamina. Type XIII is found in adhesion site of 
fibroblast and at cell matrix interfaces in some epithelia, muscles, and 
nerves.  
 Multiplexin (endostatin –forming) collagens includes type XVIII and XV are 
found in association to basement membranes, they can mediate cell 
adhesion to different collagen receptors.  
 Other collagens include type XXVI and XXVIII. Type XXVI is present in 
extracellular matrix of testis and ovary. Type XXVIII is found in the 
basement membrane around Schwan’s cells of the peripheral nervous 
system and dorsal ganglia.  
 
2.4.3.1.1 TYPE I COLLAGEN  
Type I collagen is the most predominate collagen in vertebrates forming the major 
parts of the fibrillar extracellular matrix (Stamov and Pompe, 2012). Thus, it has 
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become an almost ubiquitous biomolecule to use in modern biomimetic cell 
culture scaffolds and in tissue engineering scenarios, where new functions for 
biomedical applications are sought (Stamov and Pompe, 2012).  Type I collagen 
comprises more than 90% of the organic mass of bone and is the main collagen of 
tendons, skin, and ligaments (Gelse et al., 2003). Fibroblasts, odontoblasts, and 
osteoblasts synthesise and produce the same type I collagen. As a secretary 
protein, fibrous collagen is synthesised as a proprotein (procollagen) in a similar 
way to secretary proteins of other cells (Nanci, 2013). Type I collagen triple helix is 
usually formed as a heterotrimer by two s identical α1 (I) - chains and one α 2(I)-
chain (Gelse et al., 2003).  The type I collagen fibrils usually have small amount of 
collagen type III, V, and, XII (Nanci, 2013).  The major function of type I collagen is 
to provide structural integrity and tensile strength to connective tissues (Nanci, 
2013). 
 
2.4.3.2 GROUND SUBSTANCE (EXTRAFIBRILLAR MATRIX) 
The ground substance of extracellular matrix appears as amorphous gelatinous 
substance in the microscope. It contains a complex mixture of macromolecules 
with important function. These macromolecules interact with cells and fibrous 
components of the matrix and play some roles in adhesion and singling events. The 
ground substance of the PDL plays an important role in providing the tooth with its 
capability to endure occlusal forces placed on it. Water has been found to comprise 
about 70% of the ground substance’s composition. During inflammation or trauma, 
tissue fluids of the ground substance increase within its amorphous matrix (Nanci 
and Bosshardt, 2006). Fibroblasts synthesis and secret two main types of 
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macromolecules which form the ground substance: proteoglycans and 
glycoproteins (Nanci, 2013).  
 
2.4.3.2.1 PROTEOGLYCANS 
They are a large group of extracellular matrix and cell surface-associated 
molecules that consist of a protein core to which glycosaminoglycan chains are 
connected. Glycosaminoglycans are long chains of repeating disaccharide units 
consisting of a hexosamine and uronic acid, several different glycosaminoglycans 
are recognized depending on the combination of hexosamine and uronic acid. The 
main property of cell surface matrix proteoglycans is their capability to attach 
growth factors, cytokines, and other biologically active molecules (Nanci, 2013).  
 
2.4.3.2.2 GLYCOPROTEINS 
Several glycoproteins can be found in the ground substance such as fibronectin, 
tenascin and thrombospondine; a number of these have adhesive functions. The 
main function of glycoproteins is to attach cells to extracellular matrix (Nanci, 
2013).    
2.4.3.2.2.1 FIBRONECTIN  
Fibronectin is a main extracellular matrix and plasma glycoprotein synthesised by 
hepatocytes and fibroblasts (Nanci, 2013). Fibronectin is a complex glycoprotein 
that is thought to improve the attachment of connective tissue cells to collagen 
fibrils as well as other components of the extracellular matrix (Jones et al., 1986). 
It is believed to facilitate the migratory process of connective tissue cells since 
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these cells seem to avidly attach to fibronectin. Therefore, considering the rapid 
turnover of the PDL, one can conclude that PDL fibronectin might possess highly 
significant biological actions (Berkovitz, 1990). Fibronectin and type I collagen 
have been found to be produced by 99% of the ligament cells, while the remainder 
of PDL cells produce fibronectin only (Connor et al., 1983). 
Electron microscopic studies have shown fibronectin to be present over collagen 
fibers and at points of contact between cells and collagen (Pitaru et al., 1987). 
Fibronectin becomes lost from the ground substance of many connective tissues as 
they mature (Hassell et al., 1978, Linder et al., 1975). Thus, the persistence of PDL 
fibronectin within its ground substance may suggest a failure of PDL to attain 
maturity (Berkovitz, 1990). Fibronectin exists as a protein dimer, composed of two 
nearly identical polypeptide chains linked covalently by a pair of C- terminal 
disulfide bonds. Each fibronectin monomer contains three types of repeating units 
type I, II, and III (Pankov and Yamada, 2002). A large number of different integrins 
attach to fibronectin including the classic fibronectin receptor a5b1 (middle panel, 
Integrin interaction sites). Thorough analyses have reduced the regions associated 
with cell adhesion along the lengthy fibronictin molecule to several minimal 
integrin-recognition sequences. The best known is RGD sequence (Arg–Gly–Asp) 
which is located in fibronectin repeat III10 (Pankov and Yamada, 2002).  
 
2.5 ARGININE-GLYCINE-ASPARTIC ACID (RGD)  
The arginine-glycine-aspartic acid (RGD) cell adhesion sequence was found in 
fibronectin in 1984 (Pierschbacher and Ruoslahti, 1984). It is the most effective 
and widely used peptide to promote cell adhesion on a synthetic surface. This is 
based upon its widespread distribution and use throughout the organism, its 
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capability to label more than one cell adhesion receptor, and its biological effect on 
cell anchoring, behaviour and survival (Hersel et al., 2003).  
The RGD is a small structure and can be reproduced with peptides, indeed this is 
how the site was originally discovered (Ruoslahti, 1996). The RGD peptides 
stimulate cell adhesion when they are immobilised on surfaces (Hersel et al., 
2003), whereas in solution they act as decoys inhibiting adhesion.  (Ruoslahti, 
1996). 
 RGD peptides were also found in many other extracellular matrixes  such as 
vitronectin, fibrinogen, von Willebrand factor, collagens, laminin, osteopontin, 
tenascin and bone sialoprotein as well as in membrane proteins, in viral and 
bacterial proteins, and in snake venoms (Hersel et al., 2003). The connection of the 
cells to neighbouring cells and the surrounding extracellular matrix are usually 
mediated by Cell adhesion receptors. The intergin receptors play a major role in 
anchoring molecules and also they are important in other process such as 
embryogenesis, cell differentiation, immune response, wound healing and 
hemostasis (Ruoslahti and Pierschbacher, 1987). Integrins include two non-
covalently connected transmembrane subunits, termed a and b: To date 18 a and 8 
b subunits are known, that makes 24 different heterodimers  (Van der Flier and 
Sonnenberg, 2001). 
 The combination of the particular a and b subunits decide the ligand specificity of 
the integrin. Some integrins, however, are highly promiscuous, e.g. the avb3 
integrin links to vitronectin, fibronectin, von Willebrand factor, osteopontin, 
tenascin, bone sialopro sialoprotein and thrombospondin. Vice versa ECM 
molecules, like fibronectin, are ligands for several integrins (Van der Flier and 
Sonnenberg, 2001). In an attempt to decrease macromolecular ligands to small 
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recognition sequences, the tripeptide motif RGD was found as an important cell 
adhesion peptide sequence in fibronectin (Hersel et al., 2003). 
In several cases RGD peptides were proven to promote cell adhesion on various 
materials (Hersel et al., 2003). RGD as a mediator to cell adhesion is tested often on 
new polymers to prove their applicability as bioactive materials. More studies 
using established polymers revealed the ability of RGD peptides to mediate cell 
adhesion in vivo, thus leading e.g. to enhanced bone in growth and decreased 
fibrous encapsulation of bone implants (Eid et al., 2001, Kantlehner et al., 2000). 
Adhesive peptides have found several applications such as surface-coated RGD 
peptides are being tested to improve the compatibility of different implant devices 
(Ruoslahti, 1996). 
 
2.6 ENAMEL MATRIX DERIVATIVE (EMDOGAIN) 
Enamel matrix derivative (EMD) is an  acid extract of pig enamel matrix  
(Emdogain_; Straumann AG, Basel, Switzerland) and has been successfully used to 
stimulate functional periodontal ligament, cementum and alveolar bone to regrow 
in patients with severe periodontal attachment loss (Lyngstadaas et al., 2009). The 
enamel matrix protein in combination with an aqueous solution of propylene 
glycol alginate (PGA) called Emdogain has been on  the market in Europe, USA, and 
Japan for 12 to 13 years, offers  good clinical results after periodontal surgery of 
intraosseous defects  (Gestrelius et al., 2000).   
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2.6.1 COMPOSITION OF ENAMEL MATRIX PROTEIN AND ITS 
DERIVATIVE 
The enamel matrix consists of several proteins such as amelogenin, amelin (also 
called ameloblastin or sheathlin) enamelin, tuft protein, proteases, and albumen 
(Gestrelius et al., 2000). 
  
Amelogenins are the main component of enamel matrix protein, which are a family 
of hydrophobic proteins that account for more than 90% of the organic 
constituents of the enamel matrix (Romanelli et al., 2008). The amelogenins are 
known to self-assemble into supramolecular aggregates that form an insoluble 
extracellular matrix (Fincham et al., 1994) with high affinity for hydroxyapatite 
and collagens (Gestrelius et al., 1997).   
Enamelines are the second most common component of the enamel matrix protein, 
they have been found to have serum proteins, and the more general  term “non-
amelogenin” is now commonly used to illustrate this high molecular weight 
fraction, which comprises proline-rich enamelin, tuftelin, and tuft proteins 
(Rathva, 2011).  
Three matrix proteins (amelogenin, enamelin, sheathelin) and two enzymes (MMP-
20, EMSP1) have been extracted and the cDNA replicated from developing porcine 
teeth (Rathva, 2011). Although early immunoassay studies could not detect the 
presence of growth factors in EMD (Gestrelius, 1997) nominal levels of 
transforming growth factor β1 have been identified immunologically (Kawase et 
al., 2001). In addition by using noggin, a bone morphogenic protein (BMP)-binding 
protein, investigators have found BMP-2 and BMP-4 in an osteoinductive fraction 
of enamel extracts (Iwata et al., 2002) 
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2.6.2 MECHANISM OF ACTION 
The effect of enamel proteins on periodontal ligament formation is supported by 
their presence in early cementum formation during development of tooth 
attachment (Spahr and Hammarstrom, 1999, Hammarstrom, 1997) However, the 
mechanism(s) of how EMD stimulates periodontal regeneration is  not fully  
understood (Lyngstadaas et al., 2009). The enamel matrix is thought to have a 
regulatory effect on the initiation, propagation and maturation of hydroxyapatite 
crystallites in enamel. Temporary deposition of extracellular matrix onto the 
dentinal root surface gives an initial and important effect on a cellular cementum 
formation (Slavkin and Diekwisch, 1997). 
The formation of tooth root is started by downgrowth of the Hertwig’s epithelial 
root sheath (HERS).  This contains two layers of cells, of which the inner layer is 
the apical extension of the enamel organ. The enamel protein matrix is synthesized 
and secreted by ameloblasts. Recently it has been found that the cells of the 
Hertwig’s epithelial root sheath have the ability to secrete and deposit enamel 
matrix proteins on the root surface before cementum formation (Hammarstrom, 
1997, Fong et al., 1996). There is some evidence that the deposition of enamel 
matrix protein on the apical end of the root works as an initiating a factor for 
cementum formation (Hammarstrom, 1997). The formation of the cementum is 
usually associated with the development of the periodontal ligament and the 
alveolar bone (Gestrelius et al., 2000) .  
A number of studies have been conducted to understand the mechanism of action 
of emdogain. In these immunoassays for different growth factors, cytokines and 
attachment protein were all negative (Gestrelius et al., 1997). For better 
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understanding of the effect of the cellular level, enamel matrix protein was added 
to human periodontal ligament cells culture and monitored for cellular attachment 
rate, proliferation, DNA replication and metabolism. These studies revealed that 
the enamel matrix protein enhanced proliferation of periodontal ligaments cells, as 
well as increased protein and collagen production and mineralization (Gestrelius, 
1997) PDL fibroblasts modified  with EMD showed an increased intracellular cAMP 
concentration and autocrine releasing of TGF- _ 1, IL-6 and PDGF AB compared to 
the control group (Lyngstadaas et al., 2001). However the enamel protein matrix 
had insignificant effect on epithelial cell proliferation in vitro (Gestrelius, 1997). It 
was concluded that the application of enamel matrix protein on root surface may 
inhibit epithelial perforation in a same way of the mechanical prevention achieved 
using a barrier membrane in guided tissue regeneration procedures (Gottlow et al., 
1986, Nyman et al., 1982). 
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2.6.2.1 LITERATURE REVIEW CONCLUSION  
The foregoing has reviewed potential bioactive material which could facilitate the 
production of new dental restoratives that could enhance their capacity to 
biologically interact with the surrounding tooth and supporting structures to 
enhance durability and deprive residual caries of its nutrient supply. Aspects of 
this is explored in the work that follows.  
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- AIMS 
1. Ascertain UK and Libyan dentists’ management strategies for root caries.    
2. Identify agents capable of promoting cellular attachment to glass ionomer 
cement and determine effective dosage levels. 
3. Assess the effects of addition to some physical properties of commercially 
available glass ionomer.  
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3 MATERIALS AND METHODS  
This work sought to find biologically active agents that had the capacity to 
promote cellular attachment of gingival tissue cells to glass ionomers with the aim 
of preventing the ingress of cariogenic nutrients to subgingival glass ionomer 
restored root caries surface lesions. The work did not ascertain the clinical 
effectiveness but focused upon identifying such agents and assessing their effects 
of their addition upon some physical properties, of importance for clinical success, 
of two commercially available glass ionomers. Two strands of work were 
undertaken. 
1- A survey of UK and Libyan  dentists to ascertain their current practice as 
regards management of root caries 
2- A laboratory study that identified agents capable of promoting cellular 
attachment to glass ionomers, determined effective dosage levels and 
assessed the effects of addition to some physical properties of commercially 
available glass ionomer.  
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3.1 QUESTIONNAIRE METHODOLOGY  
A postal questionnaire and covering letters were designed according to the 
principles of Dillman (1978) for postal distribution to qualified dentists in both the 
United Kingdom and Libya. Before finalization the questionnaire was piloted upon 
convenience samples of the target groups to maximize the clarity of the 
questionnaire. Once in final form a copy was sent to the Scientific Officer of the 
Research Ethics Service of Fife, Forth Valley and Tayside, with the proposed 
covering letters, to determine if ethical approval was required. The reply received 
stated that the work proposed did not require ethical review under the terms of 
the Governance Arrangement for Research Ethics Committees GAfREC in the UK 
(Appendix A). No ethical approval is required in Libya. 
The questionnaire was constructed (Appendix B) to permit anonymous return and 
was distributed nationally, within the UK by post to 400 registered dentists. 200 
copies of the questionnaire were handed directly to 200 registered dentists in 
Libya by the author calling personally at the largest multiple practices in Tripoli, 
Al-zawia and Sabratha in January 2011.  
400 Potential participants in the United Kingdom were randomly selected from the 
electronic registers, held by the General Dental Council on February, 2009. 
Randomization was achieved by sequentially numbering each entry in the 
electronic versions of the registers and selecting those whose number coincided 
with a list of random numbers produced using the random number function in the 
spreadsheet package Excel (Microsoft Excel 2002, Microsoft Ltd., Reading UK). An 
introductory letter and stamped addressed return envelope for the completed 
questionnaires were included in the mailing (Appendix C). The introductory letter 
invited the potential participants to take part and stated that non return of the 
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questionnaire would be indicative of a lack of consent to participate in the study. 
To ensure maximum confidentiality of all respondents no hidden codes were 
embedded in any part of the questionnaires and, so it was impossible to know who 
had participated. For this reason it was impossible to send follow up letters to non 
responders. 
The questionnaires sought the views and experiences of root surface caries 
management of dentists in both United Kingdom and Libya.  
A relational database was constructed using the computer programme Paradox 
(Paradox Version 3.5, Borland International, CA 95067 - 001, USA) for input of data 
from the completed questionnaires and interrogation. Statistical analyses of the 
responses were undertaken using Prism (Graph Pad Prism, Version 4, Graph Pad 
Software Inc., San Diego, CA92121, USA) and Excel (Microsoft Excel, 2002, 
Microsoft Ltd., Reading UK). 
In some cases the questionnaire allowed the respondent to select an unknown 
response by ticking “other” than describing what this referred to. This was 
included to maximize the chances of obtaining all information. To facilitate analysis 
all such responses were filtered as follows; 
1. If the response description for “other” was one or more of the categories 
on the questionnaire such a response was transferred to those categories  
2. If the response of “other” had no description it was classified as “other” 
response.  
3. If the response of “other” had a description it was classified according to 
the description   and not included in “other”. 
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3.2 LABORATORY INVESTIGATIONS 
 
The laboratory component of this work sought to identify bioactive additions, 
potentially suitable for chairside incorporation at the time of mixing into glass 
poyalkenoate cement, to foster cellular attachment to subgingival restorations of 
root caries lesions. Although not tested in this thesis the purpose of these additions 
was to provide a tissue seal for such restorations with a view to depriving residual 
cariogenic bacteria of their nutrient supply. In addition, such additions could 
potentially affect the physical properties of the materials so these were 
determined for each material with no additions and also, in the case of bioactive 
additions shown to promote cellular attachment. 
 
  
69 
 
3.2.1 INVESTIGATION OF BIOACTIVE ADDITIONS TO GLASS 
POLYALKENOATE CEMENTS 
 
Prior to assessing the effects of biological additions upon the properties of glass 
ionomer cements their biological properties were determined using a variety of 
methods. 
      Observation under the microscope 
o Determination of the optimal materials for attachment of cells. 
o Determination of the optimal bioactive additives and 
concentration for attachment of cells    
Cell viability testing (MTT Assay) 
o Determination of optimal material for attachment of cells 
o Determination of optimal bioactive additives and concentration  
Immunocytochemistry (ICC) 
Protein biochemistry 
o Cell lysis 
o SDS PAGE (Polyacrylamide gel electrophorsis)  
o Western blotting 
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3.2.1.1 OBSERVATION UNDER THE MICROSCOPE  
In order to evaluate the visible effect of materials and bio-modified materials on 
oral mucosa fibroblast cells, the cells were cultured along with specimens for 21 
days during this period the cells were observed and monitored under a light 
microscope and pictures were taken every 3 days.  
 
3.2.1.1.1 DETERMINATION OF THE OPTIMAL MATERIALS FOR 
ATTACHMENT OF CELLS. 
 
 MATERIALS AND METHODS 
Two market leading conventional glass polyalkenoate cements, suitable for 
restoration of root caries lesions, were selected. Details of these materials are 
contained in Table 3.1. 
  
  
71 
 
Table ‎3-1 The details of the materials used in the study. 
 ChemFil Superior GC Fuji VIII GP 
Manufacturer DENTSPLY DETREY GmbH 78467 Konstanz 
GERMANY 
GC CORPORTAION 76-1 HASUNUMA-
CHO, ITABSHI, 
TOKYO, JAPAN 
 
 
 
 
 
 
Composition 
Powder 
(1g) 
-Aluminium-sodium-calcium-
fluoro-phosphoro-silicate 
(18:9:8:16:3:46)         0.84g 
 
-Polyacrylic acid (MW 30000-
45000)             0.15g 
Powder ϯ  Alumino-silicate  glass  
(99%) 
Liquid  Distilled/deionized water Liquid ϯ 2-hydroxyethyl 
methacrylate  
(30-35%) 
 
Polyacrylic acid      
(20-30%) 
 
Urethane 
Dimethacrlate  
(<10%) 
 
Distilled water  
(20-30%) 
 
 
Colour L 2 A 2 
Batch number  1110001332 1108031 
Ϯ derived from manufacture material safety data sheet (2007) 
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 PREPARATION OF MATERIAL SPECIMENS  
To make the dental material specimens Polytetrafluoroethylene (PTFE) moulds 
were prepared at the Dental School workshop at University of Dundee, with an 
inner diameter of 12 mm, and a thickness of 2 mm (Figure 3-1). PTFE rings were 
washed thoroughly with water and detergent, and then sterilized using Ultraviolet 
light for 24 hours before use. 
 
 
Figure ‎3-1 PTFE moulds. 
 
Preparation of disks was carried out under sterile condition using sterilized 
instruments. Scoops, droppers and plastic spatulas provided by the manufacturers 
were rinsed thoroughly in 70% ethanol, and left to dry under Ultraviolet light for 
24 hours before use.  All baseline specimens of both commercial types of glass 
ionomer cements (ChemFil Superior and Fuji VIII GP) were mixed according to 
manufacturers’ instructions and condensed using plastic instruments, into the 
PTFE mould which was placed on a PTFE sheet and then the PTFE mould was 
covered with another PTFE sheet before they were all screwed in between two 
metal plates. After setting the disks were removed from the mould by gentle hand 
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pressure, after unscrewed the metal plates. Then 60ml dishes were opened, inside 
the cabinet and the set disks which, made from glass ionomer cements were glued 
to the centre of the dish using superglue (SHERAMEGA 200, Espohsrabe 53, 
Lemforde, Germany) (figure 3-2). Once all the specimens were glued, the dishes 
were labelled and placed in the microbiological hood under UV light overnight (lid 
removed) for sterilization. The specimens were washed over the next 24 hours 
with Hanks balanced salt solution then left in serum free medium (SF-MEM) 
overnight. 
 
Figure ‎3-2 Glass ionomer disk attached to the dish. 
 
  
GIC DISK  
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 CELL CULTURE MATERIALS 
- 70% ethanol in distilled water. 
- MM1 (Normal Oral mucosa fibroblast cells). 
- Foetal Calf Serum (SIGMA # D-5859, Sigma-Aldrich Company Ltd. Dorset, 
England). 
- EGTA (SIGMA # E-8145, Sigma-Aldrich Company Ltd. Dorset, England). 
- L-Glutamine (SIGMA # G-7513, Sigma-Aldrich Company Ltd. Dorset, 
England). 
- Minimum Essential Medium Eagle (MEM) (SIGMA # M-0275, Sigma-Aldrich 
Company Ltd. Dorset, England). 
- Penicillin-Streptomycin stabilized (SIGMA # P-4333, Sigma-Aldrich 
Company Ltd. Dorset, England). 
- Trypsin/EDTA (SIGMA # T-4549, Sigma-Aldrich Company Ltd. Dorset, 
England). 
- PBS (Phosphate buffered saline) (SIGMA # P-4417, Sigma-Aldrich Company 
Ltd. Dorset, England) 
- Hanks balanced salt solution (SIGMA # H-4641, Sigma-Aldrich Company 
Ltd. Dorset, England). 
- DMSO (Dimethyl sulphoxide) (SIGMA # D-5859, Sigma-Aldrich Company 
Ltd. Dorset, England). 
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 CELL CULTURE PROCEDURE  
Normal oral mucosa  ibroblast cells (MM1) were cultured, in 90mm dishes with 
6ml growth medium each and incubated at 37  C in a CO2 incubator with 5% CO2 
until confluent. They were routinely passaged by trypsinization. In brief, 90mm 
dishes were opened, inside the cabinet, the growth medium was aspirated and the 
monolayer washed twice with 5ml Hanks balanced salt solution. Following this, 
2ml of Trypsin/EDTA solution was added to each 90mm dish and left for 5 minute 
over a hot plate, until the cells had fully detached. Detachment was confirmed by 
viewing under a light microscope then, 2ml of fresh growth medium was added, 
and the cells were collected and transferred to a centrifuge tube using a disposable 
pipette. The cell suspension was then centrifuged for 5 minutes at 900 rpm, and 
the growth medium decanted. Fresh growth medium was then added and the cell 
pellet re-suspended. The cellular concentration was determined by counting using 
an automatic cell counter (Biorad). Cells were seeded in each 60mm dish around 
and over the specimens at a concentration of 5 X 105 cells ml for 21 days at 37  C 
and 5% CO2. The medium was changed every other day. The cells were monitored 
under the light microscope and pictures were taken to the cells located close and 
away from the specimens every 3 days (Figure 3-3).  
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Figure ‎3-3 Cells were monitored under the light microscope. 
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 VIABILITY SCORE  
Ten examiners experienced in cell biology were asked to rank the cells using visual 
observation method as is shown in Table 3-2 (ICCVAM, 2011) 
 
Table ‎3-2 Visual Observation Scoring Table for Cell Viability. 
  
 
 STATISTICAL ANALYSIS 
The effect of the materials on cells was compared to that of the control using the scoring 
values as indicators of cell viability seen over all observation times. The data were 
analyzed using non-parametric one-way ANOVA (A Kruskal-Wallis test) (P < 0.05). 
Further analysis to localise significant difference was performed using Dunn’s Multiple 
comparison test. 
GraphPad PRISM software (Version 5.0, GraphPad Software Inc, San Diego, 
CCalifornia, USA) was used for the statistical analysis.  
  
VIABILITY SCORE  BRIEF DESCRIPTION 
1 Normal cells Morphology and cell Density  
2 Altered cell Morphology and/or  small gaps between cells  
3 Altered cell morphology and/or large gaps between cells 
4 Few (or no) visible cells  
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3.2.1.1.2 DETERMINATION OF THE OPTIMAL BIOACTIVE ADDITIVES 
AND CONCENTRATION  
ChemFil Superior glass ionomer was chosen to be modified as it showed better 
bicompatiality than Fuji VIII GP.   Three different bioactive additions [1- Collagen I, 
2- Stramuann® Emdogain, 3- Gly-Arg-Gly-Asp-Ser (RGD)] (Table 3-3) were added 
to ChemFil Superior glass ionomer in order to produce bioactive specimens. 
 
Table ‎3-3 Bioactive additions. 
MATERIALS MANUFACTURE 
Type I Collagen University of Dundee lab (Schor, 1980) 
Straumann® Emdogain Institute Stramuann®,#CH-4002, Basel, 
Switzerland 
Gly-Arg-Gly-Asp-Ser (RGD) SIGMA-ALDRICH,# 3050 Spruce Street, St. 
Louis, MO 63103 USA 
 
 
 Type I collagen was added to the  mixing water of glass ionomer in two 
different weight ratios 10µg/ml  and 100 µg /ml  to form  aqueous solutions 
of 0.1 % and 0.01% type I collagen. 
 RGD was added to glass ionomer mixing water with two different 
concentration 1mg/ml and 5mg/ml. 
 Emdogain was added to the mixing water of glass ionomer in two different 
concentration of 4mg/ml and 8mg/ml 
All bioactive additives were incorporated into the material and mixed according to 
manufactures instruction at a powder: liquid ratio of 1: 1 and mixed using plastic 
instruments, into the PTFE mould which was placed on a PTFE sheet and then the 
PTFE mould was covered with another PTFE sheet before they were all screwed in 
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between two metal plates. After setting the disks were removed from the mould by 
gentle hand pressure after being unscrewed from the metal plates. 60mm dishes 
were opened inside the sterile cabinet and the set disks made from both bio-
modified at deferent concentration and unmodified ChemFil Superior (control) 
were glued inside the dishes and labelled. The dishes were placed in the 
microbiological hood under UV light overnight (lid removed) for sterilization. Then 
the specimens were washed over the next 24 hours with Hanks balanced salt 
solution then left in SF-MEM overnight. 
CELL CULTURE AND VIABILITY SCORE  
Normal oral mucosa fibroblasts were cultured around and over the specimens and 
monitored and ranked the same way as described in the previous section 
(3.2.1.1DETERMINATION OF THE OPTIMAL MATERIALS FOR ATTACHMENT OF 
CELLS). 
STATISTICAL ANALYSIS 
The effect of the materials on cells was compared to that of the control using the 
scoring values as indicators of cell viability seen over all observation times. The 
data were analyzed using non-parametric one-way ANOVA (A Kruskal-Wallis test) 
(α=0.05).  Further analysis to localise significant difference was performed using 
Dunn’s Multiple comparison test. 
GraphPad PRISM software (version 5.0, GraphPad Software Inc, San Diego, California, 
USA) was used for the statistical analysis.  
  
80 
 
3.2.1.2 CELL VIABILITY TESTING (MTT ASSAY) 
The MTT assay is a colorimetric assay for measuring cellular viability the assay 
measures the conversion tetrazolium dye (3-[4,5-dimethylthiazol]-2-yl-2,5-
diphenyl tetrazolium bromide, or MTT), by the mitochondria of living cells to into 
insoluble formazan crystals (Mosmann, 1983),  which can be quantified after 
solubilization using a spectrophotometer (Givens et al., 1990) .  
 MATERIALS 
 70% ethanol in distilled water. 
 MM1 (Normal Oral mucosa fibroblast cells). 
 Foetal Calf Serum (SIGMA # D-5859, Sigma-Aldrich Company 
Ltd. Dorset, England). 
 EGTA (SIGMA # E-8145, Sigma-Aldrich Company Ltd. Dorset, 
England). 
 L-Glutamine (SIGMA # G-7513, Sigma-Aldrich Company Ltd. 
Dorset, England). 
 Minimum Essential Medium Eagle (MEM) (SIGMA # M-0275, 
Sigma-Aldrich Company Ltd. Dorset, England). 
 Penicillin-Streptomycin stabilized (SIGMA # P-4333, Sigma-
Aldrich Company Ltd. Dorset, England). 
 Trypsin/EDTA (SIGMA # T-4549, Sigma-Aldrich Company 
Ltd. Dorset, England). 
 PBS (Phosphate buffered saline) (SIGMA # P-4417, Sigma-
Aldrich Company Ltd. Dorset, England) 
 Hanks balanced salt solution (SIGMA # H-4641, Sigma-
Aldrich Company Ltd. Dorset, England). 
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 DMSO (Dimethyl sulphoxide) (SIGMA # D-5859, Sigma-
Aldrich Company Ltd. Dorset, England). 
 MTT (3-(4,Dimethylthiazol-2yl)-2,5-diphenyltetrazolium 
bromide) (SIGMA # M-2128, Sigma-Aldrich Company Ltd. 
Dorset, England). 
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3.2.1.2.1 DETERMINATION OF THE OPTIMAL MATERIALS FOR 
ATTACHMENT OF CELLS USING MTT ASSAY 
 SPECIMENS PREPARATION 
All baseline specimens of both commercial types of glass ionomer cements 
(ChemFil Superior and Fuji VIII GP) were prepared on the same way as described in 
the previous experiment section (3.2.1.1 DETERMINATION OF THE OPTIMAL 
MATERIALS FOR ATTACHMENT OF CELLS). 
48 well plates were opened, inside the cabinet and the set disks which, made from 
both materials (ChemFil Superior and Fuji VIII GP) were placed inside the wells. 
Once all the disks were at the bottom of the wells the 48 well plates were placed in 
the microbiological hood under UV light overnight (lid removed) for sterilization. 
After specimens were washed over the next 24 hours with Hanks balanced salt 
solution then left in SF-MEM overnight. 
Cell viability testing (MTT ASSAY) 
Normal oral mucosa  fibroblast cells (MM1) were cultured , in 90 mm dishes with 
6ml growth medium each, and incubated at 37   C in a CO2 incubator (Thermo 
scientific Hera Cell 240) with 5% CO2 until confluent. They were routinely 
passaged by trypsinization. 
In brief, 90mm dishes were opened, inside the cabinet (Class II Microbiological 
Safety Cabinet 1, BioMAT Medical Air Technology), the growth medium was 
aspirated and the monolayer washed twice with 5 ml Hanks balanced salt solution. 
Following this, 2 ml of Trypsin/EDTA solution was added to each 90mm dish and 
left for 5 minute over a hot plate, until the cells had fully detached. Detachment 
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was confirmed by viewing under a light microscope then, 2 ml of fresh growth 
medium were added, and the cells were collected and transferred to a centrifuge 
tube using a disposable pipette. The cell suspension was then centrifuged for 5 
minutes at 900 rpm, and the growth medium decanted. Fresh growth medium was 
then added and the cell pellet re-suspended. The cellular concentration was 
determined by counting using an automatic cell counter (Biorad). Cells were 
seeded in two 48-well culture plates at a concentration of 5 X 104cells/ml for 24 
hours and 72 hours at 37   C and 5% CO2. A pilot study was performed to determine 
the optimal cell density for the experiment. Cells at different density (1x104, 2x104, 
5x104 cells/ml) were seeded in 48-well culture plates for 24 and 72 hours at 37  C 
and 5% CO2. The density of 5x104 cells/ml was found to be optimal regarding to 
the confluence of the cells and was used in this study. 
 
After 24 hours of incubation, the cell attachment, morphology and confluency of 
the wells were checked for both plates and 250µL of fresh growth medium was 
added to each well of the second plate and it was then returned to the incubator 
for another 48 hours at 37   C and 5% CO2. The medium was removed from the 
wells of the first plate by aspiration and the wells were then washed twice very 
gently with serum free medium MEM (SF MEM). 250µL MTT solution was added to 
each well then the plate was incubated at 37°C, 5% CO2 for 3 hours. After, the MTT 
solution was removed from the wells by gently tapping the contents onto paper 
tissues and 250µL of DMSO was added to each well and the plate was placed on the 
shaker for 20 minutes at room temperature. Finally the resulting coloured solution 
was assessed by reading the plate spectrophotometrically on the Fluorostar 
Optima plate reader (BMG LABTECH) at a wavelength of 540nm. 
84 
 
The same procedure was repeated with the second plate after 72 hours of 
incubation at 37°C, 5% CO2.  The concentration of 4x104 cells/ml was found to be 
optimal regarding the confluence of the cells and was therefore used in this study. 
 Statistical analysis 
Absorbance values obtained for each well represent the amount of MTT reduction, 
which is proportional to the number of viable cells. In order to assess the 
percentage of viable cells present in each well, the absorbance values were related 
to those of the control. This was achieved by setting the mean absorbance of the 
control at 100%. 
                           
                 
                              
        
GraphPad PRISM software (version 5.0, GraphPad Software Inc, San Diego, California, 
USA) was used for the statistical analysis.  
The effects of the materials on the cells were compared to each other using the percent 
viability values as indicators of cell numbers, and the data were analyzed to determine 
the effect of type of materials on cell viability the data was analyzed by unpaired t test 
(P < 0.05). 
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3.2.1.2.2 DETERMINATION OF OPTIMAL BIOACTIVE ADDITIVES AND 
CONCENTRATION  
 Specimens preparation 
ChemFil Superior glass ionomer was chosen to be modified with three different 
bioactive additions and specimens prepared in the same way previous described in 
section (3.2.1.1.2 DETERMINATION OF THE OPTIMAL BIOACTIVE ADDITIVES AND 
CONCENTRATION). 
 
 Cell viability testing (MTT ASSAY) 
The MTT Assay was carried out on the same way as was described in previous 
section (3.2.1.2.1 DETERMINATION OF THE OPTIMAL BIOACTIVE ADDITIVES AND 
CONCENTRATION).  
 
 Statistical analysis 
GraphPad PRISM software (version 5.0, GraphPad Software Inc, San Diego, California, 
USA) was used for the statistical analysis.  
This data was subject to analysis of variance with post hoc testing using the Tukey 
comparison of means test.  
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3.2.1.3 IMMUNOCYTOCHEMISTRY (ICC) 
The objective is to label MM1 fixed in situ with primary antibody against Vimentin 
and visualisation by labelling with a fluorescent secondary antibody.  
 MATERIALS AND METHODS  
The normal oral mucosa fibroblast cell line (MM1) was cultured along with glass 
polyalkenoate and bio-modified glass polyalkenoate cements at an initial density of 
0.5×106 cells per 60mm dish for 3 weeks. After, medium was aspirated from the 
dishes and the cells were washed 3 times using phosphate-buffered saline (PBS). 
Cells were then fixed with methanol for 20 minutes at room temperature, washed 
with 0.2% Triton X-100 in PBS for 5 minutes, then washed again 3 times with PBS, 
(5 minutes each), and then blocked with 5% normal goat serum (NGS) in PBS-T 
(PBS+0.1% Tween 20). After 60 minutes, the blocking solution was aspirated cells 
were washed with PBS three times 5 minutes each, and then, incubated overnight 
at +4°C with Vimentin R28 rabbit monoclonal antibody (# 3932S, Cell Signalling 
Technology). The antibody was diluted in 5% NGS in PBS-T dilutions used were 
1:100 and secondary only. All dishes were rinsed gently with PBS, and then 
washed twice with PBS-T and 1 time with PBS for 5 minutes each. The cells were 
incubated with secondary antibody Anti-Rabbit IgG conjugated with Alexa Fluor 
488 (#4412, Cell Signaling Technology) diluted 1:1000 in 5% NGS in PBS-T for 2 
hours. Finally, all dishes were rinsed gently with PBS, and then washed twice with 
PBS-T and then with PBS for 5 minutes each. The overslips were mounted using 
aqueous mount (Sigma) Images were acquired using an inverted fluorescent 
microscope (Olympus Model IMT-2) equipped with a digital camera and the image 
acquisition software (Metamorph software).  
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3.2.1.4 PROTEIN BIOCHEMISTRY  
3.2.1.4.1 CELL LYSIS  
Normal oral mucosa fibroblast cell line (MM1) was cultured along with glass 
polyalkenoate and bio-modified glass polyalkenoate cements at an initial density of 
0.5 ×106 cells per 60mm dishes. After 3 weeks in culture the medium was 
aspirated from the dishes and the cells were washed 3 times using phosphate-
buffered saline (PBS). Total cell protein was then harvested using a cell  lysis buffer 
( 50mM Tris HCl pH 7.2-tris (hydroxymethyl) aminomethane, 150 mm sodium 
hydrochloride, 0.1% (W/V) SDS-Sodium dodecyl sulfate (anionic surfactant), 1.0% 
(V/V) Triton, 1.0% (E/V) sodium deoxy and 5mM and 5Mm EDTA) containing 
protease inhibitors (# 04693132001, Roche Diagnostics, Burgess hill, UK). 500 µl 
of the lysis buffer were added to each dish and the dishes were then incubated on 
ice for 10 minutes; finally, each dish was scraped and the lysates were then 
collected in Eppendorf tubes, appropriately labelled, and stored at -20°C.  
 
3.2.1.4.2 SDS PAGE (POLYACRYLAMIDE GEL ELECTROPHPRESIS) 
SDS PAGE is a common technique used to separate proteins according to their size.   
The frozen lysates were thawed and then spun at 13000rpm for 5 minutes.  
Samples were combined with equal volume of Laemmli loading buffer (62.5 mM 
Tris  HCl pH 6.8, 2% (w/v) SDS, 25% (v/v) Glycerol, 0.01% (w/v) Bromophenol 
Blue, 5% (v/v) 2-Meercaptoethanol) and were heated at 95C for 5 minutes, prior 
to loading onto the gel (Bio Rad Any KD Stain free Tax pre –cast gel). 5 μL cell 
lysate per well were loaded, and 3 μL of Magicmark XP (invitrogen Ltd, Paisely UK) 
was loaded as well, for molecular weight estimation using a Gilson pipette. Gels 
were run at a constant voltage of 110 -150 volts in running buffer (25 mM Tris HCl 
88 
 
pH 8.3, 192 mM glycine, and 0.1% (w/v) SDS). Continue electrophoresis until the 
dye front (blue line) reaches the black line at the bottom of the gel cassette. Then 
the gel was removed gently from the cassette and placed the gel to be western 
blotted into transfer buffer. 
3.2.1.4.3 WESTERN BLOTTING 
Western blotting is a method used to transfer the protein bands, obtained by SDS 
PAGE fractionation of the cell lysates, onto a nitrocellulose membrane using an 
electrical current and to subsequently probe the membrane with a primary 
antibody that specifically binds to the target protein (Vimentin). 
 MATERIALS 
- Transfer Buffer: (5.82g Tris, 2.93g Glycine, 3.75ml 10% (w/v) SDS, 200ml 
Methanol made up to 1 litre with dH2O). 
- TBST: (24.2 Tris; 80g Sodium chloride ; 5ml Tween; 14ml Hydrochloric acid 
pH 7.6; 1 litre dH2O) 
- Blocking Buffer (100ml 1x Tris-buffered saline Tween TBST (PH 7.6); 1g 
dried milk powder. 
- TBS: TBST without Tween 20  
- Bio Rad Extra thick blotting paper 
- Nitrocellulose membrane (0.2μm; Bio-Rad) 
- Bio-Rad Trans-Blot SD Semi-Dry Electrophoretic cell 
- BioRad Immun- Star Western C 
- Antibodies 
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Primary antibody 
   Anti-vimentin (#3932, Cell Signalling, Cell Signalling technology, Wilbury Way, 
UK ) 
Secondary antibody  
Anti-rabbit IgG (#7074, Cell Signalling, Cell Signalling technology, Wilbury Way, 
UK) 
 METHODS  
The sample proteins were transferred from the gel to nitrocellulose membrane. 
The gels were trimmed and then rinsed in the transfer buffer. The Western blot 
was prepared by placing  a piece of BioRad extra thick paper soaked in transfer 
buffer onto the electrode, followed by a piece of Nitrocellulose membrane, the gel 
then covered by another piece of soaked BioRad extra tick paper. The Sample 
proteins were then transferred to the Nitrocellulose membrane at 15v for 42 
minutes. After blotting, the membranes were blocked in 1% (w/v) milk TBST for 
10 minutes and then exposed to primary antibody overnight (Anti-vimentin (Cell 
Signalling #3932) diluted 1:2000 in 1% (w/v) milk TBST). Followed by washing 3 
times with TBS-T for 20 minutes each wash. Next, the membrane was incubated 
with secondary antibody from Cell Signalling (Anti-rabbit IgG –HRO labelled 
product no. 7074, Diluted 1:2,000 in 1% (w/v) milk TBST) for an hour. Membranes 
were then washed again with TBST 3 time for 20 minutes each, incubated with 
SuperSignal® West Pico chemilumniscent substrate (Thermo Scientific) for 1-5 
minutes. Finally, the chemiluminescence was detected and documented by using a 
BioRad gel doc system.  
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In order to assess the percentage of Vimentin expression by cells cultured with 
materials, the band density were related to those of the control (MM1 + ChemFil 
superior). This was achieved by setting the density of the control at 100%. 
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3.2.2 DETERMINATION OF THE PHYSICAL PROPERTIES OF THE 
GLASS POLYALKENOATE CEMENTS AT BASELINE AND 
FOLLOWING BIOACTIVE ADDITIONS    
 
At baseline and following the additions (additions identified in this work as having 
potential for cellular attachment) the following physical properties, of potential 
significance for clinical durability, were determined. 
 
 Surface hardness (5 specimens) 
 Compressive strength (15 specimens) 
 Diametral compressive strength (15 specimens) 
 3 point flexural strength (15 specimens) 
 Diametral compressive fatigue limit (15 specimens) 
 Biaxial flexural strength (10 specimens) 
 Adhesive shear bond strength to bovine enamel (15 specimens) 
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3.2.2.1 SPECIMEN FABRICATION AND STORAGE 
All baseline specimens were proportioned and mixed according to the 
manufacturer’s instructions. In the case of the bioactive additions; (1- Collagen 
TypeI, 2- Gly-Arg-Gly-Asp-Ser (RGD), 3- Stramuann® Emdogain ). These were 
added according to the methods described below. Such addition was identified 
from the cellular work of this thesis (3.2.1 INVESTIGATION OF BIOACTIVE 
ADDITIONS TO GLASS POLYALKENOATE CEMENTS) as offering greatest potential 
to foster cellular interaction. In all bioactive addition the material was dispersed 
according to the manufactures instructions at a powder: liquid ratio of 1: 1 the 
additions investigated for this part of the work were. 
a. Collagen type I 0.1% (100µg/ml)  
b. RGD (5mg/ml). 
Once fabricated all specimens were stored in distilled water at 37 °C for one 
week prior to testing. 
  
93 
 
(a) Fabrication of specimens used for compressive and flexural testing. 
A variety of moulds were used to manufacture the specimens. In the case of 
flexural specimens a sectional Perspex mould, giving a specimen size of 25 x 2 x 2 
mm was used (Figure 3.4). 
 
 
 
 
 
 
 
Figure ‎3-4 The Perspex mould used to flexural specimens. 
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For the specimens tested for compressive strength, diametral compressive 
strength and diametral compressive fatigue a split stainless steel mould, giving 
specimens sizes of 6 mm long and 4 mm diameter was used (Figure 3-5).  
 
 
 
 
Figure ‎3-5 The Split stainless steel mould used to fabricate compressive, diametral compressive and 
compressive fatigue specimens. 
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Biaxial flexural strength specimens were fabricated in silicone rubber moulds 
giving specimen sizes of 2 mm thick X 12 mm diameter (Figure 3.6).  
None of the moulds was vaselined, to facilitate specimen release, other than the 
stainless steel compressive mould. 
 
 
 
 
Figure ‎3-6 The silicone rubber moulds used to fabricate biaxial flexural strength, surface hardness, 
and adhesive shear bond strength specimens. 
.  
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Prior to mixing the cements under test the compressive strength mould was placed 
upon a flat glass slab covered by a clear cellulose matrix strip (Hawe-Neos Dental 
CH-6934 Bioggio Switzerland). In all other cases the mould designs themselves 
contained a flat base against which the base of the specimen was formed. 
Thereafter the mixed cement was applied into the well of the moulds using a 
plastic spatula, with packing action, to slight excess. A cellulose matrix strip was 
then applied to the exposed surface and pressure applied to the material through a 
flat glass slab on which was placed a 5 Kg weight for 5 minutes. Once this time had 
elapsed the specimen was removed from the mould. If upon visual inspection no 
defects were found the specimen was accepted for storage and testing. 
 
(b) Fabrication of specimens for hardness testing 
Hardness testing specimens were fabricated in a circular silicone rubber moulds 
giving specimen sizes of 2 mm X thick 12 mm diameter (figure 3-6)  to produce 20 
discs of  glass ionomer cements  in total comprises of unmodified ChemFil Superior 
and GC Fuji VIII and modified ChemFil Superior (with RGD and also collagen Type 
I). For each state 5 specimens were made and following a period of 5 minutes 
within the mould the specimens were ejected and stored for one week in distilled 
water at 37 C° prior testing.   
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The mixed cement was applied into the well of the moulds using a plastic spatula, 
with packing action, to slight excess. A cellulose matrix strip was then applied to 
the exposed surface and pressure applied to the material through a flat glass slab 
on which was placed a 5kg weight for 5 minutes. Once this time had elapsed the 
specimen was removed from the mould. If upon visual inspection no defects were 
found the specimen was accepted for storage and testing. 
 
(c) Fabrication of specimens for bond strength testing    
24 bovine molar teeth, with their roots removed and pulps extirpated, were 
sectioned longitudinally and mounted in circular epoxy resin blocks  ((Bonda Clear 
Casting Resin, Bondaglass Vost Ltd, Kent, UK)) with their buccal/palatal surfaces 
upper most. The exposed surfaces were rendered flat flush with the surrounding 
mounting  epoxy resin using  a PM5 precision lapping  and polishing machine 
(Longitech, Glasgow, Scotland) and a slurry of calcined Aluminium Oxide powder 
with a particle size of 9 µm (Longitech, Glasgow, Scotland), for subsequent cement 
application and testing. 
 
Prior to cement application all prepared samples of tooth were stored in a 
incubator, at 37 °C, in distilled water for one month prior to cement application. 
This was in an endeavour to ensure uniform inter specimen hydration. Thereafter 
the specimens were removed from storage and a circular washer (5mm diameter x 
1.5 mm deep) was placed upon the exposed tooth surface. Through this the mixed 
glass polyalkenoate cement was applied, using a flat plastic instrument, and once 
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clinically set the washer was removed. Thereafter the completed specimen was 
stored in distilled water at 37°C for one week prior to testing. 
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3.2.2.2 SPECIMEN TESTING 
An Instron Universal testing machine (Model 4469, Instron Ltd., High Wycombe, 
UK) (figure 3-7) was used to perform all tests unless stated otherwise. The testing 
procedures described in this thesis utilised standard methodology used in the 
laboratories where the tests were undertaken. 
 
 
 
 
Figure ‎3-7 An Instron Universal testing machine. 
  
100 
 
3.2.2.2.1  SURFACE HARDNESS  
A type D Shore Durometer (Shore Instrument and manufacturing Co, Jamaica, New 
York, USA) was used to measure this property (Figure 3-8). Prior to its use its 
calibration was checked against its supplied calibration and each sample was 
subjected to one indentation, yielding a shore hardness value. 
For each state and material hardness values were expressed as a mean and 
standard deviation of five samples, measured once each.  
 
 
 
 
 
Figure ‎3-8 Shore Instrument. 
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3.2.2.2.2  COMPRESSIVE STRENGTH  
This was determined at a cross head speed of 1 mm min-1. Prior to testing the 
length and diameter of each specimen was measured using a micrometer. The 
results for each material and state were expressed as a mean and standard 
deviation. This data was subject to analysis of variance with post hoc testing using 
the Tukey comparison of means test.  
The formula used to determine compressive strength was: 
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3.2.2.2.3  DIAMETRAL COMPRESSIVE STRENGTH  
This was determined at a cross head speed of 1 mm min-1. Prior to testing the 
length and diameter of each specimen was measured using a micrometer. The 
results for each material and state were expressed as a mean and standard 
deviation. This data was subject to analysis of variance with post hoc testing using 
the Tukey comparison of means test. The formula used to determine compressive 
strength was: 
                                     
  
   
 
Where F is the force (N) at failure, D is the specimen diameter (mm) and T is its 
length. 
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3.2.2.2.4  THREE POINT FLEXURAL STRENGTH 
This was determined at a cross head speed of 1 mm min-1. Prior to testing the 
breadth and depth of each specimen was measured using a micrometer. A support 
separation distance of 20 mm was used for this test.  The results for each material 
and state were expressed as a mean and standard deviation. This data was subject 
to analysis of variance with post hoc testing using the Tukey comparison of means 
test. The formula used to determine flexural strength was: 
                        
   
    
  
Where F is the force (N) at failure, L is the support separation distance in mm, b is 
the specimen width in mm and d is its depth in mm. 
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3.2.2.2.5  DIAMETRAL COMPRESSIVE FATIGUE LIMIT 
This was determined at a cross head speed of 10 mm min-1 under load control. 
Each specimen was subjected to cyclic diametral compressive loading to failure or 
survival at 1500 cycles. At the commencement of the test a load of 2 Newton’s was 
applied to the specimen before the load was increased to the maximum applied 
load for the test. Two Newton’s was therefore the minimum force applied to each 
specimen. This was undertaken to minimize the effect of any bounce of the 
specimen upon the platten of the testing machine that could occur if the minimum 
load was zero Newton’s. The starting level was the applied load necessary to 
achieve 60% of the measured diametral compressive strength at 10 mm min-1. 
Testing followed the staircase method described by Draughn (1979) and where a 
specimen survived the next test maximum load was increased by a predetermined 
load increment and where it failed the load was decreased by the same increment. 
Upon completion of the test, after typically 15 specimens had been tested, analysis 
of the data was based upon the least frequent event (failure or survival). The 
applied stress levels were arranged in descending rank order (highest to lowest 
(rank 0)) and the numbers of failures or survivals for each of these was calculated. 
For the entire test, for a given material and bioactive addition, the total number of 
failures or survivals was determined. These totals were given the letter N (total of 
least frequent event). The data was used to calculate A using: 
∑((the rank number of the applied stress of least frequent event) * (the 
frequency of event occurrence at that stress level)). 
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 Thereafter B was calculated according to the formula; 
  ∑ ((Rank number of applied stress of least frequent event) 2 * (frequency of 
event occurrence at that stress level)). 
 
Xo was assigned to the lowest stress level considered in the analysis and d 
represented the stress increment used in the test. 
 
The mean fatigue limit X was calculated using this expression; 
       
 
 
 
 
 
  
If the analysis was based on survival the positive sign was used but where based 
on failure the negative sign was used. 
 
The standard deviation (S) of the fatigue limit was calculated using the equation; 
S = 1.62 d (NB-A2/N2 + 0.029) in cases where (NB-A2)/N2 was larger than 0.3. 
In cases however where (NB-A2)/N2 was less than 0.3 it was calculated using the 
equation S = 0.53 d as advocated by Dixon and Mood (1948) and recommended, in 
such circumstances, by Draughn (1979). 
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3.2.2.2.6  BIAXIAL FLEXURAL STRENGTH  
A Universal Testing Machine (Model 4469, Instron Ltd., High Wycombe, UK), at a 
crosshead speed of 1 mm min-1, was used to determine the bi-axial flexural 
strength of the discs. Each disc was placed on three circumferentially arranged 
fixed ball bearings spaced every 1200 around the perimeter of a circle of radius 4 
mm on a specially constructed jig. Load, to fracture, was applied perpendicular to 
the specimen’s surface, at its centre, through a stainless steel rod of radius 1 mm at 
the point of specimen contact. The load at fracture was recorded and for each 
specimen bi-axial flexural strength was calculated using the following formula as 
reported by Shetty et al., (1983). 
  
  
  
 
                      )        
        
   
       
Where P is the maximum at failure,   is Poission’s ratio,   is the radius of the 
support circle (4 mm),   is the radius of disc specimen (6 mm),   is the thickness of 
the disc specimen (2 mm) and    is the radius of the ball used on the loading 
surface. For small    values such as that in the study:  
                          
Where    is an equivalent radius of contact between the loading ball and disc 
specimen, where loading can be considered to be uniform. The strength values 
were calculated using a Poisson’s ratio 0.35 for the materials used to apply 
experimentally to materials of this type (Akinmade and Nicholson, 1993a). 
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3.2.2.2.7  ADHESIVE SHEAR BOND STRENGTH TO BOVINE ENAMEL  
A specially constructed jig (Figure 3-9) mounted upon the load cell of the Instron 
Universal Testing Machine was used to determine the shear bond strengths of the 
Glass Polyalkenoate Cements to bovine tooth substance in both manufactured and 
modified form. For each combination of materials a total of 15 specimens were 
tested to failure. The blade of the assembly was applied, as close as possible, to the 
cement/tooth interface at a crosshead speed of 0.5 mm min-1.  
 
Figure ‎3-9 Schematic diagram of the adhesive shear strength testing. 
 
The shear bond strength was calculated using the formula: 
                          
                    
                
 
This data was subject to analysis of variance with post hoc testing using the Tukey 
comparison of means test.  
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4 RESULTS  
4.1 THE QUESTIONNAIRE  
In response to the invitation to participate in the questionnaire a total of 134 UK 
and 120 Libyan responses were received. These figures represent a percentage 
return rate of 34.25 % UK and 60 % Libya.  
Due to changes in registration status of those invited to participate in the UK some 
questionnaires were returned as these individuals were no longer registered. This 
did not occur in Libya. Table 4-1 summarise the reasons given for return/non 
completion of the UK questionnaires as stated by the respondents.  
 
Table ‎4-1 Reasons for Non completion /return of UK questionnaires. 
Reasons Number  
Change in addresses 8 
Not Specialty   4 
Retirement 4 
Others 1 
Numbers in the body of the table represent the number responses 
  
 
In relation to the UK responders the mean length of time they had been practicing 
dentistry was 20.64 years (SD= 11.31, Median= 20, minimum= 1, Maximum= 42). 
In the case of Libyan respondents the mean length of time they had been practicing 
dentistry was 7.96 years (SD= 6.09, Median=6, minimum= 1, Maximum= 35) 
Figures 4-1 and 4-2 graphically summaries the teeth most commonly affected by 
root surface caries in the experience of the respondents. It is evident that there is 
no clear difference between the countries in this respect.  
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Figure ‎4-1 The anterior teeth most commonly affected by root surface caries according to the respondents of the questionnaire. 
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Figure ‎4-2 The posterior teeth most commonly affected by root surface caries. 
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Table 4-2 summarises the age groups thought to be most susceptible to the 
development of root surface caries according to both UK and Libyan respondents. 
A chi square test revealed a significant (P < 0.01) difference in the distribution of 
the responses from each country. Root caries in childhood was not reported by 
either country but a greater proportion of Libyan respondents reported root caries 
in adulthood (26.49% Libya of 2.25% UK). 
 
 
 
 
Table ‎4-2 The age group most susceptible to root caries. 
Age group United kingdom Libya 
Childhood 0 0.00% 0 0.00% 
Adult 7 6.25% 31 26.49% 
Elderly 105 93.75% 86 73.50% 
Numbers in the table body are number of responses unless otherwise stated. 
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Where sex was taken into account (Table 4-3) a chi square test demonstrated 
significant differences in the responses of UK and Libyan respondents with the UK 
indicating proportionally more responses of no influence of sex upon root caries 
susceptibility. In Libya however a higher proportion of males were considered 
more likely to be susceptible to root caries. In both countries few indicated that 
females were susceptible. 
 
 
Table ‎4-3 The most susceptible sex to root caries. 
Gender United Kingdom Libya 
Males  29 25.22% 74 62.18% 
Females  04 03.47% 08 06.62% 
No difference between males and females   82 71.30% 37 31.09% 
Numbers in the table body are number of responses unless otherwise stated 
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Table 4-4 summarises the perceived proportion of patients, in the experience of 
the UK and Libyan respondents, prone to root surface caries. This was 
proportionally greater for the UK (39.13%) compared to Libya (25.66%). Chi 
square testing confirmed statistically significant (P < 0.05) differences in the 
response of the two countries. 
 
 
Table ‎4-4 proportion of patient prone to root surface caries in practices. 
Does your practice have a large proportion of 
patient prone to root surface caries?  
United kingdom Libya 
Yes 45 39.13% 29 25..66% 
No 70 60.86% 84 74.34% 
Numbers in the table body are number of responses unless otherwise stated 
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Table 4-5 summarises the methods of detecting root surface caries stated by the 
respondents. Upon inspection of this it is clear that many permutations of the basic 
methods (visual, tactile, radiographs) were employed by the respondents. A chi 
square test reveled significant differences (P < 0.05) in the responses of the 
countries. In both countries the most common method of detecting root surface 
caries was visual. In Libya however radiographic detection was used more 
commonly than in the UK (34.86% Libya cf 22.03 UK). 
 
 
Table ‎4-5 Stated methods of detection root surface caries. 
Methods of detection United Kingdom Libya 
Visually 98 41.53% 65 37.14% 
Tactile  80 33.90% 46 26.29% 
Radiographs 52 22.03% 61 34.86% 
Pain 0 02.54% 01 01.14% 
Other techniques  6 00.00% 02 00.57% 
Numbers in the table body are number of responses unless otherwise stated 
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 Table 4-6 summarises the responses as to the most common surface affected by 
root surface caries. In both countries this was the buccal but in Libya 
proportionally more reports of root caries affecting the interproximal surface were 
encountered. Chi square analysis confirmed statistically significant (P<0.05) 
differences in the responses of the two countries. 
 
 
Table ‎4-6 The surface most commonly affected by root surface caries. 
Surface most commonly affected  United kingdom Libya 
Labial (buccal) surface 68 67.33% 56 51.38% 
Interproximal surface  27 26.73% 51 48.79% 
Palatal (lingual) surface 6 5.94% 02 1.83% 
Numbers in the table body are number of responses unless otherwise stated 
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Table 4-7 summaries the methods usually used to manage root surface caries. Chi 
square testing revealed a significant difference in the responses from both 
countries (P<0.01). In both a range of techniques were used but restoration was 
more commonly used in Libya (57.00% Libya versus 28.2% UK). 
 
Table ‎4-7 The methods usually used to manage root surface caries. 
Numbers in the table body are number of responses unless otherwise stated 
 
 
 
 
 
 
  
Methods usually used to manage root surface caries United kingdom Libya 
Monitoring with prevention instruction  88 22.98% 27 15.00% 
Dietary advice  88 22.98% 17 9.44% 
Topical fluoride  90 23.50% 16 8.89% 
Restoration  108 28.20% 103 57.22% 
Ozone 3 0.78% 3 1.67% 
Extraction 2 0.52% 12 6.67% 
Oral hygiene instruction  3 0.78% 1 0.56% 
Perio treatment  1 0.26% 1 0.56% 
Others 0 0.00% 0 0.00% 
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Table 4-8 gives the factors cited by the respondents as influencing the selection of 
management method for root surface caries. Chi square testing demonstrated a 
significant (P<0.01) difference in the responses from the two countries. The diet of 
patients in the UK influenced to a greater extent the management of the root caries 
(UK= 23.86% versus Libya 08.11%)  
 
Table ‎4-8 The factors that influence the selection of the management methods. 
Factors that influence the selection of the 
management methods 
United kingdom Libya 
Patient oral hygiene  102 25.89% 74 33.33% 
Diet  94 23.86% 18 8.11% 
Patients age  59 14.97% 38 17.12% 
Tooth type  23 5.84% 20 9.01% 
Severity of the lesion  105 26.65% 70 31.53% 
Socioeconomic  0 0.00% 1 0.45% 
General health  4 1.01% 1 0.45% 
Medication  2 0.51% 0 0.00% 
Co-operation of patient  1 0.25% 0 0.00% 
Patient dexenty  1 0.25% 0 0.00% 
Attitude, special need, preference  1 0.25% 0 0.00% 
Moisture control  1 0.25% 0 0.00% 
Symptoms  1 0.25% 0 0.00% 
Other 0 0.00% 0 0.00% 
Numbers in the table body are number of responses unless otherwise stated 
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Table 4-9 gives the most commonly used restorative materials for treatment of 
root surface caries In both countries chi square testing revealed statistically 
significant differences in the responses (P<0.05) with proportionally more glass 
polyalkenoate cement being used in the UK (66.80% cf 47.02% Libya) and a 
greater amount of composite in Libya (26.49% cf 13.91% UK). Similar proportions 
of amalgam and compomer were used in both countries (approx. 10%)  
 
Table ‎4-9 The most commonly used restorative material to restore root caries. 
Most commonly used restorative 
material to restore root caries 
United kingdom Libya 
Amalgam  17 11.26% 14 10.07% 
Glass Ionomer 101 66.89% 71 47.02% 
Composite  21 13.91% 40 26.49% 
Compomer 12 07.95% 14 09.27% 
Others  0 00.0% 0 00.00% 
Numbers in the table body are number of responses unless otherwise stated 
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Table 4-10 indicates the number of respondents reporting bleeding from the 
gingival tissues as a problem in restoring root surface caries. There was no 
statistically significant difference between the countries (P > 0.05) (chi square) 
with bleeding being reported as a problem both sometimes and frequently.  
 
Table ‎4-10 Bleeding from the gingival tissues in restoring root surface caries. 
Is bleeding from Gingival tissues problem in 
restoring root caries?  
United kingdom Libya 
Never  1 0.87% 12 10.61% 
Sometimes  77 66.98% 55 48.67% 
Frequently  37 32.17% 46 40.71% 
Numbers in the table body are number of responses unless otherwise stated 
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Table 4-11 summarises the methods of finishing root surface caries restorations as 
reported by the respondents. Chi square testing revealed a difference in response 
according to country (P<0.001). With rotary cutting instruments being used to 
finish the restoration in both countries with however a greater proportion of 
respondents in Libya deferring this to a recall visit rather than at placement. (Libya 
25.00% cf. 08.92% UK). Finishing at the placement was more common in the UK 
(UK 53.50% cf. Libya 35.34%). 
 
Table ‎4-11 Methods of finishing the restoration. 
Methods of finishing United kingdom Libya 
Hand finishing (sharp knives or scalers) at placement 
visit  
53 33.76% 37 31.90% 
Rotary finishing at placement visit  84 53..50% 41 35.34% 
Hand finishing (sharp knives or scalers) at recall visit  5 3.18% 8 9.90% 
Rotary finishing at recall visit  14 8.92% 29 25.00% 
Strips- fine sand plate  1 0.64% 0 0.00% 
Seal restorative, scalar  0 0.00% 1 0.86% 
Others 0 0.00% 0 0.00% 
Numbers in the table body are number of responses unless otherwise stated 
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Tables 4-12 and 4-13 Summarises the reported follow up, and its interval, of root 
caries restorations as reported by the respondents.  
Chi square testing revealed significant (p<0.01) differences between the countries. 
In the UK it was most common to follow up root caries restorations (UK 66.67% cf. 
Libya 29.52%) every six months (UK 80%). 
 
Table ‎4-12 Follow up of patients with root caries restorations. 
Numbers in the table body are number of responses unless otherwise stated 
 
 
 
Table ‎4-13 Following up intervals of patients with root surface caries restorations. 
Following up intervals United Kingdom Libya 
1 to 4 months  11 15.71% 13 44.83% 
6 Months 56 80.00% 15 51.73% 
9 to12 months  3 4.29% 1 3.45% 
Numbers in the table body are number of responses unless otherwise stated 
  
Follow up of patients United kingdom Libya 
Yes  74 66.67% 31 29.52% 
No 15 13.50% 16 15.24% 
Sometimes  22 19.82% 58 55.24% 
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Table 4-14 summarises the respondents impression of the average life span of root 
caries restorations, formed from the preferred material of the respondents. A chi 
square test of this data demonstrated significant difference between the countries.  
Proportionately more root caries restoration failed in the first year in Libya 
(15.38% Libya cf. 0% UK). Longer survival times were reported in the UK.  
 
 
Table ‎4-14 The average life span of the restoration most commonly used for restoration root surface 
caries. 
Numbers in the table body are number of responses unless otherwise stated 
 
  
Average life span United kingdom Libya 
Less than a year  0 0.00% 16 15.38% 
1 to 5 years  85 78.70% 82 78.85% 
More than 5 years  23 21.30% 6 5.77% 
123 
 
The table 4-15 summarises the lifestyle factors reported as being associated with 
the development of root surface caries. There was no significant difference in the 
responses of the two countries (Chi Square). In both countries giving up smoking 
was the factor most considered to give rise to root surface caries. Surprisingly diet 
was considered by the respondents to be relatively unimportant (UK 4.44%, Libya 
0%) 
 
 
Table ‎4-15 The lifestyle events associated with root surface caries development. 
Numbers in the table body are number of responses unless otherwise stated 
 
  
Lifestyle events associated with root surface caries United kingdom Libya 
Bereavement  34 18.89% 19 15.78% 
Retirement  34 18.89% 26 26.49% 
Giving up smoking  39 21.67% 54 44.63% 
Loss of job 21 11.67% 14 11.57% 
Oral hygiene  10 5.56% 4 3.31% 
Alcohol  0 0.00% 2 1.63% 
Smoking  0 0.00% 1 0.83% 
General health condition  25 13.89% 1 0.83% 
Diet 8 4.44% 0 0.00% 
Partial denture  3 1.67% 0 0.00% 
Age 6 3.33% 0 0.00% 
Other 0 0.00% 0 0.00% 
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Table 4.16 and figures 4.3 to 4.21 summarise the rankings of importance of factors 
in the development of root surface caries according to the country of the 
respondents.  
These did not statistically differ in the cases of numbers of teeth present (figure 4-
3), presence of partial dentures (figure 4-4), oral hygiene state (figure 4-5), 
physical disability (figure 4-6), mental disability/senility (figure 4-7), consumption 
of fizzy drinks (figure 4-8), overhanging restoration (figure 4-9) and poor general 
health (figure 4-10). There was a statistically significant difference between the 
countries responses in the cases of Degree of crowding (figure 4-11), Cigarette 
smoking (figure 4-12), Total amount of sugars consumed (figure 4-13), Frequency 
of sugar intake (figure 4-14), Active periodontal disease (figure 4-15), 
Consumption of alcohol (figure 4-16), Poor crown margins (figure 4-17), Gingival 
recession (figure 4-18), Reduce salivary flow (figure 4-19), Presence of erosion 
(figure 4-20), Presence of abrasion cavity (figure 4-21). 
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Table ‎4-16 The factors are important in the development of root surface. 
Where significant, as identified by Chi square testing, level of significance is shown as NS= Not 
significant, *= P < 0.05, **= P < 0.01, *** = P<0.001. Numbers in the body of the table are number of 
respondents.  
  
The factors are important in the development of root surface where 1 =very important ,2=quite important, 3=fairly important, 4=not at all 
important  
 United kingdom  Libya 
1 2 3 4 1 2 3 4 
Number  of teeth present  11 32 29 39 NS 26 30 30 34 
Degree of crowding  22 39 34 19 *** 64 33 14 3 
Presence of a partial denture  52 36 18 8 NS 36 39 24 12 
Cigarette smoking  14 45 34 21 *** 52 31 25 5 
Total amount of sugars consumed 74 23 12 6 *** 35 47 31 5 
Frequency of sugar intake  96 12 2 6 *** 48 42 19 4 
Oral hygiene state  98 9 3 4 NS 100 5 4 2 
Physical disability  65 30 14 3 NS 45 40 19 6 
Mental disability/senility  64 35 10 3 NS 68 26 14 4 
Active periodontal disease  39 43 22 7 *** 79 20 7 6 
Consumption of alcohol 11 24 50 24 *** 49 40 16 5 
Consumption of fizzy drink  47 34 19 12 *** 16 40 37 14 
Overhanging restoration 31 38 34 9 NS 46 33 24 10 
Poor crown margins  39 38 28 8 ** 60 31 16 2 
Gingival recession  39 44 22 8 *** 76 24 8 4 
Reduce salivary flow 84 19 7 2 * 66 37 7 2 
Presence of erosion  13 28 47 24 *** 38 44 20 12 
Presence of abrasion cavity  9 28 43 31 *** 32 49 24 7 
Poor general health  54 38 19 2 NS 49 40 14 10 
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Figure ‎4-3 Number of teeth present. 
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Figure ‎4-4 Presence of a partial denture. 
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Figure ‎4-5 Oral hygiene states. 
  
86% 
8% 
3% 
3% 
Oral hygiene state (UK) 
1=very important  
2=quite important 
3=fairly important 
4=not at all important  
90% 
4% 
4% 
2% 
Oral hygiene state (Libya) 
1=very important  
2=quite important 
3=fairly important 
4=not at all important  
129 
 
 
Figure ‎4-6 Physical disability. 
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Figure ‎4-7 Mental disability/senility. 
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Figure ‎4-8 Consumption of fizzy drink. 
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Figure ‎4-9 Overhanging restoration. 
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Figure ‎4-10 Poor general health. 
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Degree of crowding considered proportionally more important in Libya (figure 4-
11) 
 
Figure ‎4-11 Degree of crowding. 
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Cigarette smoking considered proportionally more important in Libya (figure 4-
12) 
 
Figure ‎4-12 Cigarette smoking. 
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Total amount of sugars consumed considered proportionally more important in 
the UK (figure 4-13) 
 
Figure ‎4-13 Total amount of sugars consumed. 
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Frequency of sugar intake considered proportionally more important in the UK (figure 4-14) 
 
 
Figure ‎4-14 Frequency of sugar intake. 
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Active periodontal disease considered proportionally more important in Libya 
(figure 4-15) 
 
Figure ‎4-15 Active periodontal diseases. 
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Consumption of alcohol considered proportionally more important in Libya (figure 
4-16) 
 
Figure ‎4-16 Consumption of alcohol. 
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Poor crown margins considered proportionally more important in Libya (figure 4-
17) 
 
Figure ‎4-17 Poor crown margins. 
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Gingival recession considered proportional ly more important in Libya (figure 4-
18) 
 
Figure ‎4-18 Gingival recession. 
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Reduce salivary flow considered proportionally more important in the UK (figure 
4-19) 
 
Figure ‎4-19 Reduce salivary flow. 
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Presence of erosion considered proportionally more important in Libya (figure 4-
20) 
 
Figure ‎4-20 Presence of erosion. 
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Presence of abrasion cavity considered proportionally more important in Libya 
(figure 4-21) 
 
Figure ‎4-21 Presence of abrasion cavity. 
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4.2 THE LABORATORY INVESTIGATIONS  
 
4.2.1 THE INVESTIGATION OF BIOACTIVE ADDITIONS TO 
GLASS POLYALKENOATE CEMENTS 
4.2.1.1 OBSERVATION UNDER THE MICROSCOPE  
In order to evaluate the visible effect of materials on oral mucosa cells the cells 
were cultured along with materials specimens for 21days. During this period the 
cells were observed and monitored under a light microscope and pictures were 
taken every 3 days figures 4-22 to 4-31. Such images were ranked by ten 
observers. The raw data obtained is contained in appendices D, E, F, G and, H  
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4.2.1.1.1 DETERMINATION OF THE OPTIMAL MATERIALS FOR 
ATTACHMENT OF CELLES. 
 
The oral mucosa fibroblast cells cultured around ChemFil superior and GC Fuji VIII 
for 21 days. The pictures were taken every three days close and away to the 
specimens Figures 4-22- 4-23. 
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ChemFil Superior 24hrs 
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Control (MM1)  3 days 
 
ChemFil Superior 3 days GC Fuji VIII 3days 
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ChemFil Superior 6 days 
Control (MM1) 9 days 
 
ChemFil Superior 9 days GC Fuji VIII 9 days 
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ChemFil Superior 12 days GC Fuji VIII 12days 
Control (MM1) 15 days 
 
ChemFil Superior 15 days GC Fuji VIII 15 days 
GC Fuji VIII 24hrs 
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Figure ‎4-22 The oral mucosa fibroblast cells cultured close to ChemFil superior and GC Fuji VIII  
specimens for 21 days.  
  
Control (MM1) 18 days 
 
ChemFil Superior 18 days GC Fuji VIII 18 days 
Control (MM1) 21 days 
 
ChemFil Superior 21 days GC Fuji VIII 21days 
GIC 
GIC 
GIC 
GIC 
149 
 
 
 
 
 
 
  
Control 24 (MM1) hrs 
 
ChemFil Superior 24hrs GC Fuji VIII 24hrs 
Control (MM1)  3 days 
 
ChemFil Superior 6 days 
GC Fuji VIII 3 days 
Control (MM1) 6 days 
 
Control (MM1) 9 days 
 
Control 12 (MM1) days 
 
ChemFil Superior 3 days 
GC Fuji VIII 6 days 
ChemFil Superior 9 days 
GC Fuji VIII 9 days 
ChemFil Superior 12 days GC Fuji VIII 12 days 
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Figure ‎4-23 The oral mucosa fibroblast cells cultured away from ChemFil superior and GC Fuji VIII  
specimens for 21 days. 
 
 
 
  
Control (MM1) 15 days 
 
Control (MM1) 18 days 
 
Control (MM1) 21 days 
 
ChemFil Superior 15 days GC Fuji VIII 15 days 
ChemFil Superior 18 days GC Fuji VIII 18 days 
ChemFil Superior 21 days GC Fuji VIII 21 days 
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A Kruskal-Wallis test demonstrated that, very highly statistically significant 
differences (P < 0.0001) between the groups of the pooled rankings of cell 
viabilities of the oral mucosal cells located in contact and away from the materials 
seen over all observation times. Localisation by a Dunn’s Multiple comparison test 
showed that all groups different significantly (P < 0.001) from each other. The most 
common ranking scores for each group were,  
 Control = Rank 1 (Range = 2, Min Rank = 1, Max Rank = 3). 
 ChemFil Superior (Close) = Rank 3 (Range = 3, Min  Rank = 1, Max Rank = 4) 
 GC Fuji VIII  (Close) = Rank 4 ( Range = 2, Min Rank =3, Max Rank = 4) 
 
 Control (Away) = Rank 1 (Range = 1, Min Rank = 1, Max Rank = 2). 
 ChemFil Superior (Away) = Rank 2 (Range = 2, Min  Rank = 2, Max Rank = 4) 
 GC Fuji VIII  (Away) = Rank 4 ( Range = 2, Min Rank =2, Max Rank = 4) 
It is thus evident that the lowest cell viability was associated with GC Fuji VIII.  
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4.2.1.1.2 DETERMINATION OF THE OPTIMAL BIOACTIVE ADDITIVES 
AND CONCENTRATION   
  
 TYPE I COLLAGEN  OPTIMAL CONCENTRATION        
The oral mucosa fibroblast cells cultured around unmodified and bio-modified 
ChemFil superior with different concentration of Type I collagen for 21 days. The 
pictures to the cells were taken every 3 days close and away to the specimens 
Figure 4-24 and 4-25. 
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Figure ‎4-24 The oral mucosa fibroblast cells close  to unmodified and bio-modified ChemFil superior 
with different concentration  of Type I collagen for 21 days.  
ChemFil Superior 18 days 
ChemFil Superior 21 days 
Collagen 0.01%+ChemFil 18 days Collagen 0.1%+ChemFil 18 days 
Collagen 0.01%+ChemFil 21 days Collagen 0.1%+ChemFil 21 days 
GIC 
GIC 
GIC 
GIC GIC 
GIC 
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ChemFil Superior 3 days Collagen 0.01%+ChemFil 3 days Collagen 0.1%+ChemFil 3 days 
ChemFil Superior 6 days Collagen 0.01%+ChemFil 6 days Collagen 0.1%+ChemFil 6 days 
ChemFil Superior 9 days Collagen 0.01%+ChemFil 9 days Collagen 0.1%+ChemFil 9 days 
ChemFil Superior 12 days Collagen 0.01%+ChemFil 12 days Collagen 0.1%+ChemFil 12 days 
ChemFil Superior 15 days Collagen 0.01%+ChemFil 15 days Collagen 0.1%+ChemFil 15 days 
ChemFil Superior 24 hrs Collagen 0.01%+ChemFil 24 hrs Collagen 0.1%+ChemFil 24hrs 
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Figure ‎4-25 The oral mucosa fibroblast cells away from unmodified and bio-modified ChemFil superior 
with different concentration  of Type I collagen for 21 days.  
ChemFil Superior 18 days Collagen 0.01%+ChemFil 18 days Collagen 0.1%+ChemFil 18 days 
ChemFil Superior 21 days Collagen 0.01%+ChemFil 21 days Collagen 0.1%+ChemFil 21 days 
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A Kruskal-Wallis test of the pooled rankings of cell viabilities of the cell close and 
away from ChemFil superior glass ionomer cement modified by the addition of two 
different concentration of type I collagen (0.01%, 0.1%)  and control  at all the 
observed time points demonstrated very highly statistically significant differences 
(P < 0.0001) between the groups. These were localised using a Dunn’s Multiple 
comparison test whose outcome is summarised in tables 4.17-18 
Table ‎4-17 Dunn’s Multiple comparison test of rankings of cell viabilities cell close to unmodified and 
modified  ChemFil superior glass ionomer cement by the addition of  different concentration of type I 
collagen (0.01%, 0.1%) . 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
 
 
 
 
Table ‎4-18 Dunn’s Multiple comparison test of rankings of cell viabilities cell away from unmodified 
and modified  ChemFil superior glass ionomer cement by the addition of  different concentration of 
type I collagen (0.01%, 0.1%). 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
 
  
  
Versus 0.1% ChemFil Superior + 
Collagen type I (close) 
ChemFil Superior +  
0.01% Collagen type I 
(close) 
ChemFil Superior (close) *** *** 
ChemFil Superior +0.1% Collagen 
type I (close) 
____ *** 
Versus ChemFil Superior +0.1%   type 
I Collagen (Away) 
ChemFil Superior + 
0.01% type I  Collagen  
(Away) 
ChemFil Superior (Away) NS * 
ChemFil Superior +0.1%  type I 
Collagen (Away) 
____ *** 
158 
 
The most common ranking scores for each group were,  
 ChemFil Superior (close) = Rank 3 (Range = 3, Min Rank = 1, Max Rank = 4). 
 ChemFil Superior +0.1% Type I Collagen (Close) = Rank 2 (Range = 2, Min 
Rank = 1, Max Rank = 3).  
 ChemFil Superior +0.01% Type I Collagen (Close) = Rank 3 (Range = 3, Min 
Rank =1, Max Rank = 4). 
 
 ChemFil Superior (Away) = Rank 3 (Range = 3, Min Rank = 1, Max Rank = 
4). 
 ChemFil Superior +0.1% Type I Collagen (Away) = Rank 2 (Range = 2, Min  
Rank = 1, Max Rank = 3) 
 ChemFil Superior +0.01% Type I Collagen (Away) = Rank 4 ( Range = 3, Min 
Rank =1, Max Rank = 4) 
It is thus evident that the highest cell viability was associated with ChemFil 
Superior modified with 0.1% Type I Collagen.  
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 RGD  OPTIMAL CONCENTRATION 
The oral mucosa fibroblast cells cultured around unmodified and bio-modified 
ChemFil superior with different concentration of RGD for 21 days. The pictures to 
the cells were taken every 3 days close and away to the specimens Figure 4-26 and 
4-27. 
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‎4-26 The oral mucosa fibroblast cells close to unmodified and bio-modified ChemFil superior with 
different concentration  of RGD  for 21 days.  
ChemFil Superior 18 days 
ChemFil Superior 21 days 
RGD 1 mg/ml + ChemFil 18 days RGD 5mg/ml + ChemFil 18 days 
RGD 1 mg/ml + ChemFil 21 days RGD 5mg/ml + ChemFil 21 days 
GIC GIC 
GIC 
GIC 
GIC 
GIC 
162 
 
A Kruskal-Wallis test of the pooled rankings of cell viabilities of oral mucosal cells,  
close to unmodified ChemFil superior glass ionomer cement and modified ChemFil 
superior glass ionomer cement, by the addition of two different concentration of 
RGD  (1mg/ml, 5mg/ml )  seen at all observed time points demonstrated very 
highly statistically significant differences (P < 0.0001) between the groups. These 
were localised using a Dunn’s Multiple comparison test whose outcome is 
summarised in table 4-19 
 
Table ‎4-19 Dunn’s Multiple comparison test of rankings of cell viabilities cell close to unmodified and 
modified  ChemFil superior glass ionomer cement by the addition of  two different concentration of 
RGD (1mg/ml, 5mg/ml). 
Key; NS = not significant, * = p < 0.05, **= p < 0.001, *** = p < 0.0001 
 
The most common ranking scores for each group were,  
 ChemFil Superior (close) = Rank 3 (Range = 3, Min Rank = 1, Max Rank = 4). 
 ChemFil Superior + RGD 1mg/ml (Close) = Rank 3 (Range = 3, Min Rank = 
1, Max Rank = 3).  
 ChemFil Superior +RGD 5mg/ml (Close) = Rank 2 (Range = 2, Min Rank =1, 
Max Rank = 3). 
 
  
Versus ChemFil Superior + RGD 
1mg/ml  (close) 
ChemFil Superior +  RGD 
5ml/ml 
(close) 
ChemFil Superior (close) NS *** 
ChemFil Superior +RGD 
5mg/ml (close) 
*** ____ 
163 
 
 
 
 
 
 
 
ChemFil Superior 24hrs 
ChemFil Superior 3 days 
ChemFil Superior 6 days 
ChemFil Superior 9 days 
ChemFil Superior 12 days 
ChemFil Superior 15 days 
RGD 5mg/ml + ChemFil 24hrs RGD 1 mg/ml + ChemFil 24hrs 
RGD 1 mg/ml + ChemFil 3 days RGD 5mg/ml + ChemFil 3 days 
RGD 1 mg/ml + ChemFil 6 days RGD 5mg/ml + ChemFil 6 days 
RGD 1 mg/ml + ChemFil 9 days RGD 5mg/ml + ChemFil 9 days 
RGD 1 mg/ml + ChemFil 12 days RGD 5mg/ml + ChemFil 12 days 
RGD 1 mg/ml + ChemFil 15 days RGD 5mg/ml + ChemFil 15 days 
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Figure ‎4-27 The oral mucosa fibroblast cells away from unmodified and bio-modified ChemFil superior 
with different concentration  of RGD  for 21 days.  
ChemFil Superior 18 days 
ChemFil Superior 21 days 
RGD 1 mg/ml + ChemFil 18 days RGD 5mg/ml + ChemFil 18 days 
RGD 1 mg/ml + ChemFil 21 days RGD 5mg/ml + ChemFil 21 days 
165 
 
 
A Kruskal-Wallis test of the pooled rankings of cell viabilities of oral mucosal cells,  
away from  unmodified ChemFil superior glass ionomer cement and modified 
ChemFil superior glass ionomer cement, by the addition of two different 
concentration of RGD  (1mg/ml, 5mg/ml )  seen at all observed time points 
demonstrated highly statistically significant differences (P < 0.001) between the 
groups. These were localised using a Dunn’s Multiple comparison test whose 
outcome is summarised in table 4-20 
Table ‎4-20 Dunn’s Multiple comparison test of rankings of cell viabilities cell away from unmodified 
and modified  ChemFil superior glass ionomer cement by the addition of  two different concentration 
of RGD (1mg/ml, 5mg/ml). 
Key; NS = not significant, * = p < 0.05, **= p < 0.001, *** = p < 0.0001 
 
The most common ranking scores for each group were,  
 ChemFil Superior (Away) = Rank 2(Range = 3, Min Rank = 1, Max Rank = 4). 
 ChemFil Superior + RGD 1mg/ml (Away) = Rank 2 (Range = 3, Min Rank = 
1, Max Rank = 4).  
 ChemFil Superior +RGD 5mg/ml (Away) = Rank 2 (Range =3, Min Rank =1, 
Max Rank = 4). 
 
It is thus evident that the highest cell viability was associated with ChemFil 
Superior modified with 5mg/ml RGD.  
 
Versus ChemFil Superior + RGD 
1mg/ml  ( Away ) 
ChemFil Superior +  RGD 
5ml/ml 
( Away ) 
ChemFil Superior (Away) NS ** 
ChemFil Superior +RGD 
5mg/ml ( Away ) 
* ____ 
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 EMDOGAIN OPTIMAL CONCENTRATION  
The oral mucosa fibroblast cells cultured around unmodified and bio-modified 
ChemFil superior with different concentration of RGD for 21 days. The pictures to 
the cells were taken every 3 days close and away to the specimens Figure 4-28 and 
4-29. 
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Figure ‎4-28 The oral mucosa fibroblast cells close to bio-modified ChemFil superior with different 
concentration  of Emdogain  for 21 days.  
ChemFil Superior 18 days 
ChemFil Superior 21 days 
Emdogain 4mg/ml + ChemFil 18 days Emdogain 8mg/ml + ChemFil 18 days 
Emdogain 4mg/ml + ChemFil 21 days Emdogain 8mg/ml + ChemFil 21 days 
GIC 
GIC 
GIC 
GIC 
GIC 
GIC 
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A Kruskal-Wallis test of the pooled rankings of cell viabilities of oral mucosal cells,  
close to unmodified ChemFil superior glass ionomer cement and modified ChemFil 
superior glass ionomer cement, by the addition of two different concentration of 
Emdogain  (4mg/ml, 8mg/ml )  seen over all observation times demonstrated very 
statistically significant differences (P < 0.05) between the groups. These were 
localised using a Dunn’s Multiple comparison test whose outcome is summarised in 
table 4-21 
Table ‎4-21 Dunn’s Multiple comparison test of rankings of cell viabilities cell close to unmodified and 
modified  ChemFil superior glass ionomer cement by the addition of two different concentration of 
Emdogain (4mg/ml, 8mg/ml). 
Key; NS = not significant, * = p < 0.05, **= p < 0.001, *** = p < 0.0001 
 
The most common ranking scores for each group were,  
 ChemFil Superior (close) = Rank 3 (Range = 3, Min Rank = 1, Max Rank = 4). 
 ChemFil Superior + Emdogain 4mg/ml (Close) = Rank 3 (Range = 3, Min 
Rank = 1, Max Rank = 4).  
 ChemFil Superior +Emdogain 8mg/ml (Close) = Rank 3 (Range = 3, Min 
Rank =1, Max Rank = 4). 
 
 
  
Versus ChemFil Superior + Emdogain 
4mg/ml  (close) 
ChemFil Superior +  
Emdogain 8ml/ml 
(close) 
ChemFil Superior (close) NS ** 
ChemFil Superior +Emdogain 
8mg/ml (close) 
NS ____ 
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ChemFil Superior 24hrs 
ChemFil Superior 3 days 
ChemFil Superior 6 days 
ChemFil Superior 9 days 
ChemFil Superior 12 days 
ChemFil Superior 15 days 
Emdogain 4mg/ml + ChemFil 24hrs Emdogain 8mg/ml + ChemFil 24hrs  
Emdogain 4mg/ml + ChemFil 3days Emdogain 8mg/ml + ChemFil 3 days  
Emdogain 4mg/ml + ChemFil 6 days Emdogain 8mg/ml + ChemFil 6 days  
Emdogain 4mg/ml + ChemFil 9 days Emdogain 8mg/ml + ChemFil 9 days  
Emdogain 4mg/ml + ChemFil 12 days Emdogain 8mg/ml + ChemFil 12 days  
Emdogain 4mg/ml + ChemFil 15 days Emdogain 8mg/ml + ChemFil 15 days  
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Figure ‎4-29 The oral mucosa fibroblast cells away from unmodified and bio-modified ChemFil superior 
with different concentration of Emdogain for 21.  
ChemFil Superior 18 days 
ChemFil Superior 21 days 
Emdogain 4mg/ml + ChemFil 18days Emdogain 8mg/ml + ChemFil 18 days  
Emdogain 4mg/ml + ChemFil 21 days Emdogain 8mg/ml + ChemFil 21days  
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A Kruskal-Wallis test of the pooled rankings of cell viabilities of oral mucosal cells,  
located away from  unmodified ChemFil superior glass ionomer cement and 
modified ChemFil superior glass ionomer cement, by the addition of two different 
concentration of Emdogain  (4mg/ml, 8mg/ml)  seen at all observed time points 
demonstrated very  highly statistically significant differences (P < 0.001) between 
the groups. These were localised using a Dunn’s Multiple comparison test whose 
outcome is summarised in table 4-22 
Table ‎4-22 Dunn’s Multiple comparison test of rankings of cell viabilities cell located away from 
unmodified and modified  ChemFil superior glass ionomer cement by the addition of  two different 
concentration of Emdogain (4mg/ml, 8mg/ml). 
Key; NS = not significant, * = p < 0.05, **= p < 0.001, *** = p < 0.0001 
 
The most common ranking scores for each group were,  
 ChemFil Superior (Away) = Rank 2 (Range = 3, Min Rank = 1, Max Rank = 
4). 
 ChemFil Superior + Emdogain 4mg/ml (Away) = Rank 2 (Range = 3, Min 
Rank = 1, Max Rank = 4).  
 ChemFil Superior +Emdogain 8mg/ml (Away) = Rank 2 (Range = 2, Min 
Rank =1, Max Rank = 3). 
 
It is thus evident that better cell viability was associated with ChemFil Superior 
modified with 8mg/ml Emdogain.  
Versus ChemFil Superior + Emdogain 
4mg/ml  ( Away ) 
ChemFil Superior +  
Emdogain 8ml/ml 
( Away ) 
ChemFil Superior ( Away ) NS *** 
ChemFil Superior +Emdogain 
8mg/ml ( Away ) 
*** ____ 
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4.2.1.1.3 DETERMINATION OF OPTIMAL BIOACTIVE ADDITIVES 
The oral mucosa fibroblast cells cultured around bio-modified ChemFil superior 
with three different Bio-additives for 21 days. The pictures to the cells were taken 
every 3 days close and away to the specimens Figure 4-30 and 4-31. 
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Collagen 0.1%+ChemFil 3 days 
Collagen 0.1%+ChemFil 6 days 
Collagen 0.1%+ChemFil 9 days 
Collagen 0.1%+ChemFil 12 days 
Collagen 0.1%+ChemFil 15 days 
RGD 5mg/ml + ChemFil 3 days 
RGD 5mg/ml + ChemFil 6 days 
RGD 5mg/ml + ChemFil 9 days 
RGD 5mg/ml + ChemFil 12 days 
RGD 5mg/ml + ChemFil 15 days 
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Figure ‎4-30 The oral mucosa fibroblast cells close to bio-modified ChemFil superior with 3 different 
bio-additive for 21 days.  
Collagen 0.1%+ChemFil 18 days 
Collagen 0.1%+ChemFil 21 days 
RGD 5mg/ml + ChemFil 18 days 
RGD 5mg/ml + ChemFil 21 days 
Emdogain 8mg/ml + ChemFil 18 days 
Emdogain 8mg/ml + ChemFil 21 days 
GIC 
GIC 
GIC 
GIC 
GIC 
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A Kruskal-Wallis test of the pooled rankings of cell viabilities of oral mucosal cells,  
close to modified ChemFil superior glass ionomer cement ( 0.1% Collagen type I,  
RGD 5mg/ml,  Emdogain  8mg/ml )  seen at all observed time points demonstrated 
very highly statistically significant differences (P < 0.0001) between the groups. 
These were localised using a Dunn’s Multiple comparison test whose outcome is 
summarised in table 4-23. 
 
Table ‎4-23 Dunn’s Multiple comparison test of rankings of cell viabilities cell close to unmodified and 
modified  ChemFil superior glass ionomer cement by the addition Type I collagen, RGD and, Emdogain. 
Key; NS = not significant, * = p < 0.05, **= p < 0.001, *** = p < 0.0001 
 
The most common ranking scores for each group were,  
 ChemFil Superior+ 0.1% Collagen type I (close) = Rank 2 (Range = 3, Min 
Rank = 1, Max Rank = 4). 
 ChemFil Superior + RGD 5mg/ml (Close) = Rank 2 (Range = 1, Min Rank = 
2, Max Rank = 3).  
 ChemFil Superior +Emdogain 8mg/ml (Close) = Rank 3 (Range = 3, Min 
Rank =1, Max Rank = 4). 
  
Versus ChemFil Superior +0.1%  
Collagen type I (close) 
ChemFil Superior +  
Emdogain 8ml/ml 
(close) 
ChemFil Superior +RGD 
5mg/ml (close) 
NS *** 
ChemFil Superior +Emdogain 
8mg/ml (close) 
*** ____ 
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Collagen 0.1%+ChemFil 3 days 
Collagen 0.1%+ChemFil 6 days 
Collagen 0.1%+ChemFil 9 days 
Collagen 0.1%+ChemFil 12 days 
Collagen 0.1%+ChemFil 15 days 
Collagen 0.1%+ChemFil 24hrs RGD 5mg/ml + ChemFil 24hrs 
RGD 5mg/ml + ChemFil 3 days 
RGD 5mg/ml + ChemFil 6 days 
RGD 5mg/ml + ChemFil 9 days 
RGD 5mg/ml + ChemFil 12 days 
RGD 5mg/ml + ChemFil 15 days 
Emdogain 8mg/ml + ChemFil 24hrs  
Emdogain 8mg/ml + ChemFil 3 days  
Emdogain 8mg/ml + ChemFil 6 days  
Emdogain 8mg/ml + ChemFil 9 days  
Emdogain 8mg/ml + ChemFil 12 days  
Emdogain 8mg/ml + ChemFil 15 days  
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Figure ‎4-31 The oral mucosa fibroblast cells away from unmodified and bio-modified ChemFil superior 
with different bio-additives  for 21 days specimens for 21 days. 
.  
Collagen 0.1%+ChemFil 18 days 
Collagen 0.1%+ChemFil 21 days 
RGD 5mg/ml + ChemFil 18 days 
RGD 5mg/ml + ChemFil 21 days 
Emdogain 8mg/ml + ChemFil 18 days  
Emdogain 8mg/ml + ChemFil 21days  
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A Kruskal-Wallis test of the pooled rankings of cell viabilities of oral mucosal cells,  
located away from modified ChemFil superior glass ionomer cement (0.1% 
Collagen type I,  RGD 5mg/ml,  Emdogain  8mg/ml) seen at all observed time 
points demonstrated statistically significant differences (P < 0.05) between the 
groups. These were localised using a Dunn’s Multiple comparison test whose 
outcome is summarised in table 4.24 
Table ‎4-24 Dunn’s Multiple comparison test of rankings of cell viabilities cell close to unmodified and 
modified  ChemFil superior glass ionomer cement by the addition of  Type I collagen, RGD and, 
Emdogain. 
Key; NS = not significant, * = p < 0.05, **= p < 0.001, *** = p < 0.0001 
 
The most common ranking scores for each group were,  
 ChemFil Superior+ 0.1% Collagen type I (Away) = Rank 2 (Range = 2, Min 
Rank = 1, Max Rank = 3). 
 ChemFil Superior + RGD 5mg/ml (Away) = Rank 2 (Range =3, Min Rank =1, 
Max Rank = 4).  
 ChemFil Superior +Emdogain 8mg/ml (Away) = Rank 1 (Range = 3, Min 
Rank =1, Max Rank = 4). 
  
Versus ChemFil Superior +0.1%  
Collagen type I ( Away ) 
ChemFil Superior +  
Emdogain 8ml/ml 
( Away ) 
ChemFil Superior +RGD 
5mg/ml (Away) 
NS ** 
ChemFil Superior +Emdogain 
8mg/ml ( Away) 
NS ____ 
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4.2.1.2 CELL VIABILITY TESTING (MTT ASSAY) 
4.2.1.2.1 DETERMINATION OF OPTIMAL MATERIAL FOR 
ATTACHMENT OF CELLS  
To determine the effect of GC Fuji VIII and ChemFil superior glass ionomer 
cements on oral mucosa fibroblast viability MTT Assays were carried out. The 
viability of the oral mucosa was measured after 24 hour and 72 hours from 
culturing oral mucosa fibroblast cells with those materials.  
The absorbance values obtained for each well represent the amount of MTT 
reduction, which is proportional to the number of viable cells. In order to assess 
the percentage of viable cells present in each well, the absorbance values were 
related to those of the control. This was achieved by setting the mean absorbance 
of the control at 100%. 
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The percentages of the effect of ChemFil Superior and GC Fuji VIII on cell viability 
after 24 and 72 hours are presented in tables 4-25 and 4-26 respectively.   
 
Table ‎4-25 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the materials after 24 hours. 
Sample Fibroblast 
Cells   
ChemFil Superior  GC Fuji VIII 
1 105.54 33.95 22.80 
2 90.04 12.92 36.26 
3 104.43 46.13 38.74 
4 95.33 40.59 31.32 
5 99.73 24.72 35.71 
6 104.67 54.24 30.22 
7 60.07 39.85 22.80 
8 112.15 33.58 34.07 
9 127.43 38.01 54.40 
    
Mean 99.93 36.00 34.04 
SD 18.33 11.96 9.48 
  
Table ‎4-26 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the materials after 72 hours. 
Sample Fibroblast 
Cells  
ChemFil Superior  GC Fuji VIII 
1 103.92 9.70 0.38 
2 91.91 17.06 3.01 
3 104.44 9.70 1.50 
4 51.13 10.37 4.51 
5 122.18 10.70 2.63 
6 126.69 5.69 3.38 
7 75.25 14.72 1.13 
8 129.43 8.36 2.26 
9 95.32 8.36 0.38 
    
Mean 100.00 2.13 10.52 
SD 25.48 1.05 3.45 
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 On the first 24 hours, cells exposed to both ChemFil Superior and GC Fuji VIII showed 
similar viability around 35 %. After 72 hours the average percentages of the viability of 
the cells has been markedly reduced for both materials i.e. (ChemFil superior 10.52% 
and GC Fuji VIII 2.13%) (Figure 4.32). 
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Figure ‎4-32 Percentage of cell viability (Mean+ SD) relative to the control (100% viability) for 
materials after 24 and 72 hours. 
 
Statistical analysis (Unpaired t test) showed that no significant difference between cells 
viabilities for ChemFil superior and GC Fuji after 24 hours. However, there was very 
highly significant deference between both materials after 72 hours (P < 0.0001). 
It is thus evident that the lowest cell viability was associated with GC Fuji VIII 
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4.2.1.2.2 DETERMINATION THE OPTIMAL CONCENTRATION OF 
BIOACTIVE ADDITIVES 
To determine the optimal concentration of the bio-additives to ChemFil superior 
glass ionomer and their effect on cell viability, MTT Assays were carried out after 
24 hour and 72 hours. ChemFil Superior glass ionomer cement was modified by 
three different bio- additives (type I Collagen, RGD, Emdogain) at two different 
concentrations each. The Absorbance values obtained for each well represent the 
amount of MTT reduction, which is proportional to the number of viable cells. In 
order to assess the percentage of viable cells present in each well, the absorbance 
values were related to those of the control (unmodified ChemFil Superior). This 
was achieved by setting the mean absorbance of the control at 100%. 
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 The effects of the addition of two different concentrations of type I Collagen (10µg/ml, 
100µg/ml) to ChemFil Superior on cell viability after 24 hours and 72 hours are 
presented in tables 4-27-4-28.  
Table ‎4-27 Percentages of cell viability relative to the unmodified ChemFil Superior (100% viability) 
after direct contact with the modified ChemFil superior after 24 hours. 
Sample ChemFil 
Superior  
24hrs 
Type I Collagen 
0.01% 24hrs 
Type I Collagen 
0.1% 24 hrs 
1 95.77 87.24 80.52 
2 140.03 97.11 88.31 
3 64.14 95.37 57.15 
4 98.36 117.80 49.70 
5 80.33 92.34 105.51 
6 120.49 104.30 50.10 
7 69.29 60.66 60.66 
8 113.28 85.25 85.25 
9 117.84 63.93 63.93 
    
Mean 99.95 89.33 71.24 
SD 47.2 18.13 19.44 
 
 
 
Table ‎4-28 Percentages of cell viability relative to the control (100% viability) after direct contact with 
modified ChemFil superior after 72 hours. 
Sample ChemFil 
Superior   
Type I Collagen 
0.01%  
Type I Collagen 
0.1%  
1 137.76 200.70 117.48 
2 111.19 104.55 361.89 
3 50.70 150.00 218.18 
4 97.56 176.22 167.83 
5 70.73 337.41 65.03 
6 131.71 225.87 144.76 
7 40.00 78.05 151.22 
8 186.67 37.80 60.98 
9 66.67 9.76 118.29 
    
Mean 99.22 146.70 156.20 
SD 47.52 102.2 91.35 
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After 24 hours, cells exposed to modified ChemFil Superior with 0.1 % Type I 
collagen and 0.01% Type I collagen showed less viability than the control around 
89.9% and 71.24% respectively. After 72 hours, the average percentages of the 
viability of the cells has been markedly increased for both materials i.e. (0.01% 
Type I collagen +ChemFil superior 146.7% and 0.1 %Type I collagen +ChemFil 
superior 156.6.2%) (Figure 4-33). 
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Figure ‎4-33 Percentage of cell viability (Mean+ SD) relative to the control (100% viability) for 
materials after 24 and 72 hours. 
 
 
 
Statistical analysis (one-way ANOVA) showed significant effects between the groups 
of different Type I collagen concentration (P<0.05) on cell viability. Follow up 
186 
 
comparison by Tukey's multiple comparison test showed no significant differences 
between the different concentrations of the Type I collagen table (4-29). 
 
Table ‎4-29 Tukey’s comparison of means to different concentration of Type I collagen. 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
 
 
 
 
 
 
 
 
  
Versus ChemFil Superior + 0.1% Type I 
collagen  24 hours 
ChemFil Superior + 0.01% Type 
I collagen 72 hours 
ChemFil Superior + 0.01% Type I collagen  24 
hours  
  NS ___ 
ChemFil Superior + 0.01% Type I collagen 72 
hours 
____ NS 
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The effects of the addition of two different concentrations of RGD (1mg/ml, 5mg/ml) to 
ChemFil Superior on cell viability after 24 hours and 72 hours are presented in tables 4-
30-31. 
Table ‎4-30 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the ChemFil superior modified with 1mg/ml and 5mg/ml RGD after 24 hours. 
Sample ChemFil 
Superior 24hrs   
RGD 1mg/ml  RGD 5mg/ml  
1 163.37 64.83 83.14 
2 57.27 108.14 131.40 
3 79.07 154.65 131.98 
4 81.48 59.30 54.07 
5 88.89 57.85 109.59 
6 104.63 37.50 41.86 
7 104.63 73.15 101.85 
8 94.44 52.78 81.48 
9 100.93 77.78 109.26 
    
Mean 97.19 76.22 93.85 
SD 29.05 35.33 31.56 
 
 
Table ‎4-31 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the ChemFil superior modified with 1mg/ml and 5mg/ml RGD after 72 hours. 
Sample ChemFil 
Superior 72hrs  
RGD 1mg/ml  RGD 5mg/ml  
1 107.78 73.56 294.00 
2 94.44 94.22 48.44 
3 98.00 95.78 229.78 
4 93.33 81.33 176.44 
5 102.22 112.89 224.22 
6 102.22 83.78 93.33 
7 90.24 115.56 84.44 
8 100.00 135.56 128.89 
9 107.32 88.89 106.67 
    
Mean 99.51 97.95 154.0 
SD 6.09 19.75 81.63 
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After 24 hours, cells exposed to bio- modified ChemFil Superior (1 mg/ml RGD and 
5mg/ml RGD) showed less viability than the unmodified  ChemFil Superior around 
76.22%  for 5mg/ml RGD + ChemFil superior and 93.85%5mg/ml RGD + ChemFil 
superior. After 72 hours the oral mucosa fibroblast cells associated with 5mg/ml 
RGD + ChemFil Superior showed greater viability then the cells associated with the 
control by more than 50% (Figure 4.34). 
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Figure ‎4-34 Percentage of cell viability (Mean+ SD) relative to the control (100% viability) for 
materials after 24 and 72 hours. 
 
Statistical analysis (one-way ANOVA) showed highly significant effects between the 
groups of different RGD concentration (P<0.001) on cell viability. Follow up 
comparison by Tukey's multiple comparison test showed no significant differences 
between the different concentrations of the RGD (table 4-32). 
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Table ‎4-32 Tukey’s comparison of means the different concentrations of the RGD of means. 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
  
 Versus  ChemFil Superior + RGD 
5mg/ml  24 hours 
ChemFil Superior +  RGD 
5mg/ml  72 hours 
ChemFil Superior + RGD 1mg/ml  24 hours  NS ___ 
ChemFil Superior +  RGD 1mg/ml  72 hours ____ NS 
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The effects of the addition of two different concentrations of Emdogain (4mg/ml, 
8mg/ml) to ChemFil Superior on cell viability after 24 hours and 72 hours are presented 
in tables 4-33 and 4-34. 
 
Table ‎4-33 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the ChemFil superior modified with 4mg/ml and 8mg/ml Emdogain after24 hours. 
Sample ChemFil 
Superior  24hrs 
Emdogain 4mg/ml  Emdogain 8mg/ml  
1 110.56 85.92 -1.41 
2 77.46 48.59 -0.70 
3 111.97 0.70 -1.41 
4 69.29 15.49 21.13 
5 113.28 9.15 -0.70 
6 117.84 0.00 0.70 
7 171.11 35.68 120.99 
8 66.67 56.43 88.89 
9 63.33 22.82 127.16 
    
Mean 100.2 30.53 39.41 
SD 34.84 28.84 56.11 
 
 
 
Table ‎4-34 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the ChemFil superior modified with 4mg/ml and 8mg/ml Emdogain after72 hours. 
Sample ChemFil 
Superior   
Emdogain 4mg/ml  Emdogain 8mg/ml  
1 95.37 33.70 108.93 
2 121.82 64.89 106.90 
3 82.66 119.44 81.03 
4 68.00 173.67 168.50 
5 144.00 133.39 40.60 
6 88.00 122.57 112.85 
7 110.48 99.15 140.00 
8 70.82 135.98 120.00 
9 118.98 59.49 196.00 
    
Mean 100..00 104.7 119.40 
SD 25.55 44.43 45.86 
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On the first 24 hours, cells exposed to bo A Kruskal-Wallis th bio- modified 
ChemFil Superior with 4 mg/ml Emdogain and 8mg/ml Emdogain showed very 
low viability compared with the control around 35. After 72 the viability of the 
cells associated with ChemFil superior modified with emdogain increased to 
excess the viability of the cells associated with unmodified ChemFil superior.  
(Figure 4-35). 
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Figure ‎4-35 Percentage of cell viability (Mean+ SD) relative to the control (100% viability) for 
materials after 24 and 72 hours. 
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Statistical analysis (one-way ANOVA) showed very highly significant effects between 
the groups of different Emdogain concentration (P<0.0001) on cell viability. Follow up 
comparison by Tukey's multiple comparison test showed no significant differences 
between the different concentrations of Emdogain (table 4-35).  
 
Table ‎4-35 Tukey’s comparison of means to different concentrations of Emdogain of means. 
 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
  
Versus ChemFil Superior + 
Emdogain 8mg/ml  24 
hours 
ChemFil Superior +   
Emdogain 8mg/ml  72 
hours 
ChemFil Superior + Emdogain 4mg/ml  24 hours  NS ___ 
ChemFil Superior +   Emdogain 4mg/ml  72 hours ____ NS 
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4.2.1.2.3 DETERMINATION THE OPTIMAL BIOACTIVE ADDITIVES  
To determine the optimal bio-additives to ChemFil superior glass ionomer and 
their effect on cell viability, MTT Assay was carried out after 24 hour and 72 hours 
of culturing oral mucosa fibroblast with bio-modified ChemFil Superior glass 
ionomer cement with 3 different bio- additives (0.1% type I Collagen, RGD 5 
mg/ml, Emdogain 8mg/ml) which showed best cell viability. The absorbance values 
obtained for each well represent the amount of MTT reduction, which is 
proportional to the number of viable cells. In order to assess the percentage of 
viable cells present in each well, the absorbance values were related to those of the 
control (unmodified ChemFil Superior). This was achieved by setting the mean 
absorbance of the control at 100%. 
 
The percentages of the effect of  the  bio-modifications of  ChemFil Superior  with 
different bio-additives  (Collagen Type I  0.1%, RGD 5mg/ml, Emdogain 8mg/ml ) on 
cell viability after 24 hours is presented in table 14 and the percentages of the effect of  
the Bio-modified ChemFil Superior on cell viability after 72 hours showed in tables 4-
36 and 4-37. 
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Table ‎4-36 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the ChemFil superior modified with RGD, Type I collagen and Emdogain after 24 hours. 
Sample ChemFil 
Superior 24hrs  
RGD 5mg/ml Type I Collagen 
0.1% 
Emdogain 
8mg/ml 
1 75.96 51.06 92.42 76.21 
2 130.93 115.28 69.07 79.44 
3 93.11 3.66 117.95 65.40 
4 171.11 4.22 3.33 18.67 
5 66.67 6.22 12.22 3.78 
6 63.33 7.44 41.11 11.33 
7 171.11 4.22 18.67 3.33 
8 66.67 6.22 3.78 12.22 
9 63.33 7.44 11.33 41.11 
     
Mean 100.2 49.54 65.25 34.61 
SD 45.56 44.87 40.20 31.54 
 
Table ‎4-37 Percentages of cell viability relative to the control (100% viability) after direct contact with 
the ChemFil superior modified with RGD, Type I collagen and Emdogain after 72 hours. 
Sample ChemFil 
Superior 72hrs  
RGD 5mg/ml Type I Collagen 
0.1% 
Emdogain 
8mg/ml 
1 92.30 231.39 147.13 92.30 
2 139.34 79.67 83.03 139.34 
3 80.57 114.26 100.16 80.57 
4 40.00 73.33 140.00 78.05 
5 186.67 66.67 46.67 37.80 
6 66.67 73.33 126.67 9.76 
7 25.00 113.33 81.33 99.15 
8 162.50 40.00 112.89 135.98 
9 100.00 100.00 83.78 59.49 
     
Mean 99.23 98.67 124.6 81.38 
SD 54.47 40.15 76.99 42.27 
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On the first 24 hours (figure 1), cells exposed to ChemFil Superior modified with 
Collagen type I 0.1% showed highest viability around 65% where the cells exposed to 
ChemFil superior modified with RGD and Emdogain showed less viability with 49.54% 
and 34.61% respectively. After 72 hours the average percentages of the viability of the 
cells has been raised for all materials i.e. (ChemFil superior + collagen type I  124.60% 
, ChemFil superior +  RGD 98.67 % , ChemFil superior + Emdogain 81.38 %)  (Figure 
4-36). 
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Figure ‎4-36 Percentage of cell viability (Mean+ SD) relative to the control (100% viability) for 
materials after 24 and 72 hours. 
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Statistical analysis (one-way ANOVA) showed very highly significant effects between 
the groups (P<0.0001) on cell viability. Follow up comparison by Tukey's multiple 
comparison test table 15 showed that no significant difference between cells 
viabilities for ChemFil superior modified with all different bio-additives after 24 hours. 
There was no significant deferent between all materials after 72 hours as well (Table 4-
38). 
 
 
Table ‎4-38 Tukey comparison of  cell vibilty following different bio-addation . 
 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001  
Versus 0.1% Type 
I collagen  
24 hours 
0.1% Type 
I collagen  
72 hours 
RGD 
5mg/ml  24 
hours 
RGD 
5mg/ml  72 
hours 
Emdogain 
8mg/ml  24 
hours 
Emdogain 
8mg/ml  72 
hours 
0.1% Type I collagen  24 
hours 
___ ___ NS ___ NS ___ 
0.1% Type I collagen  72 
hours 
____ ___ ___ NS ___ NS 
RGD 8mg/ml  24 hours NS ___ ___ ___ NS ___ 
RGD 5mg/ml  72 hours ___ NS ___ ___ ___ NS 
Emdogain 8mg/ml  24 
hours 
NS ___ NS ___ ___ ___ 
Emdogain 8mg/ml  72 
hours 
___ NS ___ NS ___ ___ 
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4.2.1.3 IMMUNOCYTOCHEMISTRY (ICC) 
After 21 days from culturing of oral mucosa fibroblast (MM1) cells with 
unmodified and bio-modified glass polyalkenoate cements (ChemFil Superior). The 
cells were incubated overnight with primary antibody against Vimentin and 
visualisation with a fluorescent secondary antibody.  
In all cases the oral mucosa fibroblast cells expressed as revealed by 
immunofluorcsencence   staining.  Cells cultured around   ChemFil superior + 0.1% 
type collagen showed highest level of Vimentin expression (Figure 4-37) 
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Figure ‎4-37 Oral mucosa fibroblast cultured in presence of the unmodified and bio-modified glass 
ionomer cement (ChemFil superior) and the same cultures fluorescently labelled for Vimentin. 
ChemFil superior + 0.1% type collagen showed highest level of Vimentin expres. 
  
-Ve Control (MM1) 
 
ChemFil Superior 21days 
 
MM1 + Collagen 0.1%+ChemFil Superior 
0.1%+ChemFil 21 days 
 
MM1 +Emdogain (8mg/ml) + ChemFil Superior MM1 + RGD (5mg/ml) + ChemFil Superior 
Control (MM1) 
 
ChemFil Superior 21days 
 
MM1 + ChemFil Superior    
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4.2.1.4 PROTEIN BIOCHEMISTRY  
4.2.1.4.1 Western blotting 
After 3 weeks of culturing MM1 with the materials, cells were lysed using RIPA 
buffer. Cell lysates were then run on DDS PAGE and then western blotted. The blots 
were then incubated with anti Vimentin antibody to see the differential expression 
of Vimentin by oral mucosal fibroblast cells when cultured with different materials. 
Cells treated with ChemFil Superior were used as a negative control. All cells used 
in this experiment expressed Vimentin but the level of expression varied 
depending upon the material present. Oral mucosa fibroblast cells cultured with 
modified ChemFil superior (GIC) with bio-additives specimens expressed more 
Vimentin compared to the cells cultured with unmodified ChemFil superior (GIC) 
alone protein expression was quantified from the Western blot using ImageLab 
software (BioRad 4.0.1. build 6) (Figure 4-38).  
The highest percentage of Vimentin expression was  associated with the cells 
cultured with ChemFil superior modified with collagen type I (58% more than the 
control GIC) ( Figure 4-39) 
 
 
 
 
Figure ‎4-38 Vimentin expression from Oral mucosa fibroblast (MM1) cultured with Bio-modified and 
unmodified ChemFil superior (GIC). 
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Figure ‎4-39 The percentage of Vimentin expressed by oral mucosa fibroblast cells (MM1) cultured with 
Bio-modified and unmodified ChemFil superior (GIC) where ChemFil superior represent 100%. 
Esmated using ImageLab softwear analysis of the western blot. 
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4.2.2 DETERMINATION OF THE PHYSICAL PROPERTIES OF THE 
GLASS POLYALKENOATE CEMENTS AT BASELINE AND 
FOLLOWING BIOACTIVE ADDITIONS RESULTS  
 
The results of the physical properties are reported and analysed in this section in 
the same order as described in the materials and methods section  
4.2.2.1 SURFACE HARDNESS  
Table 4-39  gives the raw data from the testing of surface hardness of specimens of 
ChemFil Superior, GC Fuji VIII and ChemFil Superior with respective additions of 
RGD and Collagen type I. The units of measurement are shore hardness numbers. 
In additions the mean and standard deviation of these observations following one 
week of storage in distilled water are summarised in table 4-39 and Figure 4-40 
 
Table ‎4-39 Raw data from the testing of surface hardness of specimens of ChemFil Superior, GC Fuji 
VIII and ChemFil Superior with respective additions of RGD and Type I Collagen. 
 
Material Raw shore Hardness values  Mean  Standard deviation 
GC Fuji VII 85, 60, 70, 50, 50 63.0 14.8 
ChemFil Superior  50, 30, 30,38, 38, 30 36.0 7.4 
ChemFil Superior + RGD 38, 45, 65, 55,55,45 50.5 9.7 
ChemFil Superior + Type I Collagen  45, 58, 55, 50, 50, 70 54.7 8.8 
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Figure ‎4-40 The mean and standard deviation  of  surface hardness of specimens of ChemFil Superior, 
GC Fuji VIII and ChemFil Superior with respective additions of RGD and Type I Collagen. 
 
 
 
In order to compare these results a normality test was performed. This confirmed 
that the data followed a normal statistical distribution. Accordingly a one way 
analysis of variance was performed. This highlighted significant differences (P = 
0.0029) in these values. These were localised using a Tukey comparison of means 
as summarised in table 4-40. 
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Table ‎4-40 Tukey comparison of means of hardness values. 
Versus  ChemFil Superior ChemFil Superior + 
RGD 
ChemFil Superior + 
Collagen I 
GC Fuji VIII ** NS NS 
ChemFil Superior ___ NS * 
ChemFil Superior + 
RGD 
 ____ NS 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
 
The Shore hardness of ChemFil Superior was significantly lower than that for GC 
Fuji VIII. Addition of RGD and Collagen I to ChemFil Superior did not impair its 
surface hardness and in the case of collagen I addition significantly (P < 0.05) 
increased it. 
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4.2.2.2 COMPRESSIVE STRENGTH  
Tables 4-41 -4-44 give the dimensions (length, diameter) and force at failure for 
compressive specimens together with their calculated compressive strength.   
  
Table ‎4-41 Compressive strength of GC Fuji VIII measured at 1mm/ min following one week of storage 
in distilled water.  
Specimen number Length (mm) Diameter (mm)  Failure (N) Compressive strength (MPa)  
1 6.39 4.19 314.1 22.8 
2 6.53 4.12 649.7 48.8 
3 6.32 4.27 982.5 68.6 
4 6.43 4.12 790.6 59.3 
5 6.40 4.27 353.0 24.7 
6 6.35 4.32 687.2 46.9 
7 6.31 4.26 1548.0 108.7 
8 6.37 4.20 479.2 34.6 
9 6.49 4.18 1554.0 113.3 
10 6.63 4.28 1232.0 85.7 
11 6.57 4.16 864.4 63.6 
12 6.38 4.19 661.7 48.0 
13 6.39 4.30 1109.0 76.4 
14 6.27 4.18 1624.0 118.4 
15 6.24 4.10 582.6 44.2 
16 6.39 4.37 1370.0 91.4 
 
 
Table ‎4-42 Compressive strength of GC ChemFil Superior measured at a across head speed 1mm /min 
following one week of storage in distilled water.  
Specimen number Length (mm) Diameter(mm)  Failure (N) Compressive  strength (MPa)  
1 6.37 4.21 1009.1 72.5 
2 6.59 4.12 494.0 48.8 
3 6.81 4.30 661.7 45.6 
4 6.45 4.10 413.4 31.3 
5 6.55 4.10 547.7 41.5 
6 6.60 4.01 472.5 37.4 
7 6.31 4.01 843.0 66.8 
8 6.34 4.14 795.7 35.6 
9 6.40 4.21 1350.0 97.0 
10 6.49 4.10 880.0 66.7 
11 6.38 4.12 573.2 43.0 
12 6.45 4.24 785.2 55.6 
13 6.51 4.14 706.0 50.0 
14 6.28 4.16 447.0 33.2 
15 6.43 4.11 307.4 22.6 
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Table ‎4-43 Compressive strength of GC ChemFil Superior + RGD measured at 1mm/ min following one 
week of storage in distilled water.  
Specimen number Length (mm) Diameter (mm)  Failure (N) Compressive strength (MPa)  
1 6.30 4.13 1624.0 121.3 
2 6.28 4.18 1722.0 125.6 
3 6.32 4.10 910.1 69.0 
4 6.46 4.30 1392.0 95.9 
5 6.16 4.19 1119.0 81.2 
6 6.14 4.22 325.0 23.3 
7 6.35 4.16 1536.0 113.1 
8 6.16 4.90 1419.0 75.3 
9 6.46 4.24 1427.0 101.1 
10 6.33 4.18 1242.0 90.6 
11 6.26 4.22 869.8 62.2 
12 6.27 4.16 1744.0 128.4 
13 6.22 4.16 1858.0 136.8 
14 6.34 4.20 1070.0 77.3 
15 6.22 4.26 1644.0 115.4 
16 6.39 4.60 1107.0 66.6 
 
Table ‎4-44 Compressive strength of GC ChemFil Superior + Collagen I  measured at a across head speed  
1mm/ min following one week of storage in distilled water. 
Specimen number Length (mm) Diameter(mm) Failure (N) Compressive  strength (MPa) 
1 6.17 4.11 1850.0 139.5 
2 6.53 4.25 1003.0 70.7 
3 6.28 4.22 1512.0 108.2 
4 6.46 4.26 1281.0 89.9 
5 6.31 4.32 1713.0 116.9 
6 6.51 4.12 526.2 39.5 
7 6.34 4.11 1592.0 120.1 
8 6.24 4.70 1415.0 81.6 
9 6.38 4.18 1298.0 94.6 
10 6.45 4.24 1758.0 124.6 
11 6.90 4.18 1283.0 93.5 
12 6.28 4.19 1436.0 104.2 
13 6.44 4.11 1742.0 131.4 
14 6.12 4.14 1420.0 105.5 
15 6.26 4.50 1711.0 89.3 
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The mean and standard deviations of the all compressive strengths are 
summarised in Table 4-45 and Figure 4-41. 
 
Table ‎4-45 The mean and standard deviations of all compressive strengths determined. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Properties/Material Compressive strength (MPa) 
GC Fuji VIIIGP 66.0 
(31.0) 
n = 16 
ChemFil Superior 50.0 
(19.0) 
n = 15 
ChemFil Superior + RGD 93.0 
(30.0) 
n = 15 
ChemFil Superior + Collagen I 101.0 
(25.0) 
n = 15 
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Figure ‎4-41 The mean and standard deviations of all compressive strengths determined. 
  
 
 
The data conformed to a normal statistical distribution. Accordingly an analysis of 
variance was conducted and revealed highly statistically significant difference (P < 
0.0001) between these values. These were localised using a Tukey comparison of 
means whose outcome is summarised in table 4-46. This demonstrated that the 
addition of RGD and collagen I significantly increased compressive strength. 
 
Table ‎4-46 Tukey comparison of means of compressive strength. 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
  
Versus ChemFil Superior + RGD ChemFil Superior + Collagen I 
ChemFil Superior *** *** 
ChemFil Superior + RGD ____ NS 
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4.2.2.3 DIAMETRAL COMPRESSIVE STRENGTH  
Tables 4-47-4-50 give the dimensions (length, diameter) and force at failure for all 
diametral compressive specimens together with their calculated diametral 
compressive strength.  
 
Table ‎4-47 Diametral strength of GC Fuji VIII following one week of storage in distilled water. 
 
Table ‎4-48 Diametral strength of GC ChemFil following one week of storage in distilled water. 
Specimen number Length (mm) Diameter (mm) Failure (N) Diametral strength 
(MPa) 
1 6.18 3.95 255.0 6.7 
2 6.18 4.15 259.1 6.4 
3 6.65 4.20 331.5 7.6 
4 6.16 4.15 257.7 6.4 
5 6.48 4.12 340.9 8.1 
6 5.97 4.23 306.0 7.7 
7 6.45 4.34 311.4 7.1 
8 6.38 4.01 230.9 5.8 
9 6.24 4.13 236.2 5.8 
10 6.29 4.07 322.2 8.0 
11 6.07 4.27 145.0 3.6 
12 6.21 4.11 204.0 5.1 
13 6.19 3.97 169.1 4.4 
14 6.40 4.05 489.9 12.0 
15 6.18 4.12 166.5 4.2 
 
 
 
 
 
Specimen number Length (mm) Diameter (mm) Failure (N) Diametral strength 
(MPa) 
1 6.42 4.34 635.7 14.5 
2 6.41 4.18 547.7 13.0 
3 6.34 4.09 527.5 12.9 
4 6.28 4.21 947.6 22.8 
5 6.48 4.15 461.7 10.9 
6 6.54 4.21 549.0 12.7 
7 6.45 4.13 404.0 9.7 
8 6.36 4.18 426.9 10.2 
9 6.22 4.40 554.4 13.0 
10 6.47 4.10 546.3 13.1 
11 6.50 4.16 614.8 14.5 
12 6.48 4.13 562.4 13.4 
13 6.41 4.14 540.9 13.0 
14 6.37 4.17 680.5 16.3 
15 6.51 4.17 590.6 13.9 
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Table ‎4-49 Diametral strength of GC ChemFil + RGD following one week of storage in distilled water. 
Specimen number Length (mm) Diameter (mm) Failure (N) Diametral 
strength (MPa) 
1 6.21 4.25 444.3 10.7 
2 6.29 4.09 378.5 9.4 
3 6.03 4.16 410.7 10.4 
4 6.24 4.21 578.5 14.0 
5 6.14 4.08 366.4 9.3 
6 5.42 4.09 392.0 11.5 
7 6.31 4.14 451.0 11.0 
8 6.36 4.10 539.6 13.2 
9 6.35 4.10 382.6 9.4 
10 6.09 4.16 401.3 10.1 
11 6.46 4.29 355.7 8.2 
12 6.34 4.22 453.7 10.8 
13 6.33 3.09 532.9 17.4 
14 6.21 4.26 261.8 6.3 
15 6.35 4.23 577.2 13.7 
 
 
 
Table ‎4-50 Diametral strength of GC ChemFil + Collagen I following one week of storage in distilled 
water. 
 
  
Specimen number Length (mm) Diameter (mm) Failure (N) Diametral strength 
(MPa) 
1 6.47 4.35 550.3 12.5 
2 6.12 4.19 477.9 11.9 
3 6.15 4.14 374.5 9.4 
4 6.44 4.18 232.2 5.5 
5 6.44 4.08 487.3 11.8 
6 6.27 4.09 461.7 11.5 
7 6.27 4.16 471.1 11.5 
8 6.43 4.26 511.4 11.9 
9 6.08 4.27 475.2 11.7 
10 6.18 4.29 437.6 10.5 
11 6.14 4.20 483.2 11.9 
12 6.46 4.30 469.8 10.8 
13 6.10 4.32 351.7 8.5 
14 6.13 4.16 218.8 5.5 
15 6.33 4.19 373.2 9.0 
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The mean and standard deviations of the diametral compressive strength testing 
are summarised in table 4-51 and figure 4-42  
 
  
Table ‎4-51 The mean and standard deviations of all the diametral compressive strength determined 
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Figure ‎4-42 The mean and standard deviations of all the diametral compressive strength determined. 
 
Properties/Material Diametral compressive strength (MPa) 
GC Fuji VIIIGP 13.6 
(3.1) 
n = 15 
ChemFil Superior 6.6 
(2.1) 
n = 15 
ChemFil Superior + 
RGD 
11.0 
(2.7) 
n = 15 
ChemFil Superior + 
Collagen I 
10.2 
(2.3) 
n = 15 
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The data conformed to a normal statistical distribution. Accordingly an analysis of 
variance revealed highly statistically significant differences (P < 0.0001) between 
these values. These were localised using a Tuky comparison of means whose 
outcome in summary in table 4-52 this demonstrates that the addition of RGD and 
collagen I significantly increased diametral compressive strength  
 
 
Table ‎4-52 Tukey comparison of means to diametral compression of means. 
Versus  ChemFil Superior + RGD ChemFil Superior + Collagen I 
ChemFil Superior *** *** 
ChemFil Superior + RGD ____ NS 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
  
212 
 
4.2.2.4 3 POIN FLEXURAL STRENGTH  
Tables 4-53 -4-56 gives the dimensions (Depth, Width) and force at failure for all 
flexural strength specimens their together with calculated 3 point flexural 
strength.    
Table ‎4-53 3 point flexural strength of GC Fuji VIII measured at a across head speed 1mm/ min 
following one week of storage in distilled water.  
Specimen number Depth (mm) Width (mm)  Failure (N) 3 points flexural 
strength (MPa)  
1 2.50 3.02 7.0 11.1 
2 2.52 3.16 7.0 10.5 
3 2.59 3.25 7.0 9.6 
4 2.56 3.36 10.0 13.6 
5 2.54 3.29 0.0 0 
6 2.54 3.35 7.0 9.7 
7 2.58 3.40 10.0 13.3 
8 2.53 3.13 10.0 15.0 
9 2.55 3.20 10.0 14.4 
10 2.57 3.09 10.0 14.7 
11 2.64 3.29 10.0 13.1 
12 2.54 3.21 17.0 24.6 
13 2.66 3.29 12.0 15.5 
14 2.78 3.22 10.0 12.1 
15 2.76 3.12 12.0 15.2 
16 2.65 3.28 12.0 11.1 
 
Table ‎4-54 3 point flexural strength of GC ChemFil Superior measured at a across head speed 1mm/ 
min following one week of storage in distilled water.  
Specimen number Depth (mm) Width (mm) Failure (N) 3 points flexural 
strength (MPa) 
1 2.51 3.22 5.4 8.0 
2 2.37 3.11 6.7 11.5 
3 2.43 3.12 6.7 10.9 
4 2.79 3.33 8.1 9.4 
5 2.46 3.18 12.1 18.9 
6 2.58 3.24 9.4 13.1 
7 2.60 3.29 14.8 20.0 
8 2.48 3.25 6.7 10.1 
9 2.50 3.33 8.1 11.7 
10 2.51 3.14 10.7 16.2 
11 2.54 3.31 5.4 7.6 
12 2.63 3.16 5.4 7.4 
13 2.67 3.23 8.1 10.6 
14 2.53 3.21 6.7 9.8 
15 2.45 3.25 6.7 10.3 
16 2.56 3.19 8.1 8.0 
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Table ‎4-55 3 point flexural strength of GC ChemFil Superior measured at a across head speed  1mm/ 
min following one week of storage in distilled water.  
Specimen number Depth (mm) Width (mm) Failure (N) 3 points flexural 
strength (MPa) 
1 2.56 3.32 4.0 5.5 
2 2.35 3.21 12.1 20.5 
3 2.72 3.33 20.1 24.5 
4 2.51 3.60 12.1 16.0 
5 2.46 3.63 16.1 22.0 
6 2.60 3.22 4.0 5.5 
7 2.55 3.28 6.7 9.4 
8 2.43 3.05 5.4 9.0 
9 2.34 3.14 5.4 9.4 
10 2.47 3.20 4.0 6.2 
11 2.38 3.03 4.0 7.0 
12 2.59 3.25 4.0 5.5 
13 2.41 3.31 5.4 8.4 
14 2.54 3.26 4.0 5.7 
15 2.40 3.26 6.7 10.7 
 
 
Table ‎4-56 3 point Flexural strength of GC ChemFil  + RGD measured at a across head speed 1mm min 
following one week of storage in distilled water. 
Specimen number Depth (mm) Width (mm) Failure (N) 3 points flexural strength 
(MPa) 
1 2.40 3.08 9.4 15.9 
2 2.50 3.14 17.5 26.8 
3 2.55 3.11 6.7 9.9 
4 2.40 3.11 14.8 24.8 
5 2.60 3.05 8.1 11.8 
6 2.55 3.04 6.7 10.2 
7 2.57 3.18 9.4 13.4 
8 2.49 3.22 10.7 16.1 
9 2.43 3.19 6.7 10.7 
10 2.51 3.08 13.4 20.7 
11 2.36 3.09 12.1 21.1 
12 2.53 3.11 10.7 16.1 
13 2.38 3.04 8.1 14.1 
14 2.49 3.22 16.1 24.2 
15 2.47 3.04 6.7 10.8 
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The mean and standard deviations of the 3 points flexural strengths are 
summarised in table 4-57 and figure 4-43 
 
Table ‎4-57 The mean and standard deviations of all the 3 points Flexural strengths. 
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Figure ‎4-43 The mean and standard deviations of all the 3 point Flexural strengths. 
 
Properties/Material 3 points flexural strength (MPa) 
GC Fuji VIIIGP 12.7 
(3.1) 
n = 16 
ChemFil Superior 11.4 
(3.8) 
n =16 
ChemFil Superior + RGD 16.4 
(5.7) 
n = 15 
ChemFil Superior + 
Collagen I 
12.6 
(2.8) 
n = 15 
215 
 
 
The data conformed to a normal statistical distribution. Accordingly an analysis of 
variance revealed highly statistically significant differences (P < 0.0063) between 
these values. These were localised using a Tukey comparison of means whose 
outcome in summary in table 4.58 this demonstrates that the addition of RGD 
significantly increased 3 points Flexural strength 
 
Table ‎4-58 Tukey’s comparison of means to 3 point flexural strengths . 
versus ChemFil Superior + RGD ChemFil Superior + Collagen I 
ChemFil Superior ** NS 
ChemFil Superior + RGD ____ * 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
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4.2.2.5 DIAMETRAL COMPRESSIVE FATIGUE LIMIT  
 
Tables 4-59 to 4-62 give the applied load (N) and number of cycles to 
survival (at 1500 cycles or above) or failure for the glass ionomer ChemFil 
Superior and GC Fuji VIII following one week storage in distilled water at 
37°C. The results are also given for the additions of RGD and Collagen I to 
ChemFil Superior. 
 
Table ‎4-59 Diametral fatigue of GC ChemFil following one week of storage in distilled water. 
Specimen number Applied load (N) Number of cycles Survived(S)/Failed(F) Applied 
stress 
(MPa) 
1 100 1500 S 2.65 
2 110 320 F 2.92 
3 100 1500 S 2.65 
4 110 77 F 2.92 
5 100 1500 S 2.65 
6 110 661 F 2.92 
7 100 486 F 2.65 
8 90 136 F 2.39 
9 80 1500 S 2.12 
10 90 1238 F 2.39 
11 80 282 F 2.12 
12 70 512 F 1.86 
13 60 1500 S 1.59 
14 70 1500 S 1.86 
15 80 1500 S 2.12 
 
 
Table ‎4-60 Diametral fatigue of GC Fuji VIII following one week of storage in distilled water. 
Specimen number Applied load 
(N) 
Number of cycles Survived(S)/Failed(F) Applied 
stress 
(MPa) 
1 344 792 F 9.13 
2 334 444 F 8.86 
3 324 817 F 8.60 
4 314 191 F 8.33 
5 304 795 F 8.07 
6 294 130 F 7.80 
7 284 756 F 7.54 
8 274 380 F 7.27 
9 264 311 F 7.01 
10 254 831 F 6.74 
11 244 1500 S 6.48 
12 254 1500 S 6.74 
13 264 1500 S 7.01 
14 274 1500 S 7.27 
15 284 1354 F 7.34 
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Table ‎4-61 Diametral fatigue of GC ChemFil + RGD following one week of storage in distilled water. 
Specimen number Applied load (N) Number of cycles Survived(S)/Failed(F) Applied 
stress 
(MPa) 
1 240 776 F 6.4 
2 230 1500 S 6.1 
3 240 273 F 6.4 
4 230 1500 S 6.1 
5 240 1500 S 6.4 
6 250 750 F 6.6 
7 240 730 F 6.4 
8 230 1500 S 6.1 
9 240 1500 S 6.4 
10 250 1500 S 6.6 
11 260 695 F 6.9 
12 250 220 F 6.6 
13 240 250 F 6.4 
14 230 1500 S 6.1 
15 240 550 F 6.4 
 
 
Table ‎4-62 Diametral Fatigue of GC ChemFil + Collagen I following one week of storage in distilled 
water.  
Specimen number Applied load (N) Number of cycles Survived(S)/Failed(F) Applied 
stress 
(MPa) 
1 100 1500 S 2.7 
2 110 1500 S 2.9 
3 120 1500 S 3.2 
4 130 1500 S 3.5 
5 140 1500 S 3.7 
6 150 1500 S 4.0 
7 160 1500 S 4.3 
8 170 1500 S 4.5 
9 180 850 F 4.8 
10 170 1500 S 4.5 
11 180 920 F 4.8 
12 170 1500 S 4.5 
13 180 1253 F 4.8 
14 170 1500 S 4.5 
15 180 1374 F 4.8 
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Table 4-63 summarises the calculated fatigue limits for these results and their 
standard deviations. Comparison of these values by a student’s t test is 
summarised in table 4-64 and figure 4-44. 
 
Table ‎4-63 The calculated diametral fatigue limits and their standard deviations for the glass ionomer 
cements. The fatigue limit is the product of testing 15 specimens. 
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Figure ‎4-44 The calculated diametral fatigue limits and their standard deviations for the glass ionomer 
cements. 
 
 
Material and additions Fatigue limit (MPa) Standard Deviation 
GC Fuji VIIIGP 6.9 0.1 
ChemFil Superior 2.2 1.2 
ChemFil Superior + RGD 6.9 0.6 
ChemFil Superior + Collagen I 4.7 0.1 
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Table ‎4-64 Summary of student’s t test of diametral compressive fatigue specimens.  
versus ChemFil 
Superior 
ChemFil Superior + 
RGD 
ChemFil Superior + 
Collagen I 
GC Fuji VIII *** NS *** 
ChemFil Superior ___ *** *** 
ChemFil Superior + RGD  ____ *** 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
 
It is clear that GC Fuji VIII exhibits a superior fatigue limit than ChemFil  Superior 
(P < 0.001) but addition of RGD to ChemFil Superior increases the value of this 
property to level where it does not differ significantly (P > 0.05) From Fuji VIII. 
Additions of both RGD and collagen I to ChemFil Superior significantly (p < 0.001) 
improve its diametral fatigue limit but this improvement is significantly greater (P 
< 0.001) for RGD than that achieved by collagen I addition.  
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4.2.2.6 BIAXIAL FLEXURAL STRENGTH  
 Tables 4-65-4.68 give the thickness and force at failure of biaxial flexural strength 
specimens together with the associated calculated biaxial flexural strength. 
Table ‎4-65 Biaxial flexural strength of GC Fuji VIII following one week of storage in distilled water.  
 
 
Table ‎4-66 Biaxial flexural strength of GC ChemFil following one week of storage in distilled water. 
 
  
Specimen number Thickness (mm) Applied load (N) Biaxial flexural strength (MPa) 
1 2.10 179.9 80.0 
2 1.91 182.9 81.3 
3 2.22 196.0 87.2 
4 2.08 157.1 69.9 
5 2.23 202.1 89.9 
6 1.97 112.1 49.8 
7 1.98 159..7 71.0 
8 1.88 159.7 71.0 
9 2.08 170.5 75.8 
10 1.95 138.3 61.5 
Specimen number Thickness (mm) Applied load (N) Biaxial flexural strength (MPa) 
1 2.07 37.6 16.7 
2 1.91 38.9 17.3 
3 2.04 29.5 13.1 
4 1.91 83.2 37.0 
5 2.23 59.1 26.3 
6 1.85 49.7 22.1 
7 2.01 44.3 19.7 
8 2.07 60.4 26.9 
9 1.92 36.3 16.1 
10 1.85 51.0 22.7 
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Table ‎4-67 Biaxial flexural strength of GC ChemFil + RGD following one week of storage in distilled 
water. 
 
 
Table ‎4-68 Biaxial flexural strength of GC ChemFil + Collagen I following one week of storage in 
distilled water. 
 
 
 
 
 
 
 
 
 
 
  
Specimen number Thickness (mm) Applied load (N) Biaxial flexural strength (MPa) 
1 1.83 53.7 23.9 
2 1.87 59.9 26.6 
3 1.85 68.5 30.5 
4 2.05 80.5 35.8 
5 1.89 61.8 27.5 
6 1.80 63.1 28.1 
7 1.94 67.1 29.8 
8 1.60 83.1 37.0 
9 1.94 89.9 40.0 
10 1.93 85.9 38.2 
Specimen number Thickness (mm) Applied load (N) Biaxial flexural strength (MPa) 
1 1.96 108.7 48.3 
2 1.88 75.5 33.6 
3 1.94 64.4 28.6 
4 2.02 79.2 35.2 
5 1.83 72.5 32.2 
6 1.93 77.9 34.6 
7 1.90 73.8 32.8 
8 1.96 67.1 29.8 
9 1.99 80.5 35.8 
10 2.00 84.6 37.6 
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The mean and standard deviations of the biaxial flexural strength testing are and 
summarised in table 4.69 and figure 4-45. 
 
Table ‎4-69 The mean and standard deviation of the Biaxial flexural strengths of the glass ionomer 
cements. 
Properties/Material Biaxial flexural strength  (MPa) 
GC Fuji VIIIGP 73.7 
(12.0) 
n = 10 
ChemFil Superior 21.8 
(7.0) 
n =10 
ChemFil Superior + 
RGD 
31.7 
(5.6) 
n = 10 
ChemFil Superior + 
Collagen I 
34.9 
(5.5) 
n = 10 
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Figure ‎4-45 The mean and standard deviation of the Biaxial flexural strengths of the glass ionomer 
cements. 
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An analysis of variance revealed highly statistically significant difference (P < 
0.0001) between these is values. These were localised using a Tuky compression of 
means whose outcome summarised in table 4-70. This demonstrates that the 
addition of RGD and collagen I significantly increased diametral Biaxial flexural 
strength. 
 
Table ‎4-70 Tukey comparison of means to biaxial flexural strengths.  
Versus ChemFil Superior + RGD ChemFil Superior + Collagen I 
ChemFil Superior ** *** 
ChemFil Superior + RGD ____ NS 
Key; NS = not significant, * = p < 0.05, **= p < 0.01, *** = p < 0.0001 
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4.2.2.7 ADHESIVE SHEAR BOND STRENGTHS    
 
Tables 4.71-4.74 give the force at failure for Adhesive shear bond strength 
specimens together with the associated calculated adhesive shear bond strengths. 
Table ‎4-71 Adhesive shear bond strength of GC Fuji VIII following one week of storage in distilled 
water. 
Specimen number Applied load (N) Bond shear strength 
1 22.8 1.9 
2 41.6 3.5 
3 0.0 0 
4 55.0 4.7 
5 4.0 0.3 
6 0 0 
7 103.4 8.8 
8 218.8 18.6 
9 5.0 0.4 
10 32.2 2.7 
11 0 0 
12 64.6 5.5 
13 142.3 12.1 
14 240.3 20.4 
15 98.0 8.3 
16 9.4 1.9 
 
 
Table ‎4-72 Adhesive shear bond strength of GC ChemFil following one week of storage in distilled 
water.  
Specimen number Applied load (N) Bond shear strength 
1 134.2 11.4 
2 132.9 11.3 
3 157.1 13.3 
4 299.3 25.4 
5 120.8 10.3 
6 034.9 3.0 
7 268.5 22.8 
8 36.3 3.1 
9 67.1 5.7 
10 80.1 6.8 
11 114.1 9.7 
12 84.6 7.2 
13 75.2 6.4 
14 88.6 7.5 
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Table ‎4-73 Adhesive shear bond strength of GC ChemFil + RGD following one week of storage in 
distilled water. 
Specimen number Applied load (N) Bond shear strength 
1 151.7 12.9 
2 228.2 19.4 
3 197.3 16.8 
4 21.5 1.8 
5 131.6 11.2 
6 169.1 14.4 
7 126.2 10.7 
8 10.2 0.9 
9 167.8 14.3 
10 95.3 8.1 
11 84.6 7.2 
12 69.8 5.9 
13 57.7 4.9 
14 51.0 4.3 
15 72.5 6.2 
 
 
 
Table ‎4-74 Adhesive shear bond strength of GC ChemFil + Collagen I following one week of storage in 
distilled water.  
Specimen number Applied load (N) Bond shear strength 
1 38.9 3.3 
2 92.6 7.9 
3 60.4 5.1 
4 205.4 17.4 
5 85.9 7.3 
6 59.1 5.0 
7 123.5 10.5 
8 63.1 5.4 
9 115.4 9.8 
10 24.2 2.1 
11 120.8 10.3 
12 32.2 2.7 
13 0 0 
14 68.5 5.8 
15 38.9 3.3 
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Table 4-75 and figure 4-46 summary the mean and standard deviations of the 
adhesive Shear Bond Strengths. 
Table ‎4-75 Adhesive shear Bond Strengths 
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Figure ‎4-46 Adhesive shear Bond Strengths. 
 
An analysis of variance revealed no statistically significant difference (P > 0.05) 
between values. It is clear therefore that the addition of the bioactive chemicals did 
not significantly impair this property. 
Properties/Material Shear bond Strength 
GC Fuji VIIIGP 5.8 
(6.7) 
n = 15 
ChemFil Superior 10.3 
(6.2) 
n = 14 
ChemFil Superior + 
RGD 
9.3 
(5.5) 
n = 15 
ChemFil Superior + 
Collagen I 
6.3 
(4.4) 
n = 15 
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5 DISCUSSION 
 
5.1 QUESTIONNAIRE 
In discussing the results of the questionnaire it is important to be clear why this 
was undertaken. Its main purpose was to see if anything new could be ascertained 
from practicing dentists that would advance treatments of root caries.  
In broad terms no new radical treatment were found. Valuable ideas come from 
speaking to clinicians and in the field of caries treatment it should be borne in 
mind that the Hall technique (Innes et al., 2006), essentially sealing in caries with 
stainless steel crowns upon deciduous teeth to promote retention until exfoliation, 
was discovered by examining the practises of dentists. A secondary function of the 
questionnaire was to compare and contrast the root caries management practices 
of those in the UK compared to those in Libya where the author comes from.  
 
It was pleasing to see the high return rate in Libya (60.00 %), but on the other 
hand a relatively poor return rate was obtained in the UK (34.35 %). This could 
have arisen because the questionnaires in Libya were personally issued and 
followed up by the author whereas in the UK the need to preserve anonymity did 
not allow such an approach nor individual follow up to boost return rates. Low 
response rates may be due to a lack of time to complete the questionnaire, no 
interest in the subject matter or concerns about the confidentiality of the 
responses  (VanGeest et al., 2007). This last reason does not apply here for 
confidentiality of responses was stressed at the time of invitation. Robertson et al 
(2005) states that follow up letters can enhance return rate but had this been 
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done, on an individual basis, full ethical approval would have been required for the 
origin of the responses would have been known and it was felt that this increase in 
paperwork would have been off putting driving the response down. 
Notwithstanding this the study findings are interesting. It should be noted that the 
number of questionnaires that were undelivered in the UK (Table 4-1) agrees with 
the level reported in other dental surveys (Burke et al., 1994). 
An interesting finding was that the Libyan respondents had been practising for a 
significantly shorter period of time than those from the UK. This can be explained 
by appreciating that the first dental school to open in Libya (Faculty of Dentistry, 
University of Benghazi) opened in 1974 and although there were some dentists 
who trained outside the country dentists in Libya in total were few in number 
(Metz, 1987).  
As regards the age stated as being the most susceptible age to develop root caries 
(Table 4-2) both the UK and Libyan observations, that this condition is most likely 
to occur in the elderly, fits with established literature (Hassan and Omar, 2000, 
Steele and Sullivan, 2011). 
 
It is interesting to note that in the UK the respondents indicated no difference 
between the sexes in relation to susceptibility to root caries. This was not the case 
in Libya [Table 4.3] however, with a significantly higher proportion of males said 
to be more susceptible. This could be because in that country it is perceived that 
females are more likely to attend the dentists. The lack, however of robust data 
from national statistics makes this statement purely opinion for the statistics held 
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by the health ministry of Libya are incomplete. Similar cultures e.g. Jordan also 
report this trend (Al Omari and Hamasha, 2005). 
The finding that Libyan dentists use radiographic detection more frequently than 
their UK counterparts (Table 4-5) for root caries detection is perhaps a reflection 
of their training and also of the site of the caries. Libyan dentists (Table 4.6) report 
a high proportion of root caries affecting the interproximal surface compared to 
those in the UK. This observation agrees well with Hassan and Omar (2000) who 
conducted a survey of Libyan patients in Bangazi. In the UK the respondents 
indicated that root caries was more likely to be upon the labial surface. 
 
It was more common in Libya to provide a restoration for a root caries lesion than 
in the UK (Table 4.7). This could be due to the fact that in Libya such lesions are 
more likely to be interproximal and there is relatively little patient follow up 
(Table 4-12, 4-13), perhaps due to the casual nature of attendance. This is borne 
out by the very low level of dietary advice apparently offered to Libyan patients 
(Table 4-8). 
As regards to restoration both the UK and Libyan dentists used glass ionomer. In 
Libya however the proportion using composite was greater. According to recent 
guidelines (Momoi et al., 2012) composite should only be used where moisture 
control is optimal. Glass ionomer is said in this paper to be a viable alternative 
though it is acknowledged that for both materials there is a lack of clinical studies 
to support their use where moisture is present. The results of this survey (Table 
4.10) indicated that bleeding from gingival tissues is a problem in the majority of 
respondents’ experiences. This therefore warrants further investigations.  
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It should be remembered that a greater proportion of restorations placed in Libya 
were resin composite (Table 4.9). This material has no intrinsic ability to bond to 
tooth and is reliant upon acid etch and dentine bonding for its retention. Such 
mechanisms have no capacity to reform when broken. This contrasts to glass 
ionomer which can form and reform its bonds (Noble, 2012) to tooth substance 
and this property may explain, in part, the shorter life span of root caries 
restorations reported by the Libyan respondents. In addition, the experience of the 
Libyan operators was less than the UK and so this to may have been a factor. 
It is interesting to note that finishing in Libya (Table 4.11) was deferred until the 
recall visit. This is unexpected for the preferred material in that country, although 
glass ionomer and not amenable to finishing at placement. represents a much 
lower proportion of the total number of restorations, and so as resin composite 
was used relatively more than in the UK a higher proportion of finishes at 
placement would have been expected This therefore warrants further work. 
It is interesting to note that in the present study there is no significant difference in 
the responses from the two countries in terms of relative importance of life style 
events associated with root caries development (Table 4.15). It is however 
surprising to note that diet is considered to be a relatively unimportant factor for 
this provides the substrate required to develop caries. 
In relation to factors considered by the respondents to be risks important for the 
development of root caries there are significant differences between the responses 
of the countries with regard to Degree of crowding, Cigarette smoking, Total 
amount of sugars consumed, Frequency of sugar intake, Active periodontal disease, 
Consumption of alcohol, Poor crown margins, Gingival recession, Reduce salivary 
flow, Presence of erosion and presence of abrasion cavity (Table 4.16). In order to 
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compare these to the other studies in the literature (McCombes, 1999) it is 
necessary to devise a system of ranking. One such method, adopted here, is to 
multiply the percentage by the rank of importance attached to each factor, for 
response levels of 1= very important, 2= quite important and 3= fairly important, 
giving weighting of 3 to a rank of 1, 2 to a rank of 2, and 1 to a rank of 3. When this 
empirical comparison is carried out for the findings of the present study and also 
to that of the work of McCombes (1999) in an endeavour to standardise the 
comparison ( Table 5.1 results). 
It should be noted that in the preparation of this table the ranks of McCombes  
(1999)are decreased by one for in the present study the effect of altered bone 
contour after periodontal therapy was not examined. 
A crude assessment of the differences in responses is gained by subtracting the 
resultant weighted rankings of the studies being compared, to give a numerical 
value. Where this is zero there is 100 % agreement between the studies. 
Empirically a differences of 4 or greater is worthy of comment. On this basis it is 
interesting to note the general broad agreement between the present work and 
that of MaCombes (1999) with the exceptions of poor general health, cigarette 
smoking, poor crown margins and overhanging restoration. In case of poor general 
health and cigarette smoking there were considered to be lesser importance by 
McCombes whereas the opposite was true for poor crown margin and overhanging 
restorations compared to the present study. An explanation for this is not 
immediately obvious for the questionnaire contents were similar. Such an 
observation may be due to possible changes in the perceptions of dentists about 
root caries lesion since 1999 the year in which the McCombes study was 
conducted.  
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Table ‎5-1 Comparison of relative importance of risk factors for root caries from the present UK study 
and that of McCombes (1999). 
Risk factors Present UK study McCombes Level of agreement 
Oral hygiene state 1 3 2 
Frequency of sugar intake 2 2 0 
Reduce salivary flow 3 1 2 
Total amount of sugars consumed 4 5 1 
Mental disability/senility 5 4 1 
Physical disability 6 8 2 
Poor general health 7 13 6 
Cigarette smoking 8 17 9 
Presence of a partial denture 9 9 0 
Consumption of fizzy drink 10 10 0 
Active periodontal disease 11 11 0 
Gingival recession 12 12 0 
Poor crown margins 13 7 9 
Overhanging restoration 14 6 8 
Degree of crowding 15 15 0 
Presence of erosion 16 14 2 
Consumption of alcohol 17 18 1 
Number  of teeth present 18 16 2 
Presence of abrasion cavity 19 19 0 
Body of table gives relative ranking of factors importance. Level of agreement between studies being 
compared is 100% if value column is 0 and is 0% if difference is 19. 
 
Table 5-2 compares the relative ranking afforded to the risk factors by the 
respondents, both Libyan and UK, in the present study. It is clear that there are 
many differences with dentists in Libya ranking the importance of active 
periodontal disease, gingival recession, crowding and alcohol consumption higher 
than the UK respondents. In contrast the UK respondents awarded higher 
significance to dietary, physical disability, partial denture wearing, fizzy drink 
consumption and detective crown margins. From the observations of the author 
this perhaps reflects the greater emphasis upon prevention in the UK and the 
greater levels of untreated dental disease in Libya. The importance of alcohol 
consumption in Libya could be due to religions and culture beliefs prohibiting its 
consumption. 
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Table ‎5-2 Comparison of relative importance of risk factors for root caries from the UK and Libya study  
Risk factors UK Libya Level of agreement 
Oral hygiene state 1 1 0 
Frequency of sugar intake 2 9 7 
Reduce salivary flow 3 4 1 
Total amount of sugars consumed 4 15 11 
Mental disability/senility 5 5 0 
Physical disability 6 12 6 
Poor general health 7 11 5 
Cigarette smoking 8 10 2 
Presence of a partial denture 9 17 12 
Consumption of fizzy drink 10 18 8 
Active periodontal disease 11 2 7 
Gingival recession 12 3 9 
Poor crown margins 13 7 6 
Overhanging restoration 14 13 1 
Degree of crowding 15 6 9 
Presence of erosion 16 16 0 
Consumption of alcohol 17 8 9 
Number  of teeth present 18 19 1 
Presence of abrasion cavity 19 14 5 
body of table gives relative ranking of factors importance. Level of agreement between studies being 
compared is 100% if value column is 0 and is 0% if difference is 19. 
 
 
5.1.1 CONCLUSION  
In conclusion attitudes and beliefs about root caries between and Libyan 
respondents exhibit some commonality about differ in the emphasis on 
prevention. Similar treatments are carried out when prevention fails in both 
countries the decision to do so however would appear to be based upon a different 
weighting of risk factors.  
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5.2 BASELINE PROPERTIES OF THE GLASS IONOMERS USED IN 
THE STUDY  
This laboratory work sought to investigate the potential to modify existing glass 
ionomers to promote cellular adhesion to improve the treatment of root caries. In 
order to establish if modification had an adverse effect upon material properties 
baseline property values were determined of the unmodified materials using 
recognised laboratory testing techniques. 
It should be noted in preparing the specimens for testing a clinically realistic 
mixing regime was adopted. This was because it was it envisaged that the material, 
and any additions to it, would be placed immediately into the root surface cavity, 
and thus contrary to the manufacturer’s instructions would be exposed to blood 
and moisture. It was to part simulate this that no water impervious coatings were 
applied to the specimens prior to storage. 
 
5.2.1 MATERIAL SELECTION 
Two different glass ionomers were selected to be modified. These were both 
commercially available and presented in powder and liquid format for hand 
mixing. These were favoured over encapsulated materials for they more readily 
permitted modification of their constituents by the inclusion of biological 
additives. One of these was a conventional glass ionomer (ChemFil Superior), in 
freeze dried form, activated by the addition of water to bring about acid ionisation. 
This product has been on the market since 2005. The other material was Fuji VIII 
and this is recommended by the manufacturer for treatment of class V cavities 
including root caries lesion (GC, 2013). It is a more recently developed material 
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and has a resin component (HEMA) to improve mechanical properties. It is 
chemically set and like ChemFil Superior involves no light curing. 
5.2.2 TESTING METHODS AND BASELINE RESULTS  
The properties evaluated were those thought to be most relevant to clinical 
success. Although not reported here many attempts were made to obtain a value of 
flexural fatigue strength for both materials. Due however to the often premature 
failures of ChemFil superior specimens, not even making one flexural fatigue cycle, 
compared to Fuji VIII specimens flexural fatigue was not tested. A search of the 
literature failed to identify any studies that report flexural fatigue properties of 
ChemFil superior perhaps reinforcing the difficulties experienced. 
In order to simplify the comparison of the baseline property values determined in 
the present study to those reported by others in the literature Table 5-3 a,b and 
Table 5-4 summarises the values obtained by others. It should be noted however 
that the materials and storage regimes differ so a direct comparison cannot be 
made. The values however serve as good source of ball park figures to compare the 
present work against.  
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 Table ‎5-3 (a, b) The properties of glass ionomers from other laboratory studies that examined some the same physical properties as the present study.  
1FS: flexural strength; CS: compressive strength; 3-PB: three-point-bending; 4-PB: four-point-bending; BB: biaxial bending; KH: knoop hardness; VH: Vickers hardness; 
ws: wet storage; as: air storage; wc: wet cyclic.  
Authors Materials Flexural strength  (MPa) Compressive strength  (MPa) Microhardness 
 
Flexural fatigue limit (MPa) storage time  
(Prosser et al., 1986) Experimental 16.4  - - - 1 d 
Experimental 7.6   - - - 1d 
(Ewoldsen, 1997)   Fuji IX - 193±13 
 
- 
 
- 
 
 
 
(Xie et al., 2000) 
Ketac Fil 22.6 ±2.5(3-PB) 251.2±10 .0 176.8±12.8 (KH) - 7 d 
Ketac Molar 21.2±3.1 (3-PB) 301.3± 10.1 108.8±12.8(KH) - 7 d 
Fuji II 26.1± 3.9(3-PB) 202.0± 10.0 83.15± 8.20(KH) - 7 d 
(Iazzetti et al., 2001) Fuji IX 22.6/15.4  (3-PB)  - - 1 d/7 d 
(Lucksanasombool et al., 2002) Fuji IX 29.2 (BB) 211 - - 1 h 
 
(Bapna et al., 2002) 
Fuji II 30.8±7.5 /23.0 ±5.1(3-PB) - - - 1 d/9 m   
Fuji II  47.1±5.4/21.4±9.8 (3-PB) - - - 1 d/9 m 
Fuji II 17.8±8/14.6±8.7 (3-PB) - - - 1d/9 m 
 
(Fleming and Zala, 2003) 
Fuji IX GP - 87.9/67.9 - - 1d 
Ketac Fil Plus - 72.7/62.0 - - 1 d 
ChemFlex - 84.3/68.9 - - 1 d 
(Lohbauer et al., 2003)    19.7/33.0/35.2/3.7 (4-PB) - - 13.2/17.5/21.4/29.4/- 24 h/8 d/30 d/90 
d 
(Sunnegårdh-Grönberg et al., 
2003) 
Chemfil Superior 32±8/40±10/46±4    1d/1w/2w 
 
(McKenzie et al., 2003) 
Chemfil Superior 52.8±14.1/47.2±9.1/54.7±10.7/49.4±3
.1/43.1±2.1/50.73.2± (BB) 
177.1±14.7/188.9±23.1/182.7±22.9/ 
148.1±16.3 /192.0±24.5 /184.1±25.9 
-  1 d/1 w/1 m/3 
m/6 m/1 y 
Aqua Cem 29.8±6.9/44.1±2.6/31.8 ±4.4/31.9± 
3.8/45.0±3.8/40.7±3.8 (BB) 
 
130.5±22.3/132.2±16.2/154.7±18/150.6
± 25.4/214.8±18/192.1±39 
-  1 d/1 w/1 m/3 
m/6 m/1 y 
ChemFlex 67.2±5.1/51.2±11.5/49.0±13.2/58.9±7
.8/54.2±5.3/66.1±10 (BB) 
 197.8±12.5/147.2±43.5/227.1 
±18.6/232.5±22.5/268.2±24.9/240.1± 
39.2 
-  1 d/1 w/1 m/3 
m/6 m/1 y 
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Table 5-3 b. 
1FS: flexural strength; CS: compressive strength; 3-PB: three-point-bending; 4-PB: four-point-bending; BB: biaxial bending; KH: knoop hardness; VH: Vickers hardness; 
ws: wet storage; as: air storage; wc: wet cyclic. 
  
Authors Materials Flexural strength  (MPa) Compressive strength  (MPa) Microhardnes
s 
 
Flexural fatigue limit 
(MPa) 
storage time  
(Pamir et al., 2005) Chemfil Superior - 148.30±9.63 49.89± (VH)  28 d 
 
 
(Peez and Frank, 2006) 
Ketac Molar 51 ±5 (3-PB) 244±9 -  1d 
Fuji IX 42± 4(3-PB) 236±28 -  1d 
Vitro Molar 48±3 (3-PB) 141±15 -  1d 
Vidrion R 38 ± 2(3-PB) 175±11 -  1d 
Ionofil Molar 36 ±9 (3-PB) 196±12 -  1d 
 
(Irie et al., 2008) 
Fuji IX GP 1.8/29.2 (3-PB) - -  immediate/1d 
FX-II 1.7/17.3 (3-PB) - -  immediate/1d 
Ketac Molar 1.9/19.3 (3-PB) - -  immediate/1d 
Fuji II 2.0/15.3 (3-PB) - -  immediate/1d 
(Moshaverinia et al., 
2008a) 
Fuji II 14.8 (BB) 161 -  1h 
(Türkün et al., 2008) ChemFil 
Superior 
43,06±9.92 (BB) 211.1±14.1 57.23(VH)  1d 
 
(Dowling and Fleming, 2009) 
Ketac Fil Plus - 129±19 -  1d 
Fuji II - 131±14 -  1d 
ChemFil 
Superior 
- 132±18 -  1d 
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Table ‎5-4 The properties of glass ionomers from other laboratory studies that examined the same physical properties as the present study. 
Authors Materials Enamel Bond  Dentin Bond  Diametral compressive  Diametral fatigue storage time 
(Ewoldsen, 1997)   Fuji IX 2.6 ± 0.8 
 
3.8 ±1.1 
 
   
      
(Sunnegårdh-Grönberg et al., 
2003) 
ChemFil Superior     
(Türkün et al., 2008) ChemFil Superior  12.89±3.24  1d 
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5.2.2.1 SHORE HARDNESS 
In this work Shore hardness was determined. This test was selected over the more 
usually performed Vickers hardens test for it did not require the specimen surface 
to be highly polished in order to visualise the diamond indent. At the time of 
planning the study it was not known how the incorporation of additives would 
affect polishability of the samples and it seemed prudent therefore to adopt a 
relative ease of penetration test, such as afforded by the Shore tester, to enable a 
hardness assessment to be made. A downside of this approach is that the results 
presented here cannot be compared to other literature values for no other workers 
have employed this test for glass ionomers. 
 
5.2.2.2 COMPRESSIVE STRENGTHS-LONGITUDINAL AND DIAMETRAL 
Both these properties were determined using an Instron universal testing machine 
at 1mm min-1. As observed by others the ends of longitudinal compressive 
specimens must be lapped flat otherwise edge effects lead to premature failure of 
the specimen by facilitating crack initiation and propagation (Cho and Garant, 
2000) . It is however not possible to precisely lap flat and so in the present 
investigation this was not carried out. To therefore obtain a more meaningful 
assessment a diametral compressive strength test was also performed. This test 
avoids edge effects and is the test of choice for brittle materials as used in this 
study (Darvell, 2009). The baseline results obtained in this study are in general 
agreement with other values published in the literature. Thought it is 
acknowledged they are lower this is in all likelihood due to both the mixing and 
storage regime as stated in the introductory paragraph-5.2 (Baseline properties of 
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the glass ionomers used in the study). Both of these properties are considered to 
be of relevance to clinical function (Cho and Garant, 1989 ). Mastication applies 
compressive forces as tested here by the compressive strength whereas the 
diametral compressive test replicates in some way clinical failures due to tensile 
stress (Freeman and ten Cate, 1971). In this thesis convention has been broken for 
the term compressive diametral has been used to indicate the experimental set up 
and direction of applied force. Conventionally such a test is called a diametral 
tensile test for the compression plates, either side of the specimen; apply largely 
tensile forces with also an element of compression. The latter has been identified 
as a factor that to a degree prevents the propagation of the tensile crack (Darvell, 
2009). True tensile testing of brittle materials, such as glass ionomer, is not 
practicable and was internationally agreed some time ago to therefore adopt the 
diametral tensile strength test as a means of assessing this property (British 
Standards Institution, 1981). 
 
5.2.2.3 3 POINT FLEXURAL STRENGTH 
The jig used to determine the three point flexural strength of the materials tested 
contained within it two cylindrical rollers upon which the specimens sat. This was 
preferable to point contacts for these linked setting stress concentration which 
would enhance crack propagation. 
Karbhari and Wang (2007) have commented that the ratio of support separation to 
the specimen depth should be 10 in order to ensure that bending moments 
dominate over shear forces this practice, and the experimental set up, conforms to 
ISO 9917 (International Organization for Standardization, 1998) . This was 
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achieved by this experimental set up. The baseline values obtained (table 4-57) are 
similar to other comparable materials in the literature (table 5.3 a, b) although the 
author would have expected the value for Fuji VIII to be higher due to its resin 
reinforcement.  
5.2.2.4 DIAMETRAL COMPRESSIVE FATIGUE 
Although this work has examined many static properties it should not be forgotten 
that in its lifetime a dental restoration will be subjected to many cyclical forces. 
Theses cumulatively can cause a material to fail. It is therefore potentially 
misleading to report static properties alone. 
For this reason the diametral compressive fatigue limit of the materials alone and 
with additives was determined.  
In order to minimise edge effects this property was favoured over compressive 
fatigue and for practical reasons (see section 5.2.2.2 COMPRESSIVE STRENGTHS-
LONGITUDINAL AND DIAMETRAL) the flexural fatigue was not determined. The method 
used to determine this property is widely accepted and seeks to relate the number 
of cycles to failure versus the applied stress (Draughn, 1979). The definition of the 
number of cycles to be survived was set empirically at 1500 cycles so that work 
was achievable in a realistic laboratory time frame. As all materials tested followed 
the same testing regime this permitted ready comparison. Surprisingly a search of 
the literature revealed no diametral fatigue limits against which the present values 
can be compared. Perhaps unsurprisingly the fatigue limit obtained for unmodified 
Fuji VIII was statistically significantly higher than for the conventional glass 
ionomer ChemFil superior (Tables 4-63, 4.64). This can be attributed to the resin 
present in the former material. When the fatigue limits were compared to the 
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mean diametral compressive strength values they are lower as would be expected. 
The biological additions both significantly increased the fatigue strength of 
ChemFil superior.  
 
5.2.2.5 ADHESIVE SHEAR BOND STRENTGH TO BOVINE ENAMEL 
In this work an assessment of the bond of the glass ionomer to tooth substance 
was made. Self adhesion is a unique property of the glass ionomers studied here. It 
is considered important to the proposed application of the modified materials of 
this work for it will provide a marginal seal and thus, if durable prevent the ingress 
of bacteria and of recurrent caries. Its determination is however, controversial in 
respect of testing method and tooth substrate used.  
This study utilised macro testing (one tooth per test) compared to micro testing 
(sections of the same tooth used in multiple tests). This was because we lacked the 
facilities to carry out micro testing. In a critical review of bond strength test 
methods Armstrong et al., (2010) supported the continuation of macro testing. In 
terms of geometry and technique of testing it is acknowledged, as reviewed by Van 
Noort et al., (1989) that the results of such testing are affected by the specimen 
geometry, loading configuration and material stiffness. In the present work the 
first two of these were controlled by standardization of the methods but it is 
acknowledged that the material stiffness could have been affected by the additions. 
Due to the relatively easier collection of bovine teeth as compared to human teeth, 
the former tissue was used for testing. Some have indicated that the bond 
strengths to bovine enamel are in the range of 21% to 44% less than to human 
enamel (Oesterle et al., 1998). 
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An examination of the baseline bond strengths of the materials in unmodified form 
(table 4-57) the values obtained, accepting that they are not directly comparable 
by virtue of experimental set up and tissues used, mirror those reported by others 
(Table 5-4).  
 
5.2.2.6 BIAXIAL FLXURAL STRENGTH  
The materials investigated in this study are brittle. By their nature they contain 
flaws and such inclusions are exacerbated by handling and mixing. The impact of 
these upon the physical property of biaxial flexural strength is a useful test for it is 
said to be more searching for defects than a uni-axial test (Börger et al., 2002). The 
testing geometry used in this study, comprising a circular disc supported upon 
three balls, has been shown to be  
 Insensitive for a specimen whose surface is rough. 
 Insensitive to edge effects that could act as stress concentration 
precipitating early failure (Börger et al., 2002). 
The calculation uses the Poisson’s Ratio. This is defined as the Ratio of lateral 
strain to axial strain in an axial loaded specimen. it has been determined 
previously by Akinmade and Nicholson (1993b) as 0.35 for glass ionomer, the 
value used here, though in a subsequent paper they quote a value of 0.27 
(Akinmade and Nicholson, 1995). This work treats all results the same way and 
so this difference in terms of relative performance is of no relevance. 
The baseline values obtained for biaxial flexural strength in this work are in 
good agreement to those reported by others (McKenzie et al., 2003) 
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5.3 BIOACTIVE ADDITIONS TO GLASS POLYALKENOATE CEMENTS 
Materials used for cell assays were washed in HBSS for 24 hours change pH from 
2.2  to 6.6  at low pH the cells would die (Smith and Ruse, 1986). The washed 
materials were analysed using a number of techniques to analyse cell viability 
including microscope observation and MTT assay. In order to investigate a number 
of materials quickly and easily we used a simple observational technique similar to 
work by (Caughman et al., 1990). These involved observing cells close and away 
from the materials. Cells growing on the materials could not be seen. After initial 
experiments work focused on MMT assay to check the ability of cells to attach and 
grow on the materials. Immunocytochemistry and Western blotting to investigate 
the express of Vimentin. Vimentin is   intermediate protein has a molecular weight 
of 57 kD and is used as primarily a fibroblast marker (Ivaska et al., 2007). It should 
be pointed out in light of the laboratory study of the effects of the materials in 
unmodified state no bioactive addition were made to GC Fuji VIII. This material 
inhibited cell growth. It contains hydroxyl ethyl methacrylate (HEMA) and others 
have observed that it alters the morphology of human gingival fibroblasts and 
interferes with the presence of Type I collagen protein (Falconi et al., 2007). It 
therefore was inappropriate to make additions to this material in order to explore 
the potential of this material to promote cellular adhesion. This study indicates 
that the MM1 cells appear to become more fibroblastic in response to GI will added 
Type I collagen. When applied close to the material Type I collagen and RGD 
produced a better cell viability than Emdogain as addressed by both microscopy 
and MTT assay. 
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5.4 THE PHYSICAL PROPERTIES OF THE GLASS POLYALKENOATE 
CEMENTS FOLLOWING BIOACTIVE ADDITIONS    
With the exception of shear bond strength and 3 points flexural strength all the 
properties tested improved significantly, compared to the baseline values, for the 
samples of ChemFil Superior to which 0.1% collagen Type I was added. As regards 
additions of RGD similar improvements were observed for all properties except 
shear bond strength and hardness.  
In relation to shear bond strength, although no improvements in bond strength 
were observed, the addition did not statistically impair this property.  Perhaps this 
is not surprising as the additions do not have an obvious mechanism for degrading 
or improving this bond. 
Glass ionomer adheres to tooth substance by the formation of chemical linkages 
with the calcium of the tooth substance. They cannot roughen the surface of the 
tooth in order to promote micromechanical attachment as they are not of 
sufficiently low pH. 
It has been observed by others that the pH of a setting conventional glass ionomer 
(ChemFil) changes with time commencing around 2.2 and increasing to 6.2 after 
1440 minutes (Smith and Ruse, 1986). This range of pH value is conducive for the 
collagen Type I addition to form molecular aggregates, fibrils and ultimately fibres 
(Harris et al., 2013). Previously the formation of 70   nm collagen granules upon 
glass ionomers has been observed in SEM and AFM studies (Chang et al., 2009). 
These have the potential to facilitate cellular attachment to the glass ionomer and 
also the fibrils have the potential to bring about fibre reinforcement of the glass 
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ionomer providing they make attachment to the material. Evidence for this is 
provided by the improvement in physical properties, where Type I collagen was 
added, but further work is required to test this hypothesis.  
In relation to the improvements in properties seen when RGD was added to the 
conventional glass ionomer an exact mechanism has not been found in this work. It 
is however possible that the aminoacids (Arginine,glycine, and aspartic acid) in 
some way become involved in the setting reaction. They have the capacity to 
crosslink by ionic bridges to the Calcium and Aluminium of the glass particles and 
to bond with the materials particles and also by dipole dipole interaction and/or 
hydrogen bonding with materials parent acid. Further work would be required to 
determine if this was the case.  
molecular structure indicates this is possible. Others have demonstrated that RGD 
can promote adhesion and osteoblast activates in relation to a pure calcium 
phosphate cement (Wu et al., 2013). It is worth noting that in this application the 
biological scaffold Chitosan improved the calcium phosphates properties by  a fibre 
reinforcing mechanism (Wu et al., 2013). It therefore does not seem as remote a 
possibility as the first though suggests. 
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6 PRINCIPLE FINDING AND FURTHER WORK   
 
The principle findings of this study are; 
 There was no different between Libya and the UK in terms the teeth 
most commonly affected by root caries. 
 Root caries in childhood was not reported by either country but a 
greater proportion of Libyan respondents reported root caries in 
adulthood (26.49% Libya of 2.25% UK). 
 A greater proportion of patients were considered by the respondents to 
be at risk of root surface caries in the UK. 
 In both countries the most common method of detecting root surface 
caries was visual. In Libya however radiographic detection was used 
more commonly than in the UK (34.86% Libya cf 22.03 UK). 
 In both countries root surface caries was most common on the buccal 
surface but in Libya proportionally more reports of root caries affecting 
the interproximal surface were made. 
 Restoration of the caries lesions rather than preventive methods was 
undertaken more in Libya 
 The diet of patients in the UK influenced to a greater extent the 
management of the root caries (UK= 23.86% versus Libya 08.11%)  
 Gingival bleeding was a common problem encountered in both countries 
on restoring root caries lesions  
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 In the UK it was most common to follow up root caries restorations (UK 
66.67% cf. Libya 29.52%) every six months (UK 80%). 
 Proportionately more root caries restoration failed in the first year in 
Libya (15.38% Libya cf. 0% UK). Longer survival times were reported in 
the UK.  
 In both countries giving up smoking was the factor most considered to 
give rise to root surface caries. Surprisingly diet was considered by the 
respondents to be relatively unimportant (UK 4.44%, Libya 0%) 
 
 When applied close to the material collagen and RGD produced a better 
cell viability than Emdogain as addressed by both microscopy and MTT 
assay.    
 The addition of Type I collagen to ChemFil Superior increases the 
expression of Vimentin as determined by Immunocytochemistry and 
western blotting indicating that the cells have become more fibroblastic. 
This increase was not seen to the same level with emdogain.  
 
The Further work;  
 To determine if the successful bioactive additions may improve abrasion 
resistance  
 To determine if the bioactive addition if the bioactive additions maintain 
with time their beneficial effects.  
 to chemically bond the bioactive materials to the ChemFil superior  
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 Use electron scan microscopic techniques to determine the mechanism 
of Type I collagen and RGD interaction with glass ionomer. 
 Transfer the finding to clinical application. 
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Appendix B -Root Surface Caries Questionnaire 
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Root Surface Caries Questionnaire 
 
 
1. How long have you been practising dentistry? 
 
 
 
 
 
2. From your clinical experience please indicate at what age people are most 
susceptible to root surface caries? 
 
o Childhood  
o Adulthood 
o Elderly  
 
 
 
3- In your experience please indicate who are more susceptible to root caries? 
 
o Males 
o Females  
o No difference between males and females  
 
 
 
4- In your experience which age group is most susceptible to root surface caries? 
 
o 20- 30 year 
o 31- 40 year 
o 41- 50 year 
o 51- 60 year 
o > 60 years  
 
 
 
5- Does your practice base have a large proportion of patients prone to root surface 
caries? 
 
o Yes 
o No 
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6- How do you usually detect root surface caries? 
 
o Visually (inspection)  
o Tactile (probing) 
o Dental radiographs (X-ray) 
o Others ( please specify in the box )  
 
 
 
 
 
7- In your experience which surface of a tooth is most commonly infected with root 
caries? 
 
o Labial  (Buccal)  surface  
o Interproximal   surface 
o Palatal (Lingual) surface 
 
 
 
8- In your experience which anterior tooth/teeth is most commonly affected by root 
surface caries? Circle those that apply  
 
3        2       1 1        2       3 
3        2       1 1        2       3 
 
 
 
9- In your experience which posterior tooth/teeth is most commonly affected by root 
surface caries? Circle those that apply 
 
8        7        6        5        4 4        5        6        7        8 
8        7        6        5        4 4        5        6        7        8 
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10- Which method(s) do you usually use to manage root surface caries? 
 
o Monitoring with prevention instruction  
o Dietary advice  
o Topical Fluoride  
o Restoration  
o Ozone 
o Others ( please specify in the box ) 
 
 
 
 
 
11- In deciding which method you use to manage root surface caries tick those factors 
that influence your selection of the management method? 
        
o Patients oral hygiene 
o  Diet  
o Patients age  
o Tooth type  
o Severity of the lesion  
o Other ( please specify in the box ) 
 
 
 
 
 
12- Which restorative material do you most commonly use to restore a tooth with root 
surface caries? 
o Amalgam  
o Glass ionomer  
o Composite 
o Compomer  
o Others (please specify in the box ) 
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13- What other restorative materials do you sometimes use to restore a tooth with root 
surface caries?  
 
o Amalgam  
o Glass ionomer 
o Composite 
o Compomer 
o Others (please specify in the box) 
 
 
 
 
 
14- Is bleeding from the gingival tissues normally a problem in restoring root surface 
caries? 
 
o Never 
o Sometimes  
o Frequently  
 
 
 
15- After you restore a tooth with root caries, what method of finishing do you use for 
the restoration? 
 
o Hand finishing (sharp knives or scalers) at placement visit  
o Rotary finishing at placement visit  
o Hand finishing (sharp knives or scalers) at recall visit  
o Rotary finishing at recall visit  
o Others (please specify in the box ) 
 
 
 
 
 
 
16- After you treat the root caries do you follow up your patients? 
 
o Yes.  if yes specify for how long in the box below 
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o No 
o Sometimes 
 
Follow up duration = 
 
 
 
17- In your experience what is the average lifespan of the restoration you most 
commonly use for the restoration of root caries? 
 
o Less than a year  
o 1 to 5 years 
o More than 5 years  
 
 
 
18- In your experience which lifestyle events are associated with root surface caries 
development? (tick all that apply) 
 
o Bereavement  
o Retirement 
o Giving up smoking 
o Loss of job  
o Others  (please specify in the box ) 
 
 
 
 
 
 
19- From your experience, indicate which of the following factors you feel are important 
in the development of root caries. Please circle one number on each line, where 1 = 
very important, 2 = quite important, 3 = fairly important, 4 = not at all important. 
 
 
 Number of teeth present    1 2 3 4 
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 Degree of crowding     1 2 3 4 
 
 Presence of a partial denture    1 2 3 4 
 
 Cigarette smoking     1 2 3 4 
 
 Total amount of sugars consumed  1 2 3 4 
 
 Frequency of sugar intake    1 2 3 4 
 
 Oral hygiene state     1 2 3 4 
 
 Physical disability    1 2 3 4 
 
 Mental disability/senility   1 2 3 4 
 
 Active periodontal disease    1 2 3 4 
 
 Consumption of alcohol   1 2 3 4 
 
 Consumption of fizzy drinks    1 2 3 4 
 
 Overhanging restoration    1 2 3 4 
 
 Poor crown margins    1 2 3 4 
 
 Gingival recession    1 2 3 4 
 
 Reduce salivary flow     1 2 3 4 
 
 Presence of erosion     1 2 3 4 
 
 Presence of abrasion cavity    1 2 3 4 
 
 Poor general health     1 2 3 4
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Appendix D- The raw data obtained from ranking the images of oral mucosa 
fibroblast cells cultured around ChemFil superior and GC Fuji VIII for 21 days by 
ten observers. 
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Away 
24 hrs 
Control 
 
ChemFil Superior Fuji 
VIII 
 
 Close 
24hrs 
Control 
 
ChemFil Superior Fuji VIII 
 
1 1 1 3 1 1 1 3 
2 1 1 3 2 1 2 3 
3 1 1 3 3 1 1 3 
4 1 3 4 4 2 2 3 
5 1 1 4 5 2 2 4 
6 1 2 3 6 2 2 3 
7 2 2 4 7 3 3 4 
8 2 2 3 8 2 2 3 
9 2 3 4 9 2 2 4 
10 2 2 4 10 2 2 4 
 
Away 
3 days 
Control 
 
ChemFil Superior Fuji 
VIII 
 
 Close 
3 days 
Control 
 
ChemFil Superior Fuji VIII 
 
1 1 1 2 1 1 1 4 
2 1 2 2 2 1 2 3 
3 1 1 2 3 1 1 3 
4 1 1 2 4 1 2 4 
5 1 1 2 5 2 2 4 
6 1 1 2 6 1 2 4 
7 2 1 2 7 3 3 4 
8 2 2 2 8 2 2 3 
9 2 2 3 9 2 2 4 
10 2 2 3 10 2 2 4 
 
Away 
6 days 
Control 
 
ChemFil Superior Fuji 
VIII 
 
 Close 
6 days 
Control 
 
ChemFil Superior Fuji VIII 
 
1 1 1 2 1 1 2 4 
2 1 2 3 2 1 3 4 
3 2 2 2 3 2 1 3 
4 1 1 2 4 2 2 4 
5 1 2 3 5 2 3 4 
6 1 1 2 6 1 2 3 
7 1 2 2 7 1 3 4 
8 1 2 2 8 1 2 3 
9 1 2 3 9 1 2 4 
10 1 1 2 10 1 3 4 
 
 
 
 
 
 
 
Away 
9 days 
Control 
 
ChemFil Superior Fuji 
VIII 
 
 Close 
9 days 
Control 
 
ChemFil Superior Fuji VIII 
 
1 1 1 3 1 1 3 4 
2 1 2 4 2 1 3 4 
3 2 2 3 3 2 2 4 
4 1 1 3 4 1 3 4 
5 1 1 4 5 2 3 4 
6 2 1 3 6 1 2 3 
7 1 3 4 7 1 3 4 
8 1 2 3 8 1 3 4 
9 1 2 4 9 1 3 4 
10 1 1 4 10 1 3 4 
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Away 
12 days 
Control 
 
ChemFil Superior Fuji 
VIII 
 
 Close 
12 days 
Control 
 
ChemFil Superior Fuji VIII 
 
1 1 2 3 1 1 3 4 
2 1 2 4 2 1 3 4 
3 2 2 4 3 2 2 4 
4 1 2 4 4 1 3 4 
5 1 3 4 5 2 4 4 
6 1 2 3 6 1 3 4 
7 1 3 4 7 1 4 4 
8 1 3 3 8 1 3 4 
9 1 3 4 9 1 3 4 
10 1 3 4 10 1 3 4 
 
Away 
15 days 
Control 
 
ChemFil Superior Fuji 
VIII 
 
 Close 
15 days 
Control 
 
ChemFil Superior Fuji VIII 
 
1 1 2 3 1 1 3 4 
2 1 3 4 2 1 3 4 
3 2 2 4 3 2 3 4 
4 1 2 3 4 1 3 4 
5 1 3 4 5 1 4 4 
6 1 2 2 6 1 3 4 
7 1 3 4 7 1 4 4 
8 1 2 3 8 1 3 4 
9 1 3 4 9 1 4 4 
10 1 3 4 10 1 3 4 
 
 
Away 
18 days 
Control 
 
ChemFil Superior Fuji VIII 
 
 Close 
18 days 
Control 
 
ChemFil 
Superior 
Fuji VIII 
 
1 1 2 4 1 1 3 4 
2 1 3 4 2 1 4 4 
3 2 2 4 3 2 3 4 
4 1 2 4 4 1 3 4 
5 1 3 4 5 1 3 5 
6 1 2 3 6 1 3 4 
7 1 3 4 7 1 4 4 
8 1 2 3 8 1 3 4 
9 1 3 4 9 1 4 4 
10 1 3 4 10 1 3 4 
Away 
21 days 
Control 
 
ChemFil Superior Fuji VIII 
 
 Close 
21  days 
Control 
 
ChemFil 
Superior 
Fuji VIII 
 
1 1 3 4 1 1 3 4 
2 1 3 4 2 1 4 4 
3 2 3 4 3 2 3 4 
4 1 3 4 4 1 3 4 
5 1 3 4 5 1 4 4 
6 1 3 4 6 1 3 4 
7 1 3 4 7 1 4 4 
8 1 3 3 8 1 3 4 
9 1 4 4 9 1 4 4 
10 1 3 4 10 1 4 4 
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Appendix E-  The raw data obtained from ranking the images of oral mucosa 
fibroblast close and away from unmodified and bio-modified ChemFil superior 
with different concentration of Type I collagen for 21 days by ten observers. 
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AWAY 
24hr 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I Collagen 
0.1%+ChemFil 
 Close 
24hrs 
ChemFil 
Superior 
Type I 
Collagen 
0.01%+Chem
Fil 
Type I 
Collagen 
0.1%+Che
mFil 
1 1 1 1 1 1 2 1 
2 2 2 2 2 2 3 2 
3 1 1 2 3 2 3 2 
4 3 3 2 4 3 3 3 
5 2 2 2 5 2 2 2 
6 1 1 1 6 2 2 3 
7 3 2 2 7 3 3 3 
8 2 2 2 8 2 2 2 
9 2 2 2 9 2 3 3 
10 2 2 2 10 2 3 3 
 
AWAY 
3 days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I Collagen 
0.1%+ChemFil 
 Close 
3 
days 
ChemFil 
Superior 
Type I 
Collagen 
0.01%+Che
mFil 
Type I 
Collagen 
0.1%+ChemFi
l 
1 1 1 1 1 2 3 1 
2 2 2 2 2 2 3 2 
3 1 1 2 3 2 3 2 
4 3 3 3 4 3 3 2 
5 2 2 3 5 2 3 3 
6 1 1 1 6 2 3 1 
7 3 3 3 7 3 4 3 
8 2 2 2 8 2 3 2 
9 2 2 2 9 2 3 2 
10 2 2 3 10 2 3 2 
 
Away 
6 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I Collagen 
0.1%+ChemFil 
 Close 
6 
days 
ChemFil 
Superior 
Type I 
Collagen 
0.01%+Ch
emFil 
Type I 
Collagen 
0.1%+ChemFi
l 
1 1 1 1 1 2 3 1 
2 1 1 2 2 2 3 2 
3 2 2 2 3 2 3 2 
4 3 2 3 4 3 3 2 
5 1 1 2 5 2 3 2 
6 1 1 2 6 1 2 2 
7 3 1 3 7 2 3 2 
8 1 2 2 8 2 3 2 
9 2 2 2 9 2 3 2 
10 1 1 2 10 2 3 2 
 
   
Away 
9 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
 Close 
9 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
1 1 1 1 1 3 3 1 
2 1 1 1 2 2 3 2 
3 2 2 2 3 3 2 2 
4 1 2 2 4 2 2 1 
5 1 1 2 5 2 3 2 
6 1 2 1 6 2 2 2 
7 2 3 2 7 3 3 2 
8 1 2 2 8 3 3 2 
9 3 4 2 9 3 3 2 
10 1 2 2 10 3 3 2 
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Away 
12 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
 Close 
12 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
1 3 4 3 1 1 4 4 
2 3 4 2 2 2 2 3 
3 2 3 2 3 3 3 3 
4 3 3 2 4 4 3 3 
5 3 4 3 5 5 3 4 
6 2 3 1 6 6 3 1 
7 4 4 2 7 7 4 4 
8 3 3 2 8 8 3 4 
9 3 4 2 9 9 3 4 
10 3 4 3 0 10 3 3 
 
Away 
15 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
 Close 
15 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
1 3 4 1 1 4 4 1 
2 2 4 2 2 3 4 2 
3 3 4 2 3 3 4 2 
4 2 4 1 4 3 3 3 
5 3 4 3 5 3 3 2 
6 1 3 2 6 3 3 2 
7 4 4 2 7 4 4 3 
8 3 4 2 8 3 4 2 
9 3 4 2 9 3 4 2 
10 4 4 3 10 4 4 2 
 
   
Away 
18 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
 Close 
18 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
1 3 4 1 1 4 4 2 
2 3 4 2 2 4 4 3 
3 3 4 2 3 3 4 3 
4 2 4 1 4 3 4 3 
5 3 4 3 5 3 4 3 
6 2 3 1 6 3 4 3 
7 3 4 2 7 4 4 3 
8 3 4 2 8 3 4 2 
9 3 4 3 9 3 4 3 
10 3 4 2 10 4 4 3 
Away 
21 
says 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
 Close 
21 
days 
ChemFil 
Superior 
Type I Collagen 
0.01%+ChemFil 
Type I 
Collagen 
0.1%+ChemFil 
1 3 4 1 1 4 4 2 
2 3 4 2 2 4 4 2 
3 3 4 2 3 3 4 2 
4 3 4 1 4 3 4 2 
5 3 4 2 5 3 4 2 
6 3 4 2 6 2 4 3 
7 4 4 2 7 4 4 3 
8 3 4 2 8 3 4 2 
9 3 4 2 9 4 4 3 
10 3 4 2 10 4 4 2 
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Appendix F- The raw data obtained from ranking the images of oral mucosa 
fibroblast close and away from unmodified and bio-modified ChemFil superior 
with different concentration of RGD for 21 days by ten observers. 
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AWAY 
24hr 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
24hr 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 1 1 1 1 1 2 2 
2 2 2 2 2 2 2 2 
3 1 2 3 3 1 3 3 
4 2 3 3 4 2 3 3 
5 2 2 3 5 2 3 3 
6 1 2 2 6 2 3 2 
7 3 3 3 7 3 4 2 
8 2 2 2 8 2 2 2 
9 3 3 2 9 2 3 2 
10 2 2 2 10 2 3 3 
   
AWAY 3 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
3days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 1 1 1 1 1 1 1 
2 2 2 2 2 2 2 2 
3 1 2 2 3 1 3 2 
4 2 2 2 4 2 2 2 
5 2 2 2 5 2 2 2 
6 1 2 1 6 1 1 1 
7 2 3 2 7 3 3 3 
8 2 2 2 8 2 2 2 
9 2 3 2 9 2 3 2 
10 2 2 2 10 2 2 2 
AWAY 
6 days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
6days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 1 1 1 1 2 2 2 
2 2 2 2 2 2 2 1 
3 2 2 2 3 2 3 2 
4 2 2 2 4 2 2 2 
5 2 3 2 5 2 3 3 
6 1 2 1 6 2 2 2 
7 3 3 2 7 3 3 3 
8 2 2 2 8 2 2 2 
9 2 2 3 9 3 3 3 
10 1 2 2 10 3 3 3 
AWAY 
9 days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
9 days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 1 1 1 1 3 1 2 
2 2 3 2 2 3 3 3 
3 2 2 2 3 2 2 2 
4 2 3 1 4 2 2 2 
5 1 1 2 5 3 2 3 
6 1 2 2 6 2 2 2 
7 3 1 3 7 3 2 2 
8 2 2 2 8 2 2 2 
9 3 2 2 9 3 3 3 
10 1 1 2 10 3 4 2 
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AWAY 
12 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
12 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 2 2 1 1 3 4 1 
2 3 3 1 2 4 4 3 
3 3 2 2 3 2 3 2 
4 3 1 1 4 3 2 2 
5 3 2 3 5 3 3 2 
6 2 2 1 6 3 3 2 
7 4 2 1 7 4 4 3 
8 3 2 1 8 3 3 2 
9 3 3 2 9 3 3 3 
10 3 2 1 10 4 4 2 
AWAY 
15 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
15 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 2 2 1 1 4 3 3 
2 3 3 1 2 4 4 3 
3 3 2 2 3 3 3 2 
4 2 2 1 4 3 2 2 
5 3 2 1 5 4 3 2 
6 2 2 1 6 3 4 1 
7 3 3 2 7 4 3 3 
8 2 2 1 8 3 3 2 
9 3 3 2 9 3 3 3 
10 3 3 1 10 4 4 3 
AWAY 
18 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
18 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 3 3 3 1 3 4 1 
2 4 4 4 2 4 4 2 
3 3 3 2 3 3 4 2 
4 3 3 2 4 3 4 2 
5 3 3 3 5 3 4 2 
6 2 2 2 6 3 4 1 
7 4 3 3 7 3 4 3 
8 3 2 2 8 3 2 2 
9 4 4 3 9 4 4 2 
10 4 4 3 10 4 4 2 
AWAY 
21 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
 close 
21 
days 
ChemFil 
Superior 
RGD 1 mg/ml + 
ChemFil 
RGD 
5mg/ml + 
ChemFil 
1 4 4 3 1 4 4 1 
2 4 4 3 2 4 4 3 
3 3 3 3 3 3 4 2 
4 3 3 2 4 3 4 2 
5 3 3 3 5 4 4 2 
6 2 2 2 6 3 3 1 
7 4 4 3 7 4 4 3 
8 3 2 2 8 3 2 2 
9 3 4 2 9 4 4 3 
10 4 4 3 10 4 4 3 
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Appendix G- The raw data obtained from ranking the images of oral mucosa 
fibroblast close and away from unmodified and bio-modified ChemFil superior 
with different concentration of Emdogain for 21 days by ten observers. 
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AWAY 
24hr 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close 
24hr 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 1 2 1 1 1 1 1 
2 2 2 2 2 2 3 3 
3 1 2 2 3 1 2 2 
4 2 2 2 4 3 3 3 
5 2 3 2 5 3 3 2 
6 1 2 1 6 2 2 2 
7 2 3 2 7 3 3 3 
8 2 2 2 8 2 2 2 
9 2 3 3 9 2 2 2 
10 2 2 2 10 2 2 2 
 
AWAY 
3 days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close 
3 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 1 1 1 1 2 2 2 
2 2 2 2 2 2 2 2 
3 1 2 2 3 2 2 2 
4 2 2 2 4 3 3 3 
5 2 2 2 5 3 3 3 
6 1 1 2 6 3 2 2 
7 2 2 3 7 3 3 3 
8 2 2 2 8 2 2 2 
9 2 3 2 9 2 2 2 
10 2 2 2 10 3 3 3 
 
AWAY 
6 days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close 
6 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 1 1 1 1 2 3 3 
2 2 2 3 2 2 3 3 
3 2 2 2 3 2 3 3 
4 2 2 2 4 3 4 4 
5 1 2 1 5 2 4 3 
6 1 1 1 6 3 3 3 
7 2 2 1 7 3 4 4 
8 2 2 2 8 2 2 3 
9 2 2 2 9 3 3 3 
10 1 2 2 10 3 3 4 
 
AWAY 
9 days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close9 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 1 1 1 1 3 2 2 
2 2 2 2 2 3 3 3 
3 2 2 2 3 2 3 2 
4 2 2 2 4 3 2 1 
5 1 2 1 5 3 3 2 
6 1 2 2 6 3 2 3 
7 2 2 1 7 3 3 3 
8 2 2 2 8 2 2 3 
9 1 2 1 9 3 3 3 
10 1 2 1 10 3 3 4 
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AWAY 
12 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close12 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 3 2 1 1 4 3 3 
2 4 3 2 2 4 3 3 
3 3 2 2 3 3 3 2 
4 3 2 1 4 4 2 2 
5 3 3 1 5 3 3 2 
6 2 2 1 6 4 3 3 
7 4 3 1 7 4 3 3 
8 3 2 1 8 3 2 2 
9 2 2 1 9 4 3 3 
10 3 3 1 10 3 4 3 
AWAY 
15 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close 
15 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 3 2 1 1 4 3 3 
2 3 3 2 2 4 4 3 
3 3 2 2 3 3 3 3 
4 2 2 1 4 4 4 3 
5 3 3 2 5 4 3 4 
6 2 2 1 6 4 3 3 
7 3 2 1 7 4 3 3 
8 3 2 1 8 3 2 3 
9 3 3 1 9 4 3 3 
10 3 3 1 10 4 3 3 
AWAY 
18 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close 
18 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 3 2 2 1 4 4 3 
2 3 3 2 2 4 4 3 
3 3 3 2 3 3 3 3 
4 2 2 1 4 3 3 2 
5 3 2 2 5 4 3 2 
6 3 2 1 6 3 3 2 
7 4 2 1 7 4 4 3 
8 3 2 1 8 3 3 2 
9 3 3 2 9 3 3 3 
10 3 3 2 10 4 3 3 
AWAY 
21 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
 close 
21 
days 
ChemFil 
Superior 
Emdogain 
4mg/ml 
Emdogain 
8mg/ml 
1 3 2 2 1 4 3 3 
2 4 4 2 2 4 4 3 
3 3 2 2 3 4 3 2 
4 3 2 1 4 3 2 3 
5 4 2 1 5 4 2 3 
6 3 2 1 6 4 2 1 
7 4 3 1 7 4 2 3 
8 3 2 1 8 3 2 2 
9 3 3 2 9 3 3 3 
10 4 3 1 10 4 3 2 
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Appendix H- The raw data obtained from ranking the images of oral mucosa 
fibroblast close and away from unmodified and bio-modified ChemFil superior 
with different with Bio-additives for 21 days by ten observers. 
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AWAY 
24hrs 
Collagen 
0.1%+ChemFil 
RGD 5mg/ml 
+ ChemFil 
Emdogain 
8mg/ml 
 close 
24hrs 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml + 
ChemFil 
Emdogain 
8mg/ml 
1 1 1 1 1 2 2 1 
2 2 2 2 2 2 2 3 
3 2 1 1 3 1 2 2 
4 2 3 3 4 3 3 3 
5 2 2 2 5 3 3 3 
6 1 2 1 6 2 2 2 
7 3 3 3 7 3 3 3 
8 2 2 2 8 2 2 2 
9 2 2 2 9 2 2 2 
10 2 2 2 10 3 2 2 
 
AWAY 
3 days 
Collagen 
0.1%+ChemFil 
RGD 5mg/ml 
+ ChemFil 
Emdogain 
8mg/ml 
 close 
3 
days 
Collagen 
0.1%+ChemFil 
RGD 5mg/ml 
+ ChemFil 
Emdogain 
8mg/ml 
1 1 1 1 1 1 2 2 
2 2 2 2 2 2 2 3 
3 2 1 1 3 2 2 2 
4 3 3 3 4 3 3 3 
5 2 2 3 5 2 2 3 
6 1 2 1 6 2 3 2 
7 3 2 2 7 3 3 3 
8 2 2 2 8 2 2 2 
9 2 2 2 9 2 2 3 
10 2 2 2 10 2 2 3 
 
  
 
  
AWAY 
6 days 
Collagen 
0.1%+ChemFil 
RGD 5mg/ml 
+ ChemFil 
Emdogain 
8mg/ml 
 close 
6 days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/m
l + 
ChemFi
l 
Emdogain 
8mg/ml 
1 1 1 1 1 1 2 4 
2 2 2 3 2 3 3 4 
3 2 2 2 3 2 2 3 
4 3 3 2 4 3 3 4 
5 3 2 2 5 2 2 4 
6 2 2 1 6 2 3 3 
7 3 3 2 7 3 3 4 
8 2 2 2 8 2 2 3 
9 1 1 1 9 2 2 3 
10 1 1 1 10 2 2 4 
AWAY 
9 days 
Collagen 
0.1%+ChemFil 
RGD 5mg/ml 
+ ChemFil 
Emdogain 
8mg/ml 
 close 
9 
days 
Collagen 
0.1%+ChemFil 
RGD 5mg/ml 
+ ChemFil 
Emdogain 
8mg/ml 
1 1 1 1 1 1 3 3 
2 2 2 2 2 3 3 3 
3 2 2 2 3 2 2 2 
4 2 2 2 4 2 2 3 
5 2 3 2 5 2 3 2 
6 1 2 1 6 2 3 2 
7 2 3 2 7 3 3 3 
8 2 2 1 8 2 2 2 
9 1 1 1 9 2 3 3 
10 2 1 1 10 2 3 3 
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AWAY12 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml + 
ChemFil 
Emdogain 
8mg/ml 
 close 
12 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml + 
ChemFil 
Emdogain 
8mg/ml 
1 2 1 1 1 2 2 2 
2 2 1 2 2 3 3 3 
3 2 2 2 3 2 2 2 
4 2 2 2 4 2 2 3 
5 2 1 1 5 1 2 2 
6 2 1 1 6 2 2 2 
7 2 3 2 7 2 3 3 
8 2 1 1 8 2 2 2 
9 2 1 1 9 2 2 3 
10 2 1 1 10 2 2 3 
 
 
 
 
 
AWAY15 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
Emdogain 
8mg/ml 
 close 
15 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
Emdogain 
8mg/ml 
1 1 1 1 1 2 2 3 
2 2 1 2 2 3 2 3 
3 2 2 2 3 2 3 2 
4 2 2 2 4 3 2 3 
5 1 1 1 5 2 3 4 
6 1 1 1 6 3 3 3 
7 3 1 1 7 3 3 4 
8 1 1 1 8 2 2 3 
9 2 2 2 9 1 3 3 
10 2 1 1 10 2 2 3 
AWAY18 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
Emdogain 
8mg/ml 
 close 
18 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
Emdogain 
8mg/ml 
1 1 3 1 1 3 2 3 
2 2 3 3 2 3 2 3 
3 2 3 2 3 3 2 2 
4 1 3 1 4 3 2 2 
5 1 2 1 5 2 2 2 
6 1 2 1 6 3 2 3 
7 1 3 1 7 4 3 3 
8 2 2 1 8 2 2 2 
9 2 2 2 9 3 3 3 
10 2 3 2 10 3 2 3 
AWAY21 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
Emdogain 
8mg/ml 
 close 
21 
days 
Collagen 
0.1%+ChemFil 
RGD 
5mg/ml 
+ 
ChemFil 
Emdogain 
8mg/ml 
1 2 3 1 1 2 2 3 
2 1 3 2 2 2 3 3 
3 2 3 2 3 3 3 3 
4 1 3 1 4 2 2 2 
5 2 3 1 5 2 2 2 
6 1 2 1 6 2 2 2 
7 1 4 4 7 3 3 3 
8 2 2 1 8 2 2 2 
9 2 3 2 9 3 3 3 
10 2 3 2 10 3 2 3 
